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Modifications of the building units of chromatin - the histone proteins and DNA - direct the 
functional readout of the genome and are part of the so called “epigenome” (Fischle et al., 
2003b; Kouzarides, 2007). Several studies have shown that specialized proteins recognize 
these chemical modifications and thereby define the functional state of chromatin (Bartke et al., 
2010; Nikolov et al., 2011; Vermeulen et al., 2010). Several individual chromatin-binding factors 
have been analyzed in detail. Also, proteomics approaches have taken inventory of factors 
interacting with single chromatin modifications. However, the full set of factors specific to 
particular modified chromatin domains, such as for example eu-and heterochromatin, is not 
known yet.  
 
In this thesis, I report my findings from a systematic in vitro chromatin affinity purification 
approach in combination with quantitative mass spectrometry (Nikolov et al., 2011) that 
significantly expands the list of proteins regulated by heterochromatic modifications, both alone 
and in combination. The results provide a comprehensive catalogue of proteins specifically 
regulated in their chromatin binding by specific modification patterns. Moreover, the datasets 
highlight novel biological functions associated with individual modifications and reveal 
unpredicted functional relationships of the investigated chromatin modifications. 
 
The analysis of the interactomes of combinatorially modified chromatin identifies for the first time 
proteins whose binding properties to chromatin depend on the cooperative action of two 
modifications. The results provide novel insights into the communication between two chromatin 
modifications, namely positive and negative crosstalk. 
Furthermore, I introduce a new experimental workflow combining chromatin affinity purification 
and cross-linking mass spectrometry. This workflow maps physical protein-protein interactions 
sites of chromatin-bound proteins and provides first insights into the hierarchy of protein 
recruitment to chromatin. 
 
Overall, my findings demonstrate that by using a template that mimics the native form of 
chromatin, which is not accessible by the widely used reductionist approaches, chromatin 
modifications can be analyzed in multiple dimensions. In combination with the new methods 
established here, my work will help to improve our understanding of epigenetic regulation of 
chromatin-associated processes. 
  






Epigenetic is the scientific field, which investigates heritable changes in gene expression that do 
not result from changes of the underlying DNA sequence, in other words an alteration of the 
phenotype by retaining the genotype. The term was first introduced by C. Waddington in the 
1950s (Waddington, 1953) and referred in general to molecular processes affecting gene activity 
resulting in a particular phenotype. Over time, the definition of epigenetics narrowed and was 
defined as “An epigenetic trait is a stably heritable phenotype resulting from changes in a 
chromosome without alterations in the DNA sequence.” in 2009 (Berger et al., 2009). Those 
changes of chromatin can occur at several levels. Currently considered in literature are DNA 
methylation, covalent posttranslational histone modifications, histone variants and non-coding 
RNA associated silencing. All these processes are thought to be involved in the establishment 
and maintenance of certain chromatin states that alter chromatin structure and consequently 




1.1.1 Chromatin organization 
 
The eukaryotic genome is located in the cell nucleus in form of a highly compacted structure 
called chromatin, made of DNA and its associated molecules including proteins and RNA. In the 
cell, chromatin exists at several levels of compaction, each of them regulating the accessibility of 
the DNA template to the transcription machinery and gene expression factors.  
The first level of chromatin compaction consists in the linear arrangement of repeating uniform 
units of DNA and histone octamers. Histone octamers consist of two copies of each of the four 
core histone proteins H2A, H2B, H3 and H4, around which 147 base pairs (bp) of a left-handed 
DNA superhelix are wrapped in a 1.65 turn (Luger et al., 1997). These uniform units represent 
the basic packaging unit of chromatin and are referred to as nucleosome core particles (NCPs) 
(Kornberg, 1974; Olins and Olins, 1974). Histones are 11-15 kDa in size and very basic proteins. 
They belong to the most conserved proteins among eukaryotes. All core histones exhibit a 
common structural feature called the histone fold motif comprising three α-helices that are 
connected by two loops. These motifs mediate the protein-protein interactions between the 
histone pairs H2A-H2B and H3-H4 as well as the interaction between each histone pair and the 
DNA wrapped around the nucleosome. In presence of DNA or high salt concentration a tetramer 
of two copies of H3 and H4 and two H2A-H2B dimers self-assemble to a stable histone octamer 
(Luger et al., 1997). In contrast to the histone fold motif, the N- and C-terminal tails of histones 
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are far less structured. They form flexible and accessible domains protruding out of the 
nucleosome core particle and mediate multiple interactions with the neighboring nucleosomes as 
well as with non-histone proteins. 
 
 
Figure 1.1 Structure of the nucleosome core particle. 
Crystal structure at 1.9-Å (PDB_1KX5 (Davey et al., 2002)) visualized using Xlink Analyzer and Chimera 
(Kosinski et al., 2015; Pettersen et al., 2004). 147 bp of DNA (blue) is surrounding the histone octamer, 
which consists of two copies of each of the histones H2A (salmon), H2B (pink), H3 (turquois) and H4 (light 
blue).  
 
The next level of chromatin organization is stabilized by nucleosome to nucleosome 
arrangements. Nucleosomes are formed by both the nucleosome core particles and a linker 
DNA varying in length from 10 to 70 bp. Under physiological salt conditions and the presence of 
divalent cations an array of nucleosomes folds into a helical fiber of approximately 30 nm 
diameter. However, the detailed structure and the in vivo relevance of the 30 nm fiber is 
controversial and still under discussion (Kruithof et al., 2009; Schalch et al., 2005; Tremethick, 
2007). Chromatin organization on levels beyond the 30 nm fiber is even less understood. Higher 
order compaction forming tertiary chromatin structures presumably involves inter-array 
interactions e.g. looping of chromatin fibers.  
A fifth histone type, histone H1, contributes to stabilize the 30 nm fiber and higher order 
structures of chromatin by interacting with both, the linker DNA and the nucleosome core 
particles in a 1:1 ratio (NCP:H1). Nevertheless, it was shown that nucleosomal arrays fold into 
compact states even in absence of H1 (McBryant and Hansen, 2012; Woodcock et al., 2006).  
Chromatin structure is not only influenced by the presence of H1. Variance in length and 
sequence of nucleosomal repeats, the presence of different histone variants and the pattern of 
posttranslational modifications (PTMs) of histones and DNA influence the structural formation of 
chromatin. 




The structure of chromosomes can be generally distinguished in eu- and heterochromatin. The 
differentiation is ascribed to the heterogeneous staining intensities of chromosome areas 
observed with DNA staining dyes (Heitz, 1928). Heterochromatin represents chromosome 
regions formed by highly condensed chromatin and characterized by an intense DNA staining. 
These heterochromatic regions are thought to be distinctive for silenced gene loci (Dillon and 
Festenstein, 2002; Elgin and Grewal, 2003). Heterochromatin can be further distinguished into 
facultative and constitutive heterochromatin. Facultative heterochromatin mainly includes gene 
loci that are silenced in a time and tissue specific manner whereas constitutive heterochromatin 
is constituted by gene poor regions like repetitive satellite sequences, telomeres and 
centromeres. In contrast, euchromatin has a more relaxed structure. In consequence, staining 
by DNA specific dyes is less intense than the one observed for heterochromatin. The vast 
majority of transcriptionally active genes is present in euchromatin whose loose structure is 
thought to facilitate its accessibility for transcriptional factors. This explains the observations that 
constitutive heterochromatin remains condensed during the complete cell cycle while 
euchromatin undergoes decondensation during interphase.  
The structural organization of chromatin is much more complex than the historical staining 
initially suggested and exists in many structural subtypes, which appeared to play key roles in 
the regulation of essential genomic functions like transcription, replication or DNA repair.  
 
1.1.2 Chromatin modifications 
 
PTMs of histones are one of the key mechanisms regulating chromatin structure and function. 
PTMs that occur on histones are biochemically diverse and include for instant 
serine/threonine/tyrosine phosphorylation, lysine acetylation, lysine and arginine methylation, 
lysine ubiquitination, lysine sumoylation, ADP-ribosylation, arginine citrullination and proline 
isomerization (Rothbart and Strahl, 2014). More than 150 different histone modification sites 
have been identified so far. The vast majority of modification sites are found within the N-
terminal tails of histones although the number and relevance of posttranslational modifications at 
the histone globular domains are of increasing interest (Lawrence et al., 2016). Not only the 
different positions of histone modifications compose the degree of diversity, but also the level of 
the modification state. Methylation can occur in three degrees for lysine (mono-, di- and tri-) and 
arginine (mono-, symmetric and asymmetric di-) residues. 
A model of how histone PTMs function in regulating chromatin structure was postulated with the 
histone code (Jenuwein and Allis, 2001; Strahl and Allis, 2000). This concept is based on 
antagonistic acting enzymes such as kinases/phosphatases, histone acetyltransferases 
(HATs)/histone deacetylases (HDACs) and lysine methyltransferases (KMTs)/lysine 
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demethylases (KDMs) that establish specific histone modification patterns, which are recognized 
and interpreted by non-histone proteins called histone modification readers.  
The large variety of histone modifications provides a high potential for the regulation of 
chromatin organization and function. Histone modifications have been linked to cellular 
processes involved in transcriptional regulation, cell cycle process, DNA replication, DNA repair, 
splicing, epigenetic silencing and others (Izzo and Schneider, 2010; Kouzarides, 2007). 
Chromatin organization can be directly modulated by histone modifications that affect the 
interactions between nucleosomes. For instance, the incorporation of histone H4 lysine 16 
acetylation (H4K16ac) was shown to reduce chromatin compaction and increase transcription 
(Akhtar and Becker, 2000; Shogren-Knaak et al., 2006) whereas H4K20 di- and tri-methylation 
have been shown to enhance chromatin condensation in vitro (Lu et al., 2008). In addition to 
these direct effects, histone modifications can act indirectly on chromatin organization by 
promoting or preventing the recruitment of chromatin binding proteins. Basically all DNA 
processes can be influenced by the regulation of chromatin access of chromatin modifying 
protein complexes or single factors, transcription factors and effector proteins that activate 
downstream signaling (Margueron et al., 2005; Torres and Fujimori, 2015; Wysocka et al., 
2006).  
 
Genomic distribution of histone modifications 
 
The local enrichment of certain histone modification patterns is known to correlate with structural 
regions along the genome. Some histone modifications are highly enriched in heterochromatin 
and depleted from euchromatin while others are specific for euchromatin. Moreover, histone 
modification patterns correlate also with functional genomic elements along these chromatin 
subtypes. This observation allows using them as markers to differentiate certain genomic 
regions.  
 
For example, in euchromatin histone marks like tri-methylation of histone H3 at lysine 4 
(H3K4me3) and H3K27 acetylation are highly enriched at transcriptional start sites (TSS) of 
active genes (Kimura, 2013) while H3K36me3 and H3K4me1 are distributed within the gene 
body (Kimura, 2013). In contrast, heterochromatic inactive gene loci are mainly characterized by 
high levels of H3K9me3 and H3K27me3 as well as the presence of H3K9me2 and H3K27me2 
(Kimura, 2013; Wang et al., 2009). Thus, it appears that inactive genes are depleted from active 
histone marks such as H3K4 methylation while in turn active gene loci appear to be mainly free 
of histone modifications specific for silenced genes. Nevertheless, those general rules can 
deviate depending on cell type and/or developmental stage. For example, in undifferentiated 
stem cells, bivalent chromatin domains were found to be simultaneously marked by both 




H3K4me3 and H3K27me3, characteristic histone marks for eu- and heterochromatin, 
respectively (Bernstein et al., 2006; Vastenhouw and Schier, 2012). Those domains with a dual 
chromatin identity might have a potential function in the fine regulation of gene expression during 
embryonic development by the capacity of switching between a H3K4me3 transcriptionally 
active state and a H3K27me3 silenced gene state.  
 
The development of techniques such as ChIP-on-chip and ChIP-Seq have considerably 
contributed to deepen our understanding of the global chromatin landscape by providing 
genome wide pictures of the histone mark distribution (Barski et al., 2007; Mikkelsen et al., 2007; 
Wang et al., 2008).  
It was observed that histone lysine acetylation is generally found at transcribed regions of active 
genes, which links this modification to active transcription and gene expression in a more 
general way (Cui and Shi, 2016; Ucar et al., 2011; Wang et al., 2008). A set of distinct histone 
modifications is also generally linked to heterochromatin. H3K9me3, H4K20me3 and H3K27me3 
have been characterized as predominant constitutive heterochromatin marks (Bannister and 
Kouzarides, 2011; Mikkelsen et al., 2007). In agreement with previous reports, which associated 
H3K9me3 and H4K20me3 with silencing of centromeres, transposons and tandem repeats, 
genome wide mapping revealed a strong enrichment of these marks at telomeric, satellite and 
long terminal repeats (Mikkelsen et al., 2007). The group of identified repressive marks included 
next to the tri-methylation sites of H3K9, H4K20 and H3K27 H3K27me2 and H3K9me2 while 
most other modifications correlated with transcriptional activation (Barski et al., 2007; Cui and 
Shi, 2016; Wang et al., 2008). Within heterochromatin not only constitutive regions are marked 
by histone modifications. H3K27me3 is the hallmark of facultative heterochromatin that includes 
regulatory chromatin elements like boundary elements and insulators (Bannister and 
Kouzarides, 2011; Van Bortle et al., 2012) but has also been detected at inactive enhancer 
elements. Surprising and in strong contrast to their di- and tri-methylation counterparts, the 
mono-methylated states of H3K9, H3K27 and H4K20 were found to be located mainly at active 
promoter sites and within the gene body, suggesting an association with transcriptional activity. 
Nevertheless, all three mono-methylation states have been already associated in the context of 
transcriptional repression. H3K27me1 was even shown to be significantly present in 
heterochromatin (Jacob et al., 2010).  
Another histone modification assumed to be associated with heterochromatin is the symmetrical 
di-methylation of arginine 3 of histone H4 (H4R3me2). Genome wide analysis showed no 
prediction for either, active or silenced promoters (Barski et al., 2007). However, several studies 
associated H4R3me2 with transcriptional repression (Cui and Shi, 2016; Hou et al., 2008; Litt et 
al., 2009; Xu et al., 2010; Zhao et al., 2009).  
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Table 1.1 Histone modifications. 
The table represents selected N-terminal histone modifications and their associated functions. The 
information of the table is based on (Izzo and Schneider, 2010; Lawrence et al., 2016). 
 
histone modification function 
H2A H2AK4/5ac transcriptional activation 
  H2AK7ac transcriptional activation 
  H2AS1P mitosis; chromatin assembly 
  H2AK119P spermatogenesis 
  H2AK119uq transcriptional repression 
H2B H2BK5ac transcriptional activation 
  H2BK11/12ac transcriptional activation 
  H2BK15/16ac transcriptional activation 
 
H2BS14P apoptosis 
  H2BK120uq spermatogenesis/meiosis 
  H2BK123uq transcriptional activation 
H3 H3K4me2 permissive euchromatin 
  H3K4me3 transcriptional elongation; active euchromatin 
  H3K9me1 transcriptional activation/repression 
  H3K9me2 transcriptional repression 
  H3K9me3 transcriptional repression; imprinting; DNA methylation 
  H3K27me1 transcriptional activation/repression 
  H3K27me2 transcriptional activation/repression 
  H3K27me3 transcriptional silencing; X-inactivation; bivalent genes/gene poising 
  H3K36me3 transcriptional elongation 
  H3R17me transcriptional activation 
  H3K4ac transcriptional activation 
  H3K9ac histone deposition; transcriptional activation 
  H3K14ac transcriptional activation; DNA repair 
  H3K23ac transcriptional activation; DNA repair 
  H3K27ac transcriptional activation 
  H3S10P mitosis; meiosis; transcriptional activation 
  H3t11/S28P mitosis 
H4 H4K20me1 transcriptional activation/silencing 
  H4K20me3 heterochromatin 
 
H4R3me transcriptional activation 
  H4R3me2s transcriptional silencing 
  H4K5ac histone deposition; transcriptional activation; DNA repair 
  H4K8ac transcriptional activation; DNA repair; transcriptional elongation 
  H4K12ac histone deposition; telomeric silencing; transcriptional activation; DNA repair 










In addition to posttranslational histone modifications chromatin can also be chemically modified 
on the DNA. In eukaryotes, DNA is predominantly methylated at carbon-5 of cytosine (5mC) in 
the context of CpG dinucleotides. CpG dinucleotides are found throughout the genome but are 
mainly located within CpG islands, which are characterized as short CpG rich regions that are 
often associated with TSSs of promotors, gene bodies and intergenic regions (Jones, 2012). 
CpG islands are usually unmethylated and associated with the euchromatic histone modification 
H3K4me3 (Guenther et al., 2007; Illingworth and Bird, 2009; Mikkelsen et al., 2007). However, 
most of the genome is CpG-deficient and essentially methylated. 
In case DNA methylation of CpG islands occurs it is generally associated with transcriptional 
repression and connected with a functional role in imprinting, X-chromosome inactivation and 
transposon repression (Breiling and Lyko, 2015). Recent studies, however, suggest that DNA 
methylation can also be associated with promotion of transcription, indicating a far more 
complex functional diversity (Hu et al., 2013; Jin et al., 2012; Wu et al., 2010).  
The establishment of DNA methylation is performed by three DNA methyltransferases 
comprising DNMT1, which has a strong preference for hemimethylated DNA while the two 
others, DNMT3A and DNMT3B, do not show such a preference and are therefore known as the 
de novo methyltransferases (Goll and Bestor, 2005). DNMT3A and DNMT3B establish DNA 
methylation in early development and together with DNMT1 participate in maintaining DNA 
methylation (Li et al., 2015; Liao et al., 2015).  
 
1.1.3 Readout of chemical chromatin modifications 
 
The dynamic control of chemical modifications of DNA and histones include the action of 
antagonistic working enzymes referred to as “writers” and “erasers”. Those enzymes are 
targeted to chromatin by “reader” domains that recognize specifically modified (or unmodified) 
amino acid residues and DNA. “Reader” domains can be found within the protein structure of 
“writers” and “erasers” or as part of an associated factor.  
 
The most abundant binding domains involved in histone modification readout include 
bromodomains, Bromo-adjacent homology (BAH) domains, plant homeodomain (PHD) fingers, 
WD40 repeat domains, the “royal family” modules and 14-3-3 domains.  
 
Bromodomains are acetyl-binding domains that specifically recognize ε-N-acetylated lysine 
residues (Owen et al., 2000). They are present in a variety of chromatin-associated factors, 
including HAT and HMT enzymes, ATP-dependent helicases and also transcription factors (Ferri 
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et al., 2016). Bromodomains often occur in tandem with other domains within the same protein. 
They are most frequently found associated together with PHD fingers, but also with PWWP, SET 
and BAH domains (Sanchez et al., 2014).  
 
BAH domains have been found to act as protein–protein interaction modules, histone lysine 
methylation recognition and nucleosome binding modules. There are present in many proteins 
associated with DNA and histone modifications, such as DNMT1, MTA1 and the origin 
recognition complex 1 (Orc1) (Yang and Xu, 2013). For instance, the BAH domain was shown to 
be important in mediating the preferential binding of OCR1 to H4K20me2 (Kuo et al., 2012). 
BAH domains are essentially found in factors connected to processes involved in DNA 
methylation, replication and transcriptional regulation. Therefore it is also not surprising to find 
them often together with reader modules known to bind histones and DNA, such as Bromo, 
SANT and PHD domains.  
 
PHD domains are structurally conserved modules that act as readers of methylated lysine on 
histone tails as well as non-histone proteins (Musselman and Kutateladze, 2011). In rare cases, 
PHD domains have been shown to interact with methylated arginine and acetylated lysine. For 
instance, the PHD finger of RAG2 preferentially interact with symmetrically methylated H3R2 
whereas the tandem PHD finger of DPF3b was shown to bind to H3K14ac (Ramon-Maiques et 
al., 2007; Zeng et al., 2010). As most of the other reader modules, PHD fingers are flanked by 
additional reader domains, which appear to be important in combinatorial readout of histone 
modifications.  
 
The “royal family” modules are a group of structurally related protein motives, including the 
Tudor, PWWP, chromatin-binding (Chromo) and malignant brain tumor (MBT) domains that 
recognize lysine methylation by aromatic cage pockets (Maurer-Stroh et al., 2003). Besides 
individual exceptions of the PHD and the WD40 domain, Tudor domains are the only arginine 
binding motives known so far (Gayatri and Bedford, 2014). Some of the proteins harboring a 
Tudor domain have been shown to interact with specific histone methylation sites as well. While 
the Tudor domains of PHF1 and PHF19 interact specifically with H3K36me3, the Tudor domains 
of JMJD2A and UHRF1 can target several modification states, alone or in combination with a 
second binding motive, respectively (Lu and Wang, 2013).  
PWWP domains contain a highly conserved Pro-Trp-Trp-Pro motif and were initially identified as 
non-specific DNA-binding domains. However, recently the PWWP domain of Brf1 has been 
demonstrated to specifically associate with H3K36me3 (Vezzoli et al., 2010).  
Chromodomains are very well characterized as they were discovered among the first histone 
binding folds. Although chromodomains are structurally similar, they can be divided into different 




subclasses comprising HP1/CBX chromodomains, chromobarrel, chromo shadow and chromo-
ATPase/helicase-DNA-binding (CHD) domains (Yap and Zhou, 2010). The proteins 
heterochromatin protein 1 (HP1) and Polycomb were the first factors characterized as 
specifically recognizing tri-methylated lysine 9 of H3 and tri-methylated lysine 27 of H3 via their 
chromodomain (Patel, 2016; Yap and Zhou, 2010). CBX chromodomains show a similar 
preference for those two modification marks although they have been additionally functionally 
associated with H3K27me2. Interestingly, the chromo shadow domains do not interact with 
methylated histones but were shown to act as protein-protein interaction modules (Brasher et al., 
2000; Cowieson et al., 2000) while the MSL3 chromobarrel domain was shown to bind to mono-
methylation of H4K20 only in the presence of DNA (Kim et al., 2010).  
Proteins harboring MBT repeats are functionally involved in processes like mitosis, tumor 
suppression and preferentially bind to mono- and di-methylated lysines of histones (Bonasio et 
al., 2010). The MBT modules as well as the other members of the “royal family” can occur and 
act as tandem reader modules (Patel, 2016).  
 
WDR 40 motifs are another family of modules acting in form of tandem repeats, which bind to 
methylated as well as unmethylated histones. One of the best studied representatives is the 
protein WDR5 (Patel, 2016; Yap and Zhou, 2010).  
 
Histone phosphorylation mainly occurs at serine residues that can be recognized by 14-3-3 
domains as well as the tandem breast cancer susceptibility (BRCT) domain. For instance, the 
BRCT domain of the protein Breast cancer associated 1 (BRCA1) has been shown to be 
important for its function in DNA repair (Glover, 2006; Yap and Zhou, 2010). 
 
5mC methylated DNA is also recognized by certain protein-binding motifs. So far, three different 
binding motifs were identified – the meCpG-binding domain (MBD), SET and RING-associated 
(SRA) domains and Kaiso and Zpf57 zinc finger proteins (Patel, 2016). Kaiso can recognize 
symmetrically modified 5mC in the context of tandem CpG dinucleotides via a zinc finger motif 
(Prokhortchouk et al., 2001). In mammals, SRA domains are restricted to the UHRF1 protein 
family comprising UHRF1 and UHRF2 and have been demonstrated to bind hemimethylated 
5mCpG/CpG sites (Bronner et al., 2007; Unoki et al., 2004). MBD domains were shown to 
recognize symmetrically methylated CpG dinucleotides (Nan et al., 1993; Ohki et al., 2001). 
Independent of the DNA methyl binding domain, 5mC-binding proteins have been shown to 
recruit proteins associated with transcriptional repression (Patel, 2016).  
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1.1.4 Multivalent readout and crosstalk of chemical chromatin modifications 
 
The diversity of recognition of chemical chromatin modifications is already enormous when only 
considering the range of binding folds identified and their specificity, which is supported by their 
arrangement within a polypeptide and the flanking amino acid sequences of the PTMs to be 
recognized. The diversity strongly increases considering additional processes of multivalent 
readout. The discovery of the linkage of multiple binding domains, either within a single protein 
or multi protein complexes, strongly supports the assumption of complex readout. In particular, 
the readout of a certain modification can be influenced by adjacent PTMs offering countless 
PTM combinations functioning in a synergistically as well as antagonistically manner.  
 
Several mechanisms of combinatorial readout of chromatin modifications are conceivable. The 
combinatorial readout can either take place on the same histone tail or on different histone tails, 
referred as in cis and in trans, respectively. Readout in trans happens either on a particular 
histone or at the nucleosomal level. The latter can be further distinguished between intra- and 
inter-nucleosomal combinatorial readout. Additionally, multivalence can also occur concomitant 
DNA and histone recognition. Binding modules involved in combinatorial readout can be coupled 
by protein-protein interactions in multiple protein complexes or directly within a single protein. 
Possibilities of protein-binding modes reflecting the introduced mechanisms are illustrated in 
figure 1.2.  
 
To date, the combinatorial readout in cis and in trans by paired protein-binding modules within 
one protein could be demonstrated for several proteins. For instant, combinatorial readout in cis 
via a PHD-Bromo cassette has been shown for TRIM24 and TRIM33, which bind unmodified H3 
in parallel with H3K23ac and H3K9me3 concomitantly with H3K18ac, respectively (Tsai et al., 
2010; Xi et al., 2011). The tandem Tudor-PHD finger cassette of UHRF1 has also been shown to 
bind the N-terminus of H3 in cis (Arita et al., 2012). Combinatorial binding in trans is far less 
studied. One of the best studied examples is the intra-nucleosomal binding of the PHD-Bromo 
cassette of BPTF that associates with H3K4me3 and H4K16ac (Ruthenburg et al., 2011).  
Besides paired protein-binding modules within one protein, crosstalk can be addressed on the 
level of indirect protein recruitment by protein-protein interactions. Chromatin modifying protein 
complexes can contain multiple “readers” providing a wide range of binding motifs in 
combination with “writers” and “erasers”. The local accumulation of such complexes provides the 
advantage of a higher degree of specificity and the ability to establish a complex series of 
modification patterns. The HBO1 complex for instance contains several PHD finger modules that 
act cooperatively to regulate its acetyltransferase activity (Musselman et al., 2012; Torres and 
Fujimori, 2015). In a similar fashion, WD40 repeats, PHD and Tudor domains of the PRC2 




complex regulate its methyltransferase activity. Different posttranslational histone modifications 
have been shown to specifically recruit those protein complexes and additionally provided first 
insights into the multivalent impact of DNA and histone modifications (Bartke et al., 2010; Bluhm 




Figure 1.2 Combinatorial readout of posttranslational histone modifications.  
A) Readout of two histone modifications on the same histone tail by a single protein. B) Combinatorial 
readout in cis. Histone PTMs on the same histone tail are recognized by two different proteins. C) 
Combinatorial readout in trans. The readout of two PTMs at different histone tails can take place either 
within one nucleosome (intra-nucleosomal) as shown in the left panel or on different nucleosomes (inter-
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nucleosomal) as represented in the right panel. D) Combinatorial readout in trans facilitated by a multi 
protein complex. The figure is adapted from (Musselman et al., 2012).  
 
Nevertheless, recent knowledge of PTM recognition mechanisms is mainly based on specific 
binding of single proteins to distinct histone modifications or combinations thereof. The extent of 
the influence various modification patterns have on protein binding to chromatin and the 
functional consequences thereof are still not fully understood. Toward understanding the 
epigenetic language of histone and DNA modifications, the assignment of functional 
consequences and therefore the identification of the complement of proteins regulated by 
individual chromatin modifications and combinations is of immense importance.  
 
1.1.5 Chromatin arrays for systematic analysis of chemical modification readout 
 
The question of how distinct histone modifications influence the protein recruitment to chromatin 
and more globally the chromatin interactome consists in the field of epigenetics since many 
years. To approach this question several strategies have been developed over years. Modified 
histone N-terminal peptides are one of the major tools used in approaches ranging from array- to 
affinity-based protein interaction studies (Kim et al., 2006; Wysocka, 2006). In general, affinity 
purifications strategies enable an unbiased, modification-dependent identification of chromatin-
associated factors and macromolecular protein complexes. The experimental design is based on 
the incubation of unmodified or modified N-terminal histone peptides with nuclear extracts 
followed by the identification of the bound proteins by mass spectrometric analysis (Wysocka, 
2006). Recently, this approach has seen important modification by coupling it with quantitative 
mass spectrometry (Oda et al., 2010; Vermeulen et al., 2010). However, the characterization of 
histone PTMs binding proteins has, so far, essentially relied on the use of in vitro synthesized 
modified histone N-terminal peptides as bait in affinity purification that may not reflect faithfully 
the diversity and complexity of the PTM-regulated histone interactome. One strategy to 
overcome this problem has consisted in using mononucleosomes or even oligonucleosomal 
arrays (Bartke et al., 2010; Nikolov et al., 2011). Nucleosomal arrays are of particular interest as 
they offer a far more physiologically relevant model compared to the peptide-based strategy. For 
example, chromatin arrays allow to (i) control histone PTM and underlying DNA sequences, (ii) 
to investigate the binding of proteins within the nucleosomal context including the identification of 
proteins binding only in presence of more than one nucleosome, (iii) characterize the crosstalk 
between histone modifications by inserting two or more PTMs on one single chromatin array, (iv) 
investigate the crosstalk between PTMs of histones and DNA.  
 
The assembly of homogenous recombinant nucleosomal arrays has been well described in the 
literature (Dyer et al., 2004; Huynh et al., 2005; Luger et al., 1999). A general overview is shown 




in figure 1.3. The system is based on histone octamers that are uniformly position on a defined 
DNA template (Huynh et al., 2005). 
 
 
Figure 1.3 Design of recombinant nucleosomal arrays.  
Recombinant full length histones, either unmodified or modified by native chemical ligation, were 
assembled to histone octamers via dialysis against high salt. Biotinylated 12x200x601 DNA templates and 
histone octamers containing modified histones of choice were mixed and reconstituted to 12mer chromatin 
arrays by dialysis over a salt gradient.  
 
The application of chromatin based affinity purification of an unmodified and a chemically 
modified chromatin array in direct comparison demonstrated that nucleosomal arrays are well 
suited for the identification of specific protein-binding interactomes of chromatin arrays in the 
context of defined chemical modifications, when coupled with relative quantification by mass 
spectrometry (Nikolov et al., 2011). Thus, this method has the potential to elucidate the complex 
protein interactomes of diverse chromatin modification patterns and can provide insights into 
epigenetic regulated biological pathways and histone modification crosstalk. 
 
1.2 Mass spectrometry 
 
1.2.1 Mass spectrometry based protein identification of complex samples  
 
Mass spectrometry is a powerful method especially in terms of global protein identification, 
which has allowed the characterization of organelle proteomes, signaling pathways and 
complete protein complexes. Although mass spectrometry has a long history in science, it is only 
during the last 20 years that it has been developed to the standard method for protein 
identification and quantification of complex samples in proteomics.  
 
The principle of identification and quantification of molecules by mass spectrometry is based on 
the mass-to-charge ratio of the molecules. The molecule of interest is transferred into the gas 
phase and ionized. These ions can be separated according to their mass-to-charge ratio (m/z) 
by ion acceleration in an electric or magnetic field. Ion acceleration is later converted in ion 
current and gives the signal to be detected.  
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A standard proteomics workflow for MS based protein identification is carried out by tandem 
mass spectrometry comprising four main successive steps – (i) protein proteolysis, (ii) m/z 
detection of intact ions, (iii) precursor ion selection and fragmentation, (iv) peptide identification 
followed by protein identification using protein sequence databases (figure 1.4).  
 
The proteomic workflow starts with the proteolysis of the proteins of interest. For the reason that 
peptides possess solubility in a wider range of solvents and their masses can be determined 
with high accuracy, the complex protein sample is proteolytic digested into peptides prior mass 
spectrometric analysis. Consequently, the degree of complexity increases even more. To ensure 
a comprehensive, unambiguous identification, including the detection of low-abundance species, 
a sufficient separation is required. While SDS-PAGE separation can be a first step to reduce the 
degree of complexity at the protein level, the application of liquid chromatography (LC) is 
successfully in use to reduce the complexity at the peptide level. The separation is achieved by 
nanoliter flow rate reversed-phase C18 chromatography coupled to direct elution into an 
electrospray ionization (ESI) mass spectrometer. Additional LC systems are commonly in use as 
well as separation based on capillary electrophoresis and the application of multidimensional 
separation, successfully increasing the number of identified peptides (Di Palma et al., 2012; 
Heemskerk et al., 2016; Yates, 2004).  
 
 
Figure 1.4 Workflow for protein identification by MS.  
Proteins are hydrolyzed to peptides using a specific protease. The mass-to-charge ratios of the peptides 
are determined by mass spectrometry (MS1). Based on the first measurement precursor ions are selected 
and fragmented (MS2). For protein identification the information obtained from the MS1 and MS2 spectra 
are compared to the theoretical masses of a database by a search engine. The figure is adapted from 
(Schmidt, 2010). 
 




The majority of tandem mass spectrometry experiments in proteomics use data-dependent-
acquisition (DDA) for detection of m/z ratios. In a first step, the MS1 spectrum is generated by a 
complete scan over a distinct mass range that records m/z ratios of all ions eluting from the LC 
at a certain time point. The most abundant precursor ions are selected for fragmentation, 
commonly done by low-energy collision induced dissociation (CID). The scans of the fragmented 
ions provide the MS2 (or MS/MS) spectra. The DDA cycle acquires data over the length of the 
LC elution gradient.  
The peptide identification is performed in silico by database search engines. A protein sequence 
database provides the theoretically mass of proteolytically digested peptides. The mass 
information resulting from the matched MS1 and MS2 spectra is used to search for peptide 
candidates in the database with corresponding theoretically masses. A certain mass tolerance 
setting according to the mass accuracy of the mass spectrometer is used and the results are 
reported according to statistical ranking.  
 
1.2.2 Relative quantification by Stable Isotope Labeling by Amino acids in Cell culture (SILAC) 
 
Quantitative mass spectrometry is of major importance in the field of MS based proteomics. Two 
general approaches have been developed over the last years – stable isotope-based and label-
free methods. Label-free methods are based on comparison of identical peptides and proteins 
between multiple measurements and rely on either spectrum count or MS1 intensity based 
approaches (Bantscheff et al., 2012). With vast technical progress, label-free approaches have 
become more popular nowadays but still struggle with certain drawbacks. They require several 
replicates and rely on high reproducibility in terms of sample preparation and separation steps 
prior to mass spectrometric measurements. Stable isotope-based mass spectrometry relies on 
the nearly identical physicochemical properties of heavy stable isotopes and their corresponding 
light isotopes. Relative quantification is achieved by comparing the MS intensities of unlabeled 
peptides to their corresponding heavier isotopic labeled peptides. Consequently, the method 
allows the measurement of different labeled peptides (and proteins) within the same sample, 
thus reducing errors from sample preparation and ion suppression by mass spectrometers in 
different MS runs.  
 
Isotope labels can be incorporated chemically, enzymatically or metabolically (Ong and Mann, 
2005). One of the most popular metabolic labeling approaches is Stable Isotope Labeling by 
Amino acids in cell culture (SILAC) (Ong et al., 2002). The incorporation of heavy isotopes takes 
place during cellular or organismal growth with the consequence of a certain limitation in the 
range of applicable samples. This drawback was reduced with the recent development of super 
SILAC and spike-in SILAC allowing the application of SILAC to tissues and body fluids (Geiger 
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et al., 2010; Geiger et al., 2011). Another disadvantage is the number of samples that can be 
compared using SILAC. While a few years ago the complexity of analysis caused restrictions the 
actual limitations are reasoned in the limited number of parallel labels for heavy labeled amino 
acids. Widely in application are the stable isotope labeled amino acids lysine and arginine, 
containing C13 and N15. Using labeled lysines and arginines up to 5-plex SILAC experiments 
can be performed (Ong et al., 2002). Nevertheless, SILAC has proven to be a method of choice 
as it has been proven to be highly accurate and more robust compared to other stable isotope-
based methods and therefore suitable for affinity purification strategies (Chen et al., 2015).  
 
Quantitative MS-based proteomics as large scale MS-based approaches in general require 
specific algorithms for peptide/protein identification and quantification. MaxQuant is a 
quantitative software packages that enables protein identification and quantification in the 
context of SILAC based approaches but also supports quantification of additional label-based 
and label-free approaches (Cox and Mann, 2008; Cox et al., 2011). The software incorporates 
all steps of data analysis, starting from processing MS spectra to final statistical evaluation. The 
analysis pipeline starts with high intensity-weighted estimation of masses for peptide peaks 
(assignment of 3D peaks based on intensity, m/z and elution time), the determination of reliably 
isotope patterns and the assignment of SILAC peptide pairs. After improvement of mass 
accuracy, peptide and protein identification is done using an integrated database search engine. 
The last steps are directed at protein quantification based on the enrichment ratios of individual 
peptide pairs. The software package Perseus enables statistical evaluation and visualization.  
 
1.2.3 Protein-protein cross-linking mass spectrometry 
 
Cross-linking mass spectrometry (XL-MS) is a powerful approach, which allows investigating 
structural as well as physical interaction sites of proteins. A bifunctional cross-linker is used to 
covalently link proteins in physical close proximity engaged in non-covalent interactions. 
Commonly, cross-linkers used in MS possess two cross-linking reactive groups that are 
connected by a spacer but can have properties like variable spacer length, cleavability, 
composition, solubility, isotope labeling and photo reactivity (Paramelle et al., 2013). Another 
very important property is the specificity of a cross-linker that ranges from low to high specificity 
and can be modulated by altering the cross-linking conditions such as pH and the protein-cross-
linker ratio. One of the most popular cross-linking reagents in use is bis(sulfosuccinimidyl) 
suberate (BS3). BS3 is a chemical cross-linker with a spacer arm length of 11.4 Å and belongs 
to the highly reactive N-hydroxysuccinimide (NHS) ester that target nucleophiles. It is a 
homobifunctional cross-linker that can react with primary amines in the side chains of lysine (K) 




residues and the N-terminus of polypeptides resulting in stable amide bonds (Sinz, 2006; Tran et 
al., 2016).  
After cross-linking, non-cross-linked peptides are still the overrepresented peptide species in a 
given sample (Sinz, 2006). Thus, compared to linear peptides, cross-linked peptide are less 
abundant and therefore less likely to be identified by mass spectrometric measurements. To 
overcome these issues, different enrichment strategies for cross-linking containing species can 
be applied on the protein as well as on the peptide level. Based on the property of a higher 
molecular weight of cross-linked species separation according to size can successfully enrich for 
both, cross-linked proteins and cross-linked peptide pairs. Depending on experimental design 
and sample preparation SDS-PAGE and size exclusion chromatography are applicable methods 
on the protein level. Size exclusion chromatography also has been shown to be applicable on 
the peptide level (Leitner et al., 2012). Alternatively, separation of cross-linked peptides was 
successfully achieved applying strong cation exchange chromatography as they exhibit more 
charges compared to linear peptides (Fritzsche et al., 2012).  
 
Still, one of the major challenges in XL-MS is the identification of cross-linked peptides and 
proteins. Database search engines used for identification of proteins based on linear peptides 
cannot be applied for the analysis of cross-link spectra. The main reason is due to the fact that 
both, MS1 and MS2 spectra do not correspond to one peptide but to all possible combinations of 
cross-linked peptide pairs. The consequence is a dramatic increase of the database used for the 
search associated with increased risk of random assignments and higher false discovery rates. 
To date, two data processing tools, xQuest/xProphet and pLink, have been developed that 
search for cross-links against large databases exceeding a number of 30 to 40 proteins, 
implementing a false discovery rate control (Purcell et al., 2007; Rinner et al., 2008; Walzthoeni 
et al., 2012). Both have been proven to be suitable tools, sensitive enough to study protein-
structure and protein-protein-interactions. The disadvantage of xQuest/xProphet is the necessity 
of labeled cross-linker, thus pLink was the software used for my studies.  
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1.3 Hypothesis and objectives of the presented thesis 
 
Chromatin structure adopts two main configurations: a relaxed state containing most of the 
expressed genes and referred to as euchromatin and a condensed state associated with 
transcriptional silencing called heterochromatin. Both chromatin states exhibit histone 
posttranslational modifications found to be specifically associated with either eu- or hetero- 
chromatin. These chromatin modifications form a complex language whose understanding has 
been subject of constant efforts over the past decade. To date, the vast number of histone 
modification sites that have been identified, their distribution across the genome as well as their 
specific binders have provided considerable information on how chromatin functions can be 
regulated. However, a comprehensive overview of the proteomes associated with defined 
chromatin modifications and their functional outcomes were not achieved so far.  
 
The hypothesis that has set the basis of my thesis work was that the biochemical status of 
chromatin domains is brought about by single chromatin modifications and combinations thereof 
that regulate the recruitment and the exclusion of specific networks of chromatin-associated 
proteins. One important question was whether a set of factors, common to all modifications 
associated with a given chromatin stage, would be responsible of the eu- or heterochromatin 
identities. 
 
To address these questions, my primary objective was to characterize the proteomes associated 
with the majority of the known heterochromatic chromatin modifications and combinations 
thereof, by using a strategy based on chromatin affinity purification coupled to quantitative mass 
spectrometry. One of the first aims was to implement a statistical function that defines a fold 
enrichment cutoff meeting the requirements for the comparison of modification-specific regulated 
factors identified by individual performed experiments. Proteins regulated by specific 
modifications provided the basis for the identification of the biological functions of each of the ten 
heterochromatic modifications and the information regarding their functional relationships. The 
scope of my work has been broadening by introducing the question whether combinations of two 
chromatin modifications have an impact on the biochemical status of chromatin domains 
different from the individual modifications. To investigate this point, the combinations of 
H3K9me3 and H4K20me3 as well as H3K9me3 and CpG methylated DNA were investigated. 
Lastly, a new workflow coupling ChAP with cross-linking mass spectrometry was establish in 
order to map the physical interactions among chromatin-associated proteins with the aim to 
determine the hierarchy of protein recruitment to chromatin. 
 
  




2 Materials and Methods 
 
2.1 Material and reagents 
 
2.1.1 Laboratory equipment 
 
ÄKTA Explorer/Purifier/micro   GE Healthcare, Buckinghamshire (UK) 
Balances       Metler-Toledo, Gießen (DE) 
BBD 6220 CO2 incubator     Heraeus, Hanau (DE) 
Bioreactor 5L with ez-Control    Applikon, Schiedam (NL) 
Centrifuge Cryofuge 6000i     Heraeus, Hanau (DE) 
Centrifuge Sorvall Evolution RC    Thermo Scientific, Braunschweig (DE) 
Centrifuges tabletop 5415R/5810R    Eppendorf, Hamburg (DE) 
ChemiDoc MP System    Bio-Rad, München (DE) 
Electrophoresis power supplies   Bio-Rad, München (DE) 
HP1100 and HP1200 LC systems    Agilent, Santa Clara (USA) 
Laminar flow clean bench     Heraeus, Nahau (DE) 
LTQ-Orbitrap Velos      Thermo Fischer Scientific, Bremen (DE)  
LTQ-XL       Thermo Fischer Scientific, Bremen (DE) 
Mini Trans-Blot system     Bio-Rad, München (DE) 
Mini-PROTEAN Tetra PAGE cell    Bio-Rad, München (DE) 
NanoDrop ND-1000      Peqlab, Erlangen (DE) 
Peristaltic pump      Ismatec, Glattburgg (CH) 
pH meter       Metler-Toledo, Gießen (DE)  
Q-Exactive      Thermo Fischer Scientific, Bremen (DE) 
Sonication bath SONOREX Super    BANDELIN Electronic, Berlin (DE) 
Sorval SA600 rotor      Thermo Scientific, Braunschweig (DE) 
Sorval SS34 rotor      Thermo Scientific, Braunschweig (DE) 
SpeedVac Savant SPD121P    Thermo Scientific, Braunschweig (DE) 
Sub-Cell-GT agarose gel electrophoresis   Bio-Rad, München (DE) 
Thermocycler epgradientS     Eppendorf, Hamburg (DE) 
Thermomixer Comfort     Eppendorf, Hamburg (DE) 
Water bath TW12      Julabo, Selbach (DE) 
XCell Sure Lock Mini NuPAGE cell    Invitrogen, Karlsruhe (DE) 
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2.1.2 Consumables and plastic ware 
 
Amicon Ultra centrifugal filter devices   Millipore, Billerica (USA) 
(MWCO 3 and 10 kDa)  
Phase Lock Heavy Tubes (2-, 15-, 50 ml)   5PRIME, Hamburg (DE) 
Slide-A-Lyzer dialysis units and cassettes  Pierce/Thermo Scientific, Rockford (USA) 
(MWCO 3500, 7000, 10000) 
Spectra/Por dialysis membrane    Spectrum Laboratories, Rancho Domingues  




(2-bromoethyl)-tri-methylammonium bromide Sigma-Aldrich, Steinheim (DE) 
(2-chloroethyl)-dimethylammonium chloride  Merck, Darmstadt (DE) 
(2-chloroethyl)-methylammonium chloride   Karl Industries, Aurora (USA) 
2-mercaptoethanol      Sigma-Aldrich, Steinheim (DE) 
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic VWR, Poole (DE) 
acid (HEPES) 
4-Mercaptophenylacetic acid (MPAA)  Sigma-Aldrich, Steinheim (DE) 
Acetic acid       Merck, Darmstadt (DE) 
Acetonitrile, LiChrosolv     Merck, Darmstadt (DE) 
Acrylamide/Bisacrylamide (37.5:1)   Merck, Darmstadt (DE) 
Agarose       Serva, Heidelberg, (DE) 
Ammonium hydrogen carbonate    Fluka, Buchs (CH) 
Ammonium peroxodisulfate     AppliChem, Darmstadt (DE) 
Bis(sulfosuccinimidyl) suberate (BS3)  Thermo Scientific, Schwerte (DE) 
Boric acid       Merck, Darmstadt (DE) 
Bovine serum albumin (BSA)    Sigma-Aldrich, Steinheim (DE) 
Bromophenol blue      Serva, Heidelberg (DE) 
Cleland’s reagent (DTT, for MS analysis)   Calbiochem, Darmstadt (DE) 
Coomassie Briliant Blue G-250    Fluka, Buchs (CH) 
D/L-Methionine      Sigma-Aldrich (DE) 
Deoxynucleotide-5’-phosphate (dATP, dCTP, Roth, Karlsruhe (DE) 
dGTP, dTTP) 
Dipotassium hydrogen phosphate (K2HPO4) Roth, Karlsruhe (DE) 
Dithioerythrol (DTE)      Roth, Karlsruhe (DE) 
Dithiothreitol (DTT)      Alexis Biochemicals, Farmingdale (USA) 




Ethanol       Merck, Darmstadt (DE) 
Ethidium bromide       Roth, Karlsruhe (DE) 
Ethylendiamine tetraacetate (EDTA)   Roth, Karlsruhe (DE) 
Formic acid (FA)      Fluka, Buchs (CH) 
Glycerol       Merck, Darmstadt (DE) 
Guanidine hydrochloride     Sigma-Aldrich, Steinheim (DE) 
Guanidine hydrochloride (≥ 99.5%)   Roth, Karlsruhe (DE) 
Hydrochloric acid (37% HCl)    Merck, Darmstadt (DE) 
Iodacetamide (IAA)      Sigma-Aldrich, Steinheim (DE) 
LB Broth       MOBIO, Hamburg (DE) 
Magnesium chloride (MgCl2)    Merck, Darmstadt (DE) 
Methanol, LiChrosolv     Merck, Darmstadt (DE) 
N,N,N’,N’-Tetramethylethylendiamid (TEMED)  Sigma-Aldrich, Steinheim (CH) 
Non-fat dry milk powder     Regilait, Saint-Martin-Belle-Roche (FR) 
Ortho-Phosphoric acid     Merck, Darmstadt (DE) 
Phenol:Chlorophorm:Isoamil alcohol (PCI)  Roth, Karlsruhe (DE) 
[25:24:1] 
Phenyl-methylsulfonyl fluoride (PMSF)   Roche, Mannheim (DE) 
Polyethylene glycol 6000 (PEG-6000)  Merck, Darmstadt (DE) 
Ponceau S       Sigma-Aldrich, Steinheim (DE) 
Potassium chloride (KCl)     Merck, Darmstadt (DE) 
Potassium dihydrogen phosphate (KH2PO4)  Roth, Karlsruhe (DE) 
RapiGest      Waters (USA) 
S-(5’-adenosyl)-L-methionine (SAM)  New England Biolabs, Ipswitch (USA) 
Sodium acetate      Roth, Karlsruhe (DE) 
Sodium azide (NaN3)     Alfa Aesar, Massachusetts (USA) 
Sodium chloride (NaCl)     Merck, Darmstadt (DE) 
Sodium dodecyl sulfate (SDS)   VWR, Poole (DE) 
Sodium hydrogen phosphate (Na2HPO4)   Merck, Darmstadt (DE) 
Sodium hydroxide (NaOH)     Merck, Darmstadt (DE) 
Tris(hydroxymethyl)amino ethane (Tris base)  Roth, Karlsruhe (DE) 
Triton X-100       Merck, Darmstadt (DE) 
Tween-20       Sigma-Aldrich, Steinheim (DE) 
Urea        Merck, Darmstadt (DE) 
Water, LiChrosolv      Merck, Darmstadt (DE) 
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2.1.4 Chromatographic and affinity material  
 
C18 reversed phase precolumn (0.15 mm ID x Dr. Maisch, Ammerbuch-Entringen (DE) 
20 mm, Reprosil-Pur120 C18-AQ 5 µm) 
HiLoad Superdex 200 10/300   GE Healthcare, Buckinghamshire (UK) 
HiLoad Superdex 200 16/60    GE Healthcare, Buckinghamshire (UK) 
Superdex 200 Increase 3.2/300   GE Healthcare, Buckinghamshire (UK) 
Superdex Peptide 3.2/300    GE Healthcare, Buckinghamshire (UK) 
HiTrap SP HP 1ml      GE Healthcare, Buckinghamshire (UK) 
PD-10 columns      GE Healthcare, Buckinghamshire (UK) 
Q-Sepharose XK26/20     GE Healthcare, Buckinghamshire (UK) 
Reprosil AQ-3/5μm / 300Å     Dr.Maisch, Ammerbuch (DE) 
SilicaTip emmiters      New Objective, Woburn (USA) 
SP-Sepharose XK26/20     GE Healthcare, Buckinghamshire (UK) 
Streptavidin MagneSphere particles   Promega, Mannheim (DE) 
 
2.1.5 Cell culture media and materials 
 
DMEM High Glucose ([w/o] Lys, [w/o] Arg)   PAA Laboratories, Colbe (DE) 
Fetal bovine serum, dialyzed    PAA Laboratories, Colbe (DE) 
L-Arginine (Arg0)      Sigma-Aldrich, Steinheim (DE) 
L-Arginine, 13C6 (Arg6)     Euriso-top, Saarbrücken (DE) 
L-Lysine (Lys0)      Sigma-Aldrich, Steinheim (DE) 
L-Lysine, 2D4 (Lys4)      Euriso-top, Saarbrücken (DE) 
Penicillin/Streptomycin 100 x    PAA Laboratories, Colbe (DE) 
 
2.1.6 Commercial kits 
 
1 Kb Plus DNA Ladder     Invitrogen, Karlsruhe (DE) 
ECL Pus Western Blotting Detection System  GE Healthcare, Buckinghamshire (UK) 
ECL Western Blotting Detection System   GE Healthcare, Buckinghamshire (UK) 
Hybond ECL nitrocellulose membrane   GE Healthcare, Buckinghamshire (UK) 
Hybond N+ membrane     GE Healthcare, Buckinghamshire (UK) 
Imperial Protein Stain     Pierce/Thermo Scientific, Rockford (USA) 
Mini-PROTEAN 4-12% TGX gels    Bio-Rad, München (DE) 
NucleoBond PC 10000     Machery&Nagel, Düren (DE) 




NucleoBond Xtra Midi Plus     Machery&Nagel, Düren (DE) 
NucleoSpin Plasmid      Machery&Nagel, Düren (DE) 
NucleoSpin Extract II     Machery&Nagel, Düren (DE) 
NuPAGE Antioxidant      Invitrogen, Karlsruhe (DE) 
NuPAGE LDS Sample Buffer (4x)    Invitrogen, Karlsruhe (DE) 
NuPAGE MOPS SDS Running Buffer (20x)  Invitrogen, Karlsruhe (DE) 
NuPAGE Novex 4-12% Bis-Tris gels, 1mm   Invitrogen, Karlsruhe (DE) 
NuPAGE Sample Reducing Agent (10x)   Invitrogen, Karlsruhe (DE) 
SeeBlue Plus2 Protein Standard    Invitrogen, Karlsruhe (DE) 
 
2.1.7 Commonly used buffers and solutions 
 
10x DNA loading dye      30% [v/v] Glycerol 
10 mM EDTA  
0.25% [w/v] Bromophenol blue 
 
10x PBS        1.37 M NaCl 
27 mM KCl 
100 mM Na2HPO4 
20 mM KH2PO4 
 
1x PBS-T        1x PBS 
0.1% [v/v] Tween-20 
 
10x SDS running buffer      250 mM Tris base 
1.92 M Glycine 
1% [w/v] SDS 
 
1 x SDS sample buffer     60 mM Tris-HCl (pH 6.8) 
10% [v/v] Glycerol 
2% [w/v] SDS 
0.1% [w/v] Bromphenol blue 
150 mM 2-Mercaptoethanol 
 
10x TB        890 mM Tris base 
890 mM Boric acid 
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10x TBE        890 mM Tris base 
890 mM Boric acid 
20 mM EDTA NaOH (pH 8.0) 
 
1 x Transfer buffer      25 mM Tris base 
0.192 M Glycine 
0.1% [w/v] SDS 
20% [v/v] Methanol 
 
Chromatin loading buffer      10% [v/v] Glycerol 
1x RB low 
 
Colloidal Coomassie stain  0.08% [w/v] Coomassie Brilliant Blue 
G 250 
20% [v/v] Methanol 
1.6% [v/v] Ortho-Phosphoric acid 
8% [w/v] Ammonium sulfate 
 
Injection buffer      2% [w/v] SDS  
100 mM NaCl  
10 mM HEPES (pH 7.9)  
50 mM Tris-HCl (pH 7.5)  
2 mM MgCl2  
 
MC buffer        10 mM HEPES (pH 7.6)  
10 mM KOAc  
0.5 mM Mg(OAc)2  
5 mM DTT 
 
PD150 (pull-down wash buffer)     20 mM HEPES NaOH (pH 7.9) 
10% [v/v] Glycerol 
150 mM NaCl 









RB High        10 mM Tris-HCl (pH 7.5) 
1 mM EDTA NaOH (pH 8.0) 
2 M NaCl 
1 mM DTT 
 
RB Low        10 mM Tris-HCl (pH 7.5) 
1 mM EDTA NaOH (pH 8.0) 
12.5 mM NaCl 
1 mM DTT 
 
Röder C        25% [v/v] Glycerol 
20 mM HEPES (pH 7.9) 
420 mM NaCl 
1.5 mM MgCl2 
0.2 mM EDTA NaOH (pH 8.0) 
 
Röder D        10% [v/v] Glycerol 
20 mM HEPES (pH 7.9) 
100 mM KCl 
1.5 mM MgCl2 
0.2 mM EDTA NaOH (pH 8.0) 
0.5 mM DTT 
0.5 mM PMSF 
 
SAU200       7 M Urea,  
20 mM Sodium acetate (pH 5.2)  
1 mM EDTA 
200 mM NaCl 
2 mM DTT 
 
SAU600       7 M Urea 
20 mM Sodium acetate (pH 5.2) 
1 mM EDTA 
600 mM NaCl 
2 mM DTT 
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TW buffer       50 mM Tris-HCl (pH 7.5) 
100 mM NaCl 
1 mM EDTA 
1% [v/v] Triton X-100 
2 mM DTT 
 
Unfolding buffer       7 M Guanidinium-HCl 
20 mM Tris-HCl (pH 7.5) 
10 mM DTT 
 
Wash buffer        50 mM Tris-HCl (pH 7.5) 
100 mM NaCl 
1 mM EDTA 
1 mM PMSF 
1 mM Benzamidine 
2 mM DTT 
 
XL-SEC buffer       0.2% [w/v] SDS 
100 mM NaCl 
10 mM HEPES (pH 7.9)  
 
1 M Tris-HCl buffer  1 M Tris base, desired pH adjusted 
with 37% [w/w] HCl 
 
1 M HEPES buffer  1 M HEPES, desired pH adjusted 
with 5 M NaOH or 5 M KOH 
 
2.1.8 Cell lines 
 
HeLa S3 (human cervical cancer, Computer cell culture centre, BE) were provided by the facility 









2.1.9 Chemically competent Escherichia coli strains 
 
DH5α™      Invitrogen, Karlsruhe (DE) 
dam-/dcm-       New England Biolabs, Ipswitch (USA) 




Table 2.1 Plasmids used for chromatin reconstitution and protein expression. 
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2.1.11 Enzymes, Proteins and inhibitors 
 
Antarctic phosphatase     New England Biolabs, Ipswitch (USA) 
Benzonase       Calbiochem, Darmstadt (DE) 
M.SssI CpG methyltransferase    New England Biolabs, Ipswitch (USA) 
Proteinase Inhibitor Cocktail Complete,  Roche, Mannheim (DE) 
EDTA free 
Restriction endonuclease enzymes    New England Biolabs, Ipswitch (USA) 
T4 DNA ligase      New England Biolabs, Ipswitch (USA) 
Taq polymerase      Chromatin Biochemistry (MPIbpc) (DE) 
Trypsin       Roche, Mannheim (DE) 
Trypsin       Promega, Mannheim (DE) 
 
 




Table 2.2 Antibodies and antisera used for western blot analysis. 
 















rabbit, polyclonal William S. Trimble, SickKids Toronto (CA) 
(Surka et al., 2002) 
1 : 250 
α-Sept2 
 
rabbit, polyclonal William S. Trimble, SickKids Toronto (CA) (Xie 
et al., 1999) 





Reinhard Lührmann, MPI for Biophysical 
Chemistry Göttingen (DE) (Sharma et al., 
2014) 
1 : 2000 
α-Bdp1 rabbit, polyclonal Robert White, University of York (UK) (Fairley 
et al., 2003) 
1 : 500 




Antibiotics:      Final concentrations used: 
 
Ampicillin      100 µg/ml  
Kanamycin      50 µg/ml 
Chloramphenicol      34 µg/ml 




Oligonucleotides were purchased from SIGMA (Steinheim, DE) and or were kindly provided by 
Alexandra Stützer (Chromatin Biochemistry Group, Max Planck Institute for Biophysical 
Chemistry, Göttingen, DE). 
 
 Primers for PCR amplification of scavenger DNA for chromatin array reconstitution: 
Forward 5’ GTTATCCGCTCACAATTCCACACAACATAC 3’ 
Reverse 5’ TAATGCAGCTGGCACGACAGGTTTC 3’ 











Table 2.3 Peptides used for native chemical ligation. 
 























































Adobe Creative Suite 4    Adobe Systems, San Hose (USA) 
Cytoscape 3.3.0    Cytoscape Consortium (Shannon et al., 2003) 
DAVID Bioinformatics Resources 6.6 National Institute of Allergy and Infectious Diseases 
(Huang da et al., 2009a, b) 
MaxQuant and Andromeda   Max Planck Institute for Biochemistry (Cox and 
Mann, 2008; Cox et al., 2011) 
Microsoft Office    Microsoft Corporation, Redmont (USA) 
pLink  Broad Institute of Harvard and Massachusetts 
Institute of Technology, Cambridge (USA) (Purcell et 
al., 2007) 
ProMass Deconvolution   Thermo Scientific (USA) 
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Proteome Discover    Thermo Scientific (USA) 
R language for statistical computing  R Foundation for Statistical Computing (R, 2011) 
Xlink Analyzer     (Kosinski et al., 2015; Pettersen et al., 2004) 
 
2.2 Molecular biology methods 
 
2.2.1 Transformation of chemically competent bacteria 
 
A minimum of 10 ng of the respective plasmids were added to chemical competent cells and 
incubated for 30 min on ice. The transformation took place by a heat shock that was introduced 
by incubating the cell/plasmid mixture for 30 s at 42 °C. Following, the sample was incubated for 
2 min on ice and 500 µl LB-medium were added. The cell suspension was shaken at 37 °C for 
60 min before 100 µl were plated on antibiotic (2.1.13) containing LB agar plates. The agar 
plates were incubated overnight at 37 °C.  
 
2.2.2 Analysis of nucleic acids 
 
2.2.2.1 Concentration determination of nucleic acids 
 
The concentration of DNA was determined by measuring the absorbance against a reference at 
260 nm using the nanodrop spectrophotometer NanoDrop ND-1000. The DNA concentrations 
were calculated with the following equation: 1 OD260nm = 50 μg/ml double-stranded DNA 
(Sambrook, 2001). 
 
2.2.2.2 Nucleic acid gel electrophoresis 
 
DNA fragments were separated according to their size on 0.5% to 2% [w/v] agarose gels in a 
TBE (or TB) buffer system (Sambrook, 2001). In general samples containing 300 ng of DNA and 
1 x loading dye were loaded onto an agarose gel. Using a horizontal DNA electrophoresis cell 
(Sub-Cell-GT) 90 V to 120 V were applied for approximately 60 min. As a size reference 5 µl of a 
1 kb Plus DNA Ladder run with all samples in parallel. Subsequently, the DNA was stained with 
0.5 µg/ml ethidium bromide for 20 min and visualized on the ChemiDoc MP imaging system.  
 








DNA was incubated with 0.3 M sodium acetate (pH 5.2) and 3 volumes ice cold ethanol (99% 
[v/v]) overnight at -20 °C (Sambrook, 2001). Afterwards, the mixture was centrifuged at 16000 x 
g for 30 min at 4 C. The pellet was washed with 70% [v/v] ethanol, air dried and dissolved in 




DNA was mixed with 0.3 M sodium acetate (pH 5.2) and 0.7 volumes isopropanol and 
centrifuged immediately at 16000 x g for 30 min at 4 °C. The pellet was washed with 70% [v/v] 




In order to separate large DNA fragments from smaller ones, DNA was sequentially precipitated 
using PEG (Lis and Schleif, 1975). For this, DNA was incubated with 0.5 M NaCl and 4 % [v/v] 
PEG-6000 for 10 min at RT. The mixture was centrifuged at 16000 x g for 15 min at 4 C. The 
supernatant was collected and the PEG-6000 concentration was increased in 1% steps up to 9% 
[v/v] by repeating the centrifugation step of the resulting supernatants. The pellets resulting from 
each fraction were washed with ice cold 70% [v/v] ethanol, air dried at RT and dissolved in 
ddH2O.  
 
2.2.4 Preparation of DNA templates for chromatin array assembly 
 
2.2.4.1 Preparation of biotinylated 12x200-601 DNA template 
 
For amplification of pUC18_12x200-601 (2.1.10) the plasmid was transformed into chemically 
competent dam-/dcm- E. coli cells (2.1.9). 200 ml ampicillin containing LB medium were 
inoculated with a single bacteria colony at 37 °C and 120 rpm overnight. For large scale 
preparation, 2.5 l of LB medium supplemented with ampicillin were inoculated with 5 ml of the 
overnight culture. This culture was grown at 37 °C overnight, shaking at 120 rpm. Cells were 
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harvested by centrifugation for 15 min at 6000 x g at 4 °C. Cell lysis and DNA purification were 
done using the NucleoBond PC 10000 kit according to the manufacturer’s instructions.  
The 12x200-601 sequence was obtained by digestion of purified plasmid DNA using the 
restriction endonuclease enzymes BsrI, EcoRI, HaeII, and DdeI. For the digest, 300 U of each 
enzyme per mg of DNA were used. The reaction took place in 1 x NEBuffer 2.1 (New England 
Biolabs) at 37 °C overnight. After inactivation of the restriction endonuclease enzymes (at 80°C 
for 20 min) the 2.4 kb 12x200-601 DNA template was separated by PEG precipitation (2.2.3.3).  
The 12x200-601 DNA was biotinylated by ligation of a biotinylated ds oligonucleotide to the 5’ 
EcoRI overhang of the DNA. An equimolar mix of the “EcoRI_3’P” and “EcoRI_5’P_3’bio” 
oligonucleotides were annealed by heating them to 95 °C and allowing them to cool down to RT. 
Prior ligation, the 12x200-601 DNA was dephosphorylated using 1 U Antarctic phosphatase per 
2 µg DNA according to the manufacturer’s instructions. The ligation was performed using a 
tenfold molar excess of the (ds) oligonucleotide. The reaction was carried out with 2.5 U T4 DNA 
ligase per 1 µg of DNA for at least three hours at RT. The biotinylated DNA was extracted by 
addition of an equal volume of phenol:chlorophorm:isoamyl alcohol [25:24:1] in phase lock 
heavy tubes followed by isopropanol precipitation (2.2.3.2) of the aqueous phase.  
 
2.2.4.2 Methylation of biotinylated 12x200-601DNA template 
 
CpG sites of the 12x200-601 DNA template were methylated using the M.SssI 
methyltransferase. 500 µg of DNA were incubated with 240 U of M.SssI in 50 mM NaCl, 10 mM 
EDTA, 10 mM Tris-HCl, pH 7.9 and 160 µM SAM at 37 °C. After three hours, 80 µM SAM and 
100 U of M.SssI were added, the reaction was left to proceed overnight at 37 °C. To ensure 
complete methylation another 130 µM of SAM and 80 U of M.SssI were added and the reaction 
was incubated for four more hours. The DNA was extracted with PCI [25:24:1] and precipitated 
using ethanol (2.2.3.1).  
The efficiency of methylation was tested using restriction endonucleases unable to cleave at 
methylated CpG sites, like BsaAI, according to the manufacturer’s instructions.  
 
2.2.4.3 Preparation of scavenger DNA 
 
The scavenger DNA is a 147 bp sequence of the backbone of the pUC18_12x200-601 plasmid 
(2.1.10) that does not contain the 200-601 nucleosome positioning sequence. The DNA was 
amplified by polymerase chain reaction (PCR) according to the following PCR mix and PCR 
cycle program: 
 




PCR mix (100 µl):     PCR cycle program: 
100 mM  Tris-HCl pH 8.8  Temperature   Time 
500 mM  KCl    95 C    2 min 
0.8% [v/v]  NP-40    95 C    30 s 
0.2 mM (each) dNTP mix   68 C    30 s    40x 
0.2 µm (each)  primers   72 C    30 s 
1.5 mM  MgCl2    72 C    1 min 
50 ng   DNA template   10 C    ∞  
20 U/ml  Taq polymerase 
 
The PCR product was extracted with PCI [25:24:1] and subsequently precipitated with 
isopropanol (2.2.3.2).  
 
2.3 Protein biochemistry methods  
 
2.3.1 Detection and analysis of proteins 
 
2.3.1.1 Concentration determination of proteins 
 
The concentration of histone proteins was determined by UV adsorption at 276 nm on a 
NanoDrop ND-1000 using published molar extinction coefficients listed in table 2.4 (Luger et al., 
1999). The protein concentration of nuclear extracts was measured by UV adsorption at 280 nm 
assuming 1 OD280 = 1 mg/ml.  
 
Table 2.4 Values used for the determination of histone concentrations. 
 



















H4 11236 5400 
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2.3.1.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Proteins were separated and visualized by discontinuous polyacrylamide gel electrophoresis in 
presence of SDS based on the method of Laemmli (Laemmli, 1970) according to standard 
protocols (Gallagher, 2006). 15% or 18% Tris-glycine resolving gels in combination with a 4% 
stacking gel were used for the analysis of histone proteins. The gels were cast and run using the 
Mini-PROTEAN electrophoresis system according to instructions provided by the manufacturer. 
Before loading the protein samples onto the gel, they were boiled for 5 min at 95 °C in SDS 
sample buffer. As a reference 5 µl of SeeBlue Plus2 pre-stained protein standard was used. 
Protein samples were run in 1 x SDS running buffer at constant current at 15 mA (250 V 
maximum) per gel until the bromophenol blue front reached the bottom of the gel.  
The separation of complex protein mixtures, including samples for mass spectrometry analysis, 
was performed using NuPAGE Novex 4-12% Bis-Tris gradient gels in combination with the 
NuPAGE Pre-cast system according to the manufacturer instructions. For all runs 1 x MOPS 
buffer, antioxidant, LDS sample buffer and reducing agent were used. 
  
2.3.1.3 Coomassie staining of protein SDS-PAGE gels 
 
Proteins separated on SDS-PAGE gels were either stained overnight with Colloidal Coomassie 
stain solution or for 10 to 20 min with Imperial Protein Stain. Gels were destained with ddH2O for 
at least four hours.  
 
2.3.1.4 Silver staining of protein SDS-PAGE gels 
 
Silver staining was performed according to the protocol of Blum at al. (Blum H., 1987). For silver 
staining of proteins separated on SDS-PAGE gels all incubation steps took place at RT on a 
shaker. Gels were incubated in fixative solution (50% MetOH, 12% HOAc) overnight. Afterwards, 
they were incubated twice in 50% EtOH followed by an incubation in 30% EtOH for 20 min each. 
Gels were sensitized in 0.8 mM sodium thiosulfate for exactly 60 s. Sodium thiosulfate solution 
was removed by three wash steps with ddH2O, 20 sec each time. Subsequently, the gels were 
incubated in silver nitrate solution (2 g/l silver nitrate, 0.026% formaldehyde) for 20 min. Before 
development the gels were washed three times with ddH2O. The water was replaced by 
developer solution (60 g/l Na2CO3, 0.0185% formaldehyde, 16 µM sodium thiosulfate) until 
protein bands on the gel turned brown. The process was terminated by addition of fixative 
solution.  
 




2.3.1.5 Western blot 
 
Immunoblotting of protein samples separated by SDS-PAGE was done using the MiniTrans Blot 
system. Proteins were transferred onto nitrocellulose membranes. For this, the membrane was 
directly laid onto the SDS-PAGE gel and both were sandwiched between three layers of 
Whatman paper equilibrated in 1 x transfer buffer. Proteins were blotted onto the membrane in 1 
x transfer buffer for one hour at 100 V at 4 °C. The membrane was rinsed with 1 x PBS-T and 
subsequently blocked with 5% milk for 30 min at RT. Afterwards, the membrane was incubated 
with a primary antibody overnight at 4 °C. All antibodies were diluted in 5% milk according to 
table 2.2. In order to remove non-bound antibodies, the membrane was washed three times with 
1 x PBS-T for 10 minutes each. The membrane was then incubated with a secondary antibody 
at RT for at least two hours, followed by three wash steps as described above. The detection 
was done using an enhanced chemiluminescence system (ECL) according to the manufacturer’s 
instructions. The imaging was done using the ChemiDoc MP System.  
 
2.3.2 Recombinant proteins 
 
2.3.2.1 Expression and purification of recombinant histone proteins 
 
Purification of Xenopus leavis histones was performed as described before (Luger et al., 1999) 
with certain alterations. 
The respective plasmids (2.1.10) were transformed into BL21-CodonPlus (DE3)-RIL E. coli cells. 
200 ml of ampicillin containing 2xYT medium were inoculated with a single bacteria colony 
overnight at 37 °C and shaking at 120 rpm. The overnight culture was used to inoculate 2xYT 
medium (1:1000) that was incubated at 37 °C and shaking at 120 rpm. When the culture 
reached an OD600 = 0.5 expression was induced with 0.2 mM IPTG and the culture was 
incubated for four more hour. Afterwards, cells were harvested by centrifugation at 6000 x g for 
15 min at 4 °C.  
In order to purify the histone proteins inclusion bodies were isolated. All steps were performed at 
4 °C. The cell pellet resulting from 2 l bacteria culture was resuspended in 100 ml Wash buffer 
and cells were lysed using a Canadian Press. After 4 cycles the suspension was centrifuged for 
20 min at 23000 x g. The pellet was resuspended in 100 ml TW buffer and centrifuged for 20 min 
at 23000 x g. The wash step was repeated twice. In order to remove Triton X-100 the inclusion 
bodies were additionally washed two times with Wash buffer.  
To extract histone proteins from inclusion bodies the pellet was soaked with 1 ml DSMO, minced 
and incubated at RT for 30 min. Next, 30 ml of Unfolding buffer were added. The suspension 
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was stirred for 1 h at RT and then centrifuged at 23000 x g for 20 min. The resulting pellet was 
re-extracted by adding another 10 ml of Unfolding buffer for 30 min. After another centrifugation 
step both supernatants were pooled and dialyzed three times against 2 l of SAU200.  
For purification of the histone proteins a Q-Sepharose XK26/20 and a SP-Sepharose XK26/20 
column were connected in series and equilibrated with SAU200 before the extracted proteins 
were loaded onto the column combination. After the input has passed the Q-Sepharose column 
was disconnected and washing was continued only with the SP-Sepharose column. Histone 
proteins were eluted applying a linear gradient from 0% to 100% of SAU600 over one column 
volume. Histone containing elution fractions were pooled, dialyzed three times against 2 mM 
DTT, lyophilized and stored at – 80 °C. 
 
For H4R23C Δ1-22 additional alterations to the protocol were implemented. The expression of 
the protein was not induced before the bacteria culture reached an OD600 = 1 and induction took 
place for one hour. Protein extraction from inclusion bodies was extended to two hours. H4R23C 
Δ1-22 proteins were eluted from the SP column applying a step gradient that was first set to 
20% of SAU600, until the UV absorption at 276 nm reached again the value that was detected 
when the column was equilibrated, followed by a gradient from 20% to 100% of SAU600 over 
one column volume. The elution of proteins was visible by two peaks monitored at 276 nm. 
Elution fractions of the first peak were kept whereas the elution fractions of the second peak 
were pooled, diluted 1:3 with SAU0 (the same as SAU200 but without NaCl) and reloaded onto 
the newly equilibrated SP column in a second run. H4R23C Δ1-22 was again eluted with 20% 
SAU600. Histone containing elution fractions of the first and the second run were pooled, 
dialyzed three times against 2 mM DTT, lyophilized and stored at – 80 °C. 
 
2.3.2.2 Introduction of posttranslational modifications by native chemical ligation 
 
The introduction of methylation sites at the N-termini of histone H3 and histone H4 was achieved 
by native chemical ligation as described before (Shogren-Knaak and Peterson, 2004) with a few 
alterations. Synthetic N-terminal histone polypeptides containing modified amino acid residues 
were ligated to the truncated histones H3A21C Δ1-20 or H4R23C Δ1-22, respectively. The 
reaction took place using a molar histone:peptide ratio of 1:5 with a final peptide concentration of 
2 mM.  
Briefly, the respective amount of histone proteins were dissolved in ligation buffer (6 M 
guanidinium-HCl, 100 mM KPi pH 7.9, 20 mM TECEP, 50 mM MPAA) and added to the 
lyophilized peptides. The reaction mixture was incubated at RT for at least 40 h and finally 
dialyzed three times against SAU200. The reaction mixture was loaded onto a HiTrap SP HP 
1ml column equilibrated with SAU200. The histone proteins were eluted by applying a linear 




gradient from 0% to 100% of SAU600 over 20 column volumes. Fractions containing full length 
histone proteins were pooled, dialyzed three times against 2 mM DTT, lyophilized and stored at 
– 80 °C. The progress of the reaction was monitored by SDS-PAGE and confirmed by 
electrospray mass spectrometry. 
 
2.3.2.3 Introduction of methyl lysine analogs 
 
The introduction of methyl lysine analogs (MLA) was achieved by performing an alkylation 
reaction as described before (Simon, 2010). All methylation states of H3K27 were produced 
using the histone mutant H3K27C, C110A that was dissolved in Alkylation buffer (4 M guanidine 
hydrochloride, 1 M HEPES pH 7.8, 10 mM DL-methionine). All alkylation reactions were 
performed with 10 mg of H3K27C, C110A in a final volume of 1ml.  
The introduction of the tri-methyl lysine analog was performed at 50 °C in presence of 400 mM 
(2-bromoethyl)-tri-methylammonium bromide and 20 mM DTT in the dark with occasional 
flicking. After 5 h the reaction was quenched with 50 µl 2-mercaptoethanol for 30 min at RT. The 
MLA histones were purified using a PD-10 column according to the manufacturer’s instructions 
using 2 mM 2-mercaptoethanol for equilibration and elution.  
The introduction of the di-methyl lysine analog was performed at RT in the presence of 50 mM 
(2-chloroethyl)-di-methylammonium chloride and 20 mM DTT in the dark with occasional flicking. 
After 2.5 h additional 50 mM of (2-chloroethyl)-di-methylammonium chloride were added to the 
reaction mixture. After a total of 4.5 h the reaction was quenched with 50 µl 2-mercaptoethanol 
for 30 min at RT. The MLA histones were purified using a PD-10 column as described for the tri-
methyl lysine analog.  
The introduction of the mono-methyl lysine analog was performed at RT in the presence of 300 
mM (2-chloroethyl)-methylammonium chloride and 20 mM DTT in the dark with occasional 
flicking. After 5 h the reaction was quenched with 50 µl 2-mercaptoethanol for 30 min at RT. The 
MLA histones were purified as described for the tri-methyl lysine analog. 
 
2.3.3 Preparation of recombinant chromatin 
 
2.3.3.1 Assembly of histone octamers 
 
The assembly of octamers composed of the histone proteins H2A, H2B, H3 and H4 were 
performed according to a generalized protocol (Luger et al., 1999). Each of the lyophilized 
histone proteins were completely dissolved in Unfolding buffer to a concentration of 2 mg/ml. All 
four histone variants were mixed in equimolar ratios and adjusted to a final concentration of 1 
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mg/ml. The protein mixture was dialyzed three times against 2 l RB high at 4 °C. Afterwards, the 
assembled octamers were concentrated to a final volume of 50 µl using Amicon Ultra centrifugal 
filter devices and loaded onto a HiLoad 16/60 Superdex 200 prep grade gel filtration column 
installed on an ÄKTA FPLC system. The octamer-containing fractions were pooled and 50% 
[v/v] glycerol was added for long term storage at -20 °C.  
 
2.3.3.2 Chromatin reconstitution by salt dialysis 
 
The reconstitution of oligonucleosomal chromatin arrays composed of 12 nucleosomes was 
performed according to a previously established protocol by dialysis from high salt to low salt 
(Luger et al., 1999). The concentration of octamers in RB high buffer was determined by UV 
spectroscopy (0.45 OD276 nm = 1 mg/ml octamer = 92.2 μM). The DNA template described at 
2.2.4.1 and histone octamers (2.3.3.1) were mixed in a molar ratio of 1.1(-1.3):1 (octamer:DNA) 
in RB high buffer. Additionally, an equimolar amount of scavenger DNA (2.2.4.3) was added to 
bind excess octamer. The salt gradient from 2 M NaCl to 12.5 mM NaCl was achieved by 
continuously replacing RB high with RB low over 30 h using a peristaltic pump.  
The reconstitution was analyzed by agarose gel electrophoresis on a 0.5% [w/v] gel in 0.2 x TB 
buffer at 4 °C. Furthermore, the saturation level of reconstituted chromatin arrays was analyzed 
by restriction digest using the AvaI restriction enzyme and analytical ultracentrifugation (2.3.4.2).  
 
2.3.4 Molecular characterization of recombinant chromatin  
 
2.3.4.1 AvaI digest  
 
The saturation level of reconstituted chromatin arrays was analyzed by a digest with the 
restriction enzyme AvaI, which cuts within the 200-601 nucleosome positioning sequence of the 
chromatin DNA template (2.2.4.1) only when not occupied by histone octamers.  
1 µg of chromatin arrays (2.3.3.2) and 0.5 µg of the DNA template (2.2.4.1) were incubated with 
20 U of AvaI in a total volume of 30 µl for 3 h at 37 °C according to the manufacturer 









2.3.4.2 Analytical ultracentrifugation 
 
For the analysis of oligonucleosomes by the sedimentation velocity method using a Beckmann 
XL-A centrifuge, 400 μl containing 0.5 OD260 oligonucleosomes were prepared in RB low buffer. 
The buffer sector of the cells was filled with 400 µl RB low buffer, while the sample sector was 
filled with 390 µl of the chromatin containing solution. A speed of 15.000 rpm was used for 
sedimenting the oligonucleosomes within a series of 25-35 scans. Data analysis was performed 
using the software UltraScan II (Demeler). In general, after assignment of meniscus, cell bottom 
and plateau for each of the analyzed cells, spikes and time-invariant noise as well as 
unsatisfactory scans (where a sigmoidal sedimentation curve cannot be assigned) were 
manually removed. Initial sedimentation distribution was calculated for the viscosity of RB low 
and the sample frictional coefficient. The initial result was used to perform van Holde-Weischet 
boundary analysis on each of the sedimentation scans. The resulting boundary analysis was 
used for plotting the distribution of corrected sedimentation coefficients. 
 
2.4 Cell culture and metabolic labeling  
 
2.4.1 Stable isotope labeling by amino acids in cell culture (SILAC) of HeLa S3 cells 
 
HeLa S3 cells were cultivated as described before (Nikolov et al., 2011). The cells were grown in 
custom High Glucose Dulbecco’s Modified Eagle’s Medium (DMEM) lacking arginine and lysine. 
The medium was supplemented with either light arginine (Arg0) and lysine (Lys0) or heavy 
amino acids (Arg6 and Lys4) (2.1.5) to a final concentration equivalent to 50 mg/ml light amino 
acids. In addition, 1/10 volume of dialyzed fetal bovine serum and 1 x Penicillin/Streptomycin 
were added to the medium.  
The culture was started by bringing 108 cells into a spinner flask containing 100 ml medium. 
Cells were grown at 37 °C, 5% CO2 and 95% relative humidity. Over at least six passages the 
culture was expanded to 1.5 l and finally transferred to a 5 l bioreactor where cells were grown 
under standard conditions (2 x 106 cells/ml, continuously addition of synthetic air and dissolved 
oxygen level kept at pO2 = 20 using a feedback monitoring system). 
 
2.4.2 Preparation of nuclear extracts 
 
The preparation of nuclear extracts was done as described before (Dignam et al., 1983). 
Generally, 1010 SILAC labeled HeLa S3 cells were harvested by centrifugation for 5 min at 2000 
rpm. The pellet was washed twice with 1 x PBS and resuspended in 1.25 volumes MC buffer 
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supplemented with 1/500 volumes 0.25 M DTE and EDTA-free protease inhibitor cocktail 
according to the manufacturer’s instructions. The suspension was incubated on ice for 5 min and 
homogenized using a 50 ml Dounce homogenizer, performing 18 strokes. Nuclei were pelleted 
by centrifugation at 18 000 x g for 5 min at 4 °C. The pellet was resuspended in 1.3 volumes 
Röder C buffer supplemented with 1/500 volumes 0.25 M DTE and 1/200 volumes 0.1 M PMSF. 
Nuclei were disrupted using a Dounce homogenizer, performing 20 strokes. The suspension 
was stirred for 40 min at 4 °C and finally centrifuged at 30 000 x g for 30 min at 4 °C. The 
supernatant was frozen in liquid nitrogen and stored at -80 °C.  
Three nuclear extracts were prepared from individual cell cultures for each labeling, heavy and 
light labeled. The three extracts were pooled according to their labeling and dialyzed three times 
against 2 l of Röder D buffer and centrifuged at 9000 x g for 2 min at 4 °C. The supernatant was 
aliquoted, frozen in liquid nitrogen and stored at -80 °C.  
 
2.5 Biochemical binding assays  
 
2.5.1 Chromatin affinity purification 
 
Chromatin affinity purification using differentially SILAC-labeled HeLa S3 nuclear extracts was 
essentially done as described before (Nikolov et al., 2011). All steps were performed at 4 °C. 40 
µg of chromatin arrays of two different modification states were separately immobilized on 160 µl 
paramagnetic streptavidin coated beads in PD150 buffer supplemented with 1 mg/ml BSA 
overnight. Chromatin-bound beads were washed three times with 800 µl PD150 wash buffer. In 
parallel, 1 ml of heavy and light labeled nuclear extract was incubated with 40 µl paramagnetic 
streptavidin coated beads for 1h to remove unspecific binding proteins. 4 mg of nuclear extract 
were separated from beads and incubated with chromatin-bound beads. After four hours of 
incubation, beads were washed three times with PD150 wash buffer and proteins were eluted 
with 1 x NuPAGE LDS Sample buffer supplemented with 2 mM MgCl2 and 10 mM Tris-HCL pH 
7.9. Eluates from pull-downs done with heavy and light nuclear extracts were mixed in a 1:1 
ratio. To ensure complete release of all chromatin-bound proteins and to improve the following 
separation step, the mixed sample was digested with 1250 U benzonase for 45 min at 37 °C. 
After addition of 1 x NuPAGE reducing agent the samples were heated at 70 °C for 10 min 
before loading onto a 4% - 12% SDS-PAGE gel. After separation, the gel was stained with 
Coomassie overnight.  
 
 




2.5.2 Protein-protein cross-linking on beads 
 
150 µg of chromatin arrays (2.3.3.2) were immobilized on 600 µl paramagnetic streptavidin 
coated beads in PD150 buffer overnight. Chromatin-bound beads were washed 3 times with 3 
ml PD150 wash buffer and incubated with 2 ml pre-cleared nuclear extract (2.5.1) at 4 °C. After 
3 h 20 µM BS3 was added to the sample, which was incubated for 4 h in total. Chromatin-bound 
beads were washed once with 3 ml PD150 wash buffer to remove non-specifically bound 
proteins. To chemically cross-link chromatin-bound proteins beads were incubated twice in 2 ml 
PD150 wash buffer supplemented with 200 µM BS3 for 10 min at RT. Cross-linked proteins and 
chromatin were eluted from the beads by adding 55 µl Injection buffer and 1250 U benzonase 
followed by incubation for 45 min at 37 °C. Afterwards the sample was heated to 70 °C, mixed 
several times using a vortex mixer, and finally separated from magnetic beads using a magnetic 
rack.  
50 µl of the sample were injected onto a Superdex 200 column equilibrated with XL-SEC buffer. 
For separation, a flow rate of 55 µl/min was applied and 50 µl fractions were collected. Elution 
fractions were pooled according to the peaks of the elution profile monitored at 215 nm and 
analyzed by silver staining of SDS-PAGE gels and western blot analysis.  
Proteins of the pooled fractions containing cross-linked material were precipitated using acetone 
at -20 °C overnight. Pellets were resuspended in 1% RapiGest before tryptic digestion (2.6.2). 
Subsequently, acetonitrile was added to the digested samples to a final proportion of 10% [v/v]. 
Following, the sample was injected onto a Superdex peptide column that was equilibrated with 
30% acetonitrile and 0.1% formic acid. For separation, a flow rate of 55 µl/min was applied and 
50 µl fractions were collected. Elution fractions were pooled according to the peaks of the elution 
profile monitored at 215 nm and subjected to mass spectrometric analysis (2.6.4). 
 
2.6 Mass spectrometry methods 
 
2.6.1 In-gel proteolysis of proteins and peptide extraction 
 
In-gel digest of proteins and the following extraction of peptides were essentially done as 
described before (Shevchenko et al., 2006; Shevchenko et al., 1996). All steps of the in-gel 
digest were performed at 25 °C under shaking at 1050 rpm. Each SDS-PAGE gel lane was 
sliced into either 11 or 22 equidistant gel pieces regardless of staining. In order to reduce 
proteins embedded in gel, slices were dehydrated with acetonitrile and rehydrated with 100 mM 
dithiothreitol (DTT) in 50 mM ammonium hydrogen carbonate (NH4HCO3) pH 8.0 and incubated 
at 56 °C for 50 min. After dehydrating the gel slices in acetonitrile, reduced cysteine residues 
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were alkylated in 60 mM iodoacetamide, 50 mM NH4HCO3 pH 8.0 for 20 min at 26 °C in the 
dark. Gel pieces were washed afterwards with 50 mM NH4HCO3 pH 8.0, which was replaced by 
acetonitrile to completely dehydrate them. Finally, gel pieces were rehydrated by incubation in 
20 µl digestion buffer (12.5 ng/µl trypsin (Roche), 41.7 mM NH4HCO3 pH 8.0, 4.2 mM CaCl2) for 
40 min on ice. 60 µl digestion buffer without trypsin were added to the gel pieces and incubated 
at 37 °C overnight.  
For the extraction of peptides from gel pieces incubation steps were performed at 37 °C, shaking 
at 1050 rpm for 15 min. 60 µl ddH2O and 160 µl acetonitrile were added to the digested samples. 
Once gel pieces were shrank, the supernatants were collected and 100 µl 5% formic acid were 
added to the dehydrated gel pieces. Subsequently, gel pieces were dehydrated again by adding 
acetonitrile and the supernatants were collected and pooled with those from the first extraction 
step. Supernatants were evaporated to dryness in a centrifugal concentrator. Dried peptides 
were kept at -20 °C or were immediately dissolved in loading buffer (5% [v/v] acetonitrile, 1% 
[v/v] formic acid) and analyzed by LC-MS/MS (2.6.3). 
 
2.6.2 In-solution proteolysis of proteins 
 
For the in-solution digest of proteins all reagents used were dissolved in 25 mM ammonium 
bicarbonate pH 8.5. Proteins precipitated with acetone were dried in a centrifugal concentrator. 
The pellet was dissolved in 5 µl 1% RapiGest (sodium 3-[(2-methyl-2-undecyl-1,3-dioxolan-4-
yl)methoxy]-1-propanesulfonate) (Yu et al., 2003). In order to reduce the proteins 5 µl 50 mM 
DTT were added and the sample was incubated for 1h at 37 °C. Subsequently, 5 µl 100 mM 
iodoacetamide were added and the sample was incubated for 1 h at 37 °C in the dark. The 
concentration of RapiGest was decreased to 0.1% by adding 35 µl trypsin (Promega) solution 
corresponding to an enzyme:protein ratio of approximately 1:20 enzyme-to-substrate ratio (w:w). 
The digest took place at 37 °C overnight. To decompose the RapiGest the sample was 
supplemented with 5 µl 40% TFA and incubated at 37 °C for two more hours. Finally, the sample 
was centrifuged at 16 000 x g for 30 min and the supernatant was transferred to a new tube. 
Tryptic peptides were dried in a centrifugal concentrator, dissolved in loading buffer (5% [v/v] 
acetonitrile, 1% [v/v] formic acid) immediately afterwards and analyzed by LC-MS/MS (2.6.4).  
 
2.6.3 LC-MS/MS analysis of peptides on LTQ-Orbitrap  
 
Tryptic peptides from in-gel digestion (2.6.1) were analyzed by nanoflow chromatography 
coupled to hybrid ion trap-orbitrap mass spectrometry using a vented column setup (Licklider et 
al., 2002). Dried peptides were dissolved in 20 μl loading buffer (5% [v/v] acetonitrile, 1% [v/v] 




formic acid) and 20% of the sample was injected and enriched on a custom-packed reversed-
phase C18 precolumn, followed by separation on a custom-packed reversed-phase C18 column 
(0.075 mm ID x 150 mm, Reprosil-Pur 120 C18-AQ, 3 µm) using a 90 min linear gradient of 5-
35% [v/v] acetonitrile, 0.1% [v/v] formic acid at 300 nl/min. The eluent was analyzed in positive 
ion mode on a LTQ-Orbitrap Velos hybrid quadrupole/orbitrap mass spectrometer equipped with 
a FlexIon nanoSpray source with a stainless steel emitter and operated under Excalibur software 
2.1.0.1140 to perform data-dependent acquisition. Each experimental cycle consisted of one full 
MS scan across the 350-1600 m/z range that was acquired at a resolution setting of 30,000 
FWHM, an automatic gain control target of 10e6 and lock mass correction for m/z 441.120025 
from polysiloxane. Up to the 15 most abundant peptide precursors of charge states 2 to 4 above 
an intensity threshold of 2x10e3 were selected at an isolation width of 2.0 Th, fragmented by 
collision-induced dissociation (CID) using helium as collision gas at a normalized collision 
energy setting of 37.5% and an activation time of 10 ms. The product ion spectra were recorded 
using an AGC target of 2x10e5 and a maximum fill time of 100 ms. Precursor m/z values 
selected for MS/MS were excluded for 30 s after one occurrence. Three technical replicates 
were acquired per sample. 
In-gel digestions resulted in eleven samples per chromatin affinity purification experiment were 
measured on a LTQ-Orbitrap Velos using a 90 min total gradient, in-gel digestions resulted in 22 
samples were analyzed on a LTQ-Orbitrap XL mass spectrometer using a 50 min gradient. 
 
2.6.4 LC-MS/MS analysis of peptides on QExactive 
 
Tryptic in-solution digested peptides (2.6.2) were analyzed by nanoflow chromatography coupled 
to a hybrid quadrupole-orbitrap mass spectrometer using a vented column setup (Licklider et al., 
2002). Samples were injected and enriched on a custom-packed reversed phase-C18 
precolumn, followed by separation on a custom-packed reversed-phase C18 column (0.075 mm 
ID x 150 mm, Reprosil-Pur 120 C18-AQ, 3 µm) using a 70 min total gradient of 5-40% [v/v] 
acetonitrile, 0.1% [v/v] formic acid at 300 nl/min. The eluent was analyzed in positive ion mode 
on a QExactive hybrid quadrupole-orbitrap mass spectrometer equipped with a FlexIon 
nanoSpray source with a stainless steel emitter and operated under Excalibur software 2.2.0.48 
to perform data-dependent acquisition. Each experimental cycle consisted of one full MS scan 
across the 350-1600 m/z range that was acquired at a resolution setting of 70,000 FWHM, an 
automatic gain control target of 10e6 and lock mass correction for m/z 441.120025 from 
polysiloxane. Up to the 15 most abundant peptide precursors of charge states 3 to 7 above an 
intensity threshold of 2x10e4 were selected at an isolation width of 2.0 Th, fragmented by higher 
energy collisional dissociation (HCD) using nitrogen as collision gas at a normalized collision 
energy setting of 25%, and their product ion spectra recorded using an AGC target of 2x10e5 
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and a maximum fill time of 60 ms. Precursor m/z values selected for MS/MS were excluded for 
30 s after one occurrence. 
 
2.6.5 Molecular weight determination of histone proteins 
 
Histone proteins were dissolved in 20% [v/v]  acetonitrile and 0.1% [v/v] formic acid and injected 
to a LTQ XL Linear Ion Trap mass spectrometer. The proteins were analyzed in a scan mode 
ranging from 500-2000 m/z. The spectra were extracted and deconvoluted using the Small 
Protein mode of the ProMass Deconvolution software.  
 
2.7 Raw data processing and data analysis 
 
2.7.1 Mass spectrometric raw data processing with MaxQuant 
 
Protein identification and quantification of raw data files derived from mass spectrometric 
measurements (2.6.3, 2.6.4) were performed using the MaxQuant software, version 1.5.2.8 (Cox 
and Mann, 2008; Cox et al., 2011). Enzyme specificity was set to trypsin/P at a maximum of two 
missed cleavages, methionine oxidation was set as variable and cysteine carbamidomethylation 
was set as fixed modification. All other parameters were set according to the default settings 
with the following exceptions. For experiments done with SILAC-labeled nuclear extracts 13C6-
arginine and 13C4-lysine were set as fixed modifications. Additionally, the minimum length of 
peptides was decreased to 6 and the maximal number of modification per peptide to 4.  
Proteins were identified using the Andromeda algorithm searching against the UniProtKB 
SwissProt Human protein sequence database 2014.01 (134921 protein entries) supplemented 
with the MaxQuant common contaminants database (248 entries).  
 
2.7.2 Mass spectrometric raw data processing with pLink 
 
In order to identify cross-linked peptides, raw files obtained from mass spectrometric 
measurements (2.6.4) were transformed into mgf files using Proteome Discover and analyzed by 
the pLink software version 1.07 (Purcell et al., 2007). Raw files of one experiment were analyzed 
in parallel and results were summarized in one output table. The ini file used for the data search 
was configured in the following way. Carbamidomethyl was set as a fixed modification, oxidation, 
pyro-glutamic acid and N-terminal acetylation were set as variable modifications, the search was 
done in mode 1, noninterexport was set as true and the fdr was set to 0.01. All other settings 




were defined according to the experimental design and/or correspond to the default setting of 
the example ini file downloaded with the software. Raw files used for the pLink search were also 
analyzed by MaxQuant (2.7.1). Identified proteins summarized in the proteinGroups.txt of 
MaxQuant were used as the reverence database for the pLink search. The reverence database 
included only identified proteins with more than 2 “razor and unique peptides”. Additionally, 
contaminants and reverse hits were excluded. The amino acid sequences of identified histone 
proteins were exchanged by those from Xenopus laevis (2.1.10). The most abundant proteins of 
the samples were determined by dividing the number of identified “unique and razor peptides” by 
the molecular weight of the corresponding proteins. The most abundant proteins were arranged 
according to the quotient starting with the highest value.  
In total, three pLink searches using different databases were performed for each experiment. 
The first database included the top 100 of the most abundant proteins, the second database was 
composed of the top 150 most abundant proteins and the third database included all identified 
proteins of each experiment, respectively. For spectra that were annotated in more than one of 
the pLink searches the spectrum with the highest score was chosen for further analysis. Those 
spectra that were annotated in more than one pLink search displaying different outcomes were 
excluded from further analysis.  
Visualization of identified protein-protein cross-links was done using xiNET (Combe et al., 2015).  
Visualization and analysis of cross-linking data in the context of their three-dimensional protein 
structures were done using the Xlink Analyzer software (Kosinski et al., 2015; Pettersen et al., 
2004).  
 
2.7.3 Data filtering and visualization of quantified MS data 
 
The MaxQuant output table proteinGroups.txt was imported to the statistical software package 
PERSEUS (Cox and Mann, 2008), version 1.5.0.26. Normalized heavy-to-light ratios (H/L) and 
intensities were extracted and log2-transformed. Only proteins with a ratio count of at least 3 in 
forward and reverse experiments for a given modification state were considered for 
quantification. After removal of reverse and contaminant entries, the statistical significance of 
individual quantification results was assessed using Perseus’ “significance A” algorithm using a 
two-sided False Discovery Rate estimation to a p value of 0.1 and application of a Benjamini-
Hochberg correction (Cox and Mann, 2008). The processed data were visualized using the 
open-source statistical software package R (version 3.2.3). For data visualization only, missing 
values in one of the experiments were imputed to zero.  
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2.7.4 Protein-protein interaction analysis 
 
Protein-protein interaction analyses were done using the STRING database (Jensen et al., 
2009). Leading UniProt IDs reported in the proteinGroups.txt of MaxQuant (2.7.1) were used to 
identify known and predicted functional and structural interactions (default settings) for the 
design of protein-protein association networks. 
 
2.7.5 Annotation enrichment analysis 
 
Functional annotation enrichment analyses were done using the functional annotation chart of 
the online software package DAVID (Huang da et al., 2009a, b). Results were obtained by using 
default settings of the statistical parameters with the exception of the EASE score (enrichment) 
cutoff, which was set to 0.05. All genome genes of Homo sapiens were used as the background 
database. The background database was provided by DAVID (Huang da et al., 2009a, b). Terms 
were annotated to significant enriched and significant depleted proteins of a certain chromatin 
modification state, respectively. Only enriched annotated terms were included in further 
analyses. The processed data were visualized using the open-source statistical software 










Nucleosomal arrays have been successfully used to characterize the diversity and complexity of 
PTM-regulated protein interactomes associating with chromatin (Nikolov et al., 2011). 
Nevertheless, comprehensive information regarding the impacted of heterochromatic chromatin 
modifications on proteins binding specifically to chromatin is still lacking. The current information 
content rarely allows drawing conclusions about the extent of functional outcomes associated 
with certain histone modification patterns. 
In this study, chromatin affinity purification (ChAP) coupled to quantitative mass spectrometry 
was optimized predominately in terms of statistical evaluation, to investigate the interactomes 
brought about by ten different chromatin modifications. Furthermore, the method was extended 
to not only identify the interactomes in the context of singly-modified chromatin arrays but also 
the combination of two posttranslational histone modifications. Thus, the extended workflow 
enabled the investigation of the impact of histone PTMs on protein binding to chromatin and 
histone modification crosstalk on a global level. Additionally, a workflow combining ChAP, 
chemical cross-linking and mass spectrometry is introduced. The new combination of 
experimental steps enabled the identification of site-specific protein-protein interactions. 
Moreover the assignment of a network on the basis of these physical protein interactions 
provided information about the hierarchy of protein binding to chromatin. 
 
3.1 12mer nucleosomal arrays are of reproducible quality independent of 
incorporated modifications 
 
In order to expand the extent of modification-specific protein-binding interactomes investigated 
so far, homogenous, recombinant nucleosomal 12mer arrays carrying different chemical 
modifications, alone and in combination, were generated. These chromatin arrays were used as 
templates for affinity purification studies investigating protein-chromatin interactomics in the 
context of single modification and combinations thereof.  
 
3.1.1 Native chemical ligation and alkylation of cysteine residues successfully introduce PTMs 
to recombinant Xenopus laevis histones 
 
Two different approaches were used to introduce site-specific posttranslational modifications to 
recombinant Xenopus laevis histones. Modifications within the first 20 amino acids of the N-
terminus of histone H3 and the first 22 amino acids of the N-terminus of histone H4 were 
introduced by native chemical ligation (NCL) (Shogren-Knaak and Peterson, 2004). The histone 
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methylation sites H3K9me1/-me2/-me3, H4K20me1/-me3 and H4R3me2 were successfully 
created by NCL. The products of the reactions were visualized by SDS-PAGE and mass 
spectrometry. This is exemplarily shown for the NCL of H4K20me3 in figure 3.1 A and B. 
As a second approach to introduce PTMs, methyl lysine analogs (MLAs) were used. Here, lysine 
27 of histone H3 was modified to H3KC27me1/-me2/ and -me3. The method is based on the 
alkylation of an artificially introduced cysteine residue. The cysteine undergoes alkylation with an 
electrophilic ethylamine resulting in aminoethylcysteine, which is an analog of lysine (Simon et 
al., 2007). The completeness of the MLA reaction was verified by mass spectrometry using ESI-
MS, exemplarily shown for H3KC27me3 in figure 3.1 C.  
 
 
Figure 3.1 Introduction of posttranslational histone modifications.  
A) SDS-PAGE analysis of the recombinant histone H4, H4R23C Δ1-22, the thioester peptide composed of 
the N-terminal amino acids 1-22 of H4 and the ligated product H4K20me3. B) ESI-LTQ mass 
spectrometric analysis of H4R23C Δ1-22 (upper part of the panel) and the ligation product H4K20me3 




(lower part of the panel). C) ESI-LTQ mass spectrometric analysis of the non-alkylated H3K27C C110A 
(left part of the panel) and H3KC27me3 (right part of the panel). 
 
3.1.2 Octamer-DNA molar ratios from 1.1 to 1.3 assemble fully saturated, reproducible 
nucleosomal arrays  
 
The assembly of nucleosomal arrays is based on histone octamers that uniformly position on a 
DNA template. The optimal octamer-DNA molar ratio was determined for each chromatin 
species separately. An octamer-DNA molar ratio from 1.1 up to 1.3 was found to be sufficient to 
obtain a saturation of more than 90% of the DNA template with histone octamers. The success 
of the reconstitution was visualized by native agarose gel electrophoresis (Figure 3.2 A). The 
exact rate of saturation of the nucleosomal arrays was determined by a restriction enzyme digest 
using AvaI (Figure 3.2 B). AvaI cuts the DNA template of chromatin arrays within the 601 
sequence only once per 200 bp repeat. Depending on octamer occupancy AvaI digestion results 
in mononucleosomes and free DNA. 
We additionally tested the reproducibility of the chromatin reconstitution method using analytical 
ultracentrifugation. The distribution of sedimentation coefficients (S) of nucleosomal arrays, 
either fully or subsaturated (saturation level of 75%) were determined by sedimentation velocity 
and van Holde-Weischet analysis. As shown in figure 3.2 C, different fully saturated chromatin 
arrays displayed a similar sedimentation distribution, mainly in the range between 40 and 50 S. 
The similar sedimentation coefficient distribution of both replicates demonstrated that the 
reconstitution method generates highly reproducible chromatin arrays. In comparison, the 
subsaturated chromatin species showed a distribution of sedimentation coefficients in a lower 
range, between 30 and 40 S, indicating lower compaction of the chromatin species. The results 
verified that the saturation level of oligonucleosomal arrays can be reproducibly adjusted over 
the octamer-DNA molar ratio, generating arrays of comparable quality.  
 
3.2 The statistical tool “significance A” determines significant protein fold 
enrichment cutoffs  
 
To investigate the extent of changes in protein composition and binding to chromatin, affected by 
distinct chromatin modification patterns, chromatin-based affinity purification in combination with 
relative quantification by mass spectrometry was established in our lab (Figure 3.3) (Nikolov et 
al., 2011).  
ChAP coupled to quantitative MS is based on the relative quantification of proteins binding to 
unmodified and modified chromatin arrays. This is possible by using SILAC-labeled HeLa 
nuclear extracts. For each modification state two biological replicates were performed in parallel 
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as a label swap experiment. In the “forward” experiment unmodified chromatin arrays were 
incubated with light nuclear extract and modified chromatin arrays with heavy isotope-labeled 
nuclear extract. For the “reverse” experiment modified and unmodified chromatin arrays were 




Figure 3.2 Quality controls of assembled chromatin arrays.  
A) Native agarose gel electrophoresis of reconstituted chromatin arrays and free DNA. The samples were 
separated by gel electrophoresis on a 0.5% agarose gel using 0.2x TB buffer. The gel was stained with 
ethidium bromide. M defines the DNA size marker. B) AvaI digestion of reconstituted chromatin arrays and 
free DNA. Digested samples were separated by agarose gel electrophoresis on a 2% agarose gel using 
TBE buffer. The gel was stained with ethidium bromide. C) Analytical ultracentrifugation of fully saturated 
and 75% saturated chromatin arrays. The distribution of sedimentation coefficients was obtained using 
sedimentation velocity and van Holde-Weischet analysis (analyzed by Dr. Ron Finn, Max Planck Institute 
for Biophysical Chemistry, Göttingen, Germany).  
 
 




The method enables the identification of all proteins binding to chromatin and that are 
specifically regulated by the underlying chromatin modification. Throughout this study, I will refer 
to this pool of proteins as the “chromatin-binding interactome”. By investigating different 
modification patterns several interactomes were generated by performing experiments with 
individual chromatin modifications. Hereby, a statistical evaluation strategy ensuring a valid 
interpretation of the results not only for individual experiments but also for comparison of 
different interactomes is of immense importance.  
 
In previous studies, a fixed fold enrichment cutoff was defined and applied to all individual 
experiments, not meeting the requirements of a significant determination of a fold enrichment 
cutoff for each individual experiment. To verify significant protein enrichment, I optimized the 
strategy of statistical evaluation to faithfully investigate and interpret the interactomes brought 
about by twelve different chromatin modification patterns.  
 
 
Figure 3.3 Workflow of SILAC-based chromatin affinity purification coupled with mass 
spectrometry.  
Unmodified and modified chromatin arrays are incubated with light and heavy SILAC-labeled nuclear 
extracts from HeLa cells, respectively. Chromatin arrays and their associated proteins of both pull-downs 
are eluted, mixed in a 1:1 ratio, treated with benzonase and finally separated by SDS-PAGE. Proteins are 
in-gel digested using trypsin. The resulting peptides are analyzed by LC-MS/MS. Identification and 
quantification is achieved using the MaxQuant software.  
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To determine the impact of histone PTMs on the chromatin-binding interactome, the proteins 
associated with modified and unmodified chromatin arrays were compared and their relative 
enrichment level was determined. Quantification using SILAC-labeled nuclear extracts assumes 
that unspecific binders, i.e. proteins binding to both templates to the same extent, feature a 
heavy/light ratio (H/L ratio) value of 1. However, due to small variations inherent to all biological 
preparations this value might vary from one experiment to another. Considering all performed 
experiments this theoretical heavy/light ratio of 1 (log2 1 = 0) for unspecific binders in fact ranged 
from -3.2 log2 up to 2.3 log2 (visualized in chapter 3.3 for each individual experiment) as 
calculated by applying a statistical significance test as described in the following. 
The definition of a fixed fold enrichment cutoff is not sufficient to faithfully reflect which proteins 
are significantly enriched or depleted when two different data sets are compared. To overcome 
this problem, the statistical significance of individual quantification results was defined using the 
Perseus’ “significance A” algorithm (Cox and Mann, 2008). This algorithm determines the values 
that are significant outliers relative to a certain population. The “significance A” algorithm was 
used by applying a two-sided False Discovery Rate estimation to a p-value of 0.1 and a 
Benjamini-Hochberg correction.  
To determine significant enrichment values, SILAC ratios of the forward and the reverse 
experiment were averaged. This resulted in a narrowed distribution range of H/L ratios of the 
protein population bound to chromatin. This can be visualized when comparing the distribution of 
H/L ratios of proteins resulting from the individual experiments with the distribution of the 
averaged forward and reverse experiments (Figure 3.4 A-C). Consequently, an increased 
number of significant outliers was calculated compared to calculations using non-averaged 
SILAC ratios, as significant values are determined as outliers relative to the spread of the input 
population (Figure 3.4 A-C).  
 
In order to visualize the results, SILAC ratios of forward and reverse experiments were scatter 
plotted on the x- and y- axis, respectively (Figure 3.4 D). The advantage of this presentation 
style is the complexity of information that can be visualized. 
First, the protein-binding affinity to modified chromatin arrays is demonstrated. Therefore, H/L 
ratios of the reverse experiment were inversed due to the label-swap approach. Data were log2 
scaled, where positive values of the H/L ratio represent an increased protein-binding affinity, 
whereas negative H/L ratios represent a lower binding affinity to modified chromatin arrays 
compared to the unmodified chromatin species. Thus, the scatter plots display proteins whose 
binding is either increased or decreased as a consequence of a specific histone modification 
state.  







Figure 3.4 Determination and visualization of significantly regulated proteins using the example of 
the H3K9me3 interactome.  
A) Log2 SILAC ratios of proteins identified in the forward experiment are plotted on the x-axis. Total 
summed peptide intensities of the forward experiment are plotted on the y-axis in log2 scale. Proteins 
identified as significant outliers by application of the “significance A” algorithm are marked in blue. B) The 
same as in A) but with values of the reverse experiment. SILAC ratios are inverted. C) The same as in A) 
but with averaged values of the forward and the reverse experiments. D) Log2 scaled H/L ratios of proteins 
of the forward experiment are plotted on the x-axis and of the reverse experiment on the y-axis. Statistical 
analyses were performed with averaged H/L ratios of the datasets. Proteins determined as significantly 
enriched are displayed in the upper right square, while proteins significantly depleted are displayed in the 
lower left square of the plot. Proteins determined as false positives are displayed in the upper left and the 
lower right square. Significantly recruited and depleted proteins are colored in blue. False positive proteins 
are marked in black. Proteins that were significantly regulated but only identified in either the forward or 
the reverse experiment are not plotted. 
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Second, the scatter plots visualize the correlation of both biological replicates. In case of positive 
correlation, for both replicates proteins displaying the same trend in terms of binding affinity to 
modified chromatin arrays and are located in the upper right (increased binding) and in the lower 
left square of the scatter plot (decreased binding). Negative correlation is observed for proteins 
displaying an opposed H/L ratio in both biological replicates. Those proteins are located in the 
upper left and the lower right square of the scatter plot (Figure 3.4 D). Accordingly, negative 
correlation is indicative of false positives. Therefore, significant outliers that displayed a 
diametrically opposed significance score in the forward and reverse experiments were 
eliminated from further analysis (Figure 3.4 D).  
Third, statistically evaluated information is represented by a color code. Significant outliers that 
correspond to proteins significantly regulated by a certain modification state are marked in blue, 
whereas proteins constituting the background are labeled in grey. Proteins identified as false 
positive are colored in black.  
With this statistical evaluation strategy all further introduced chromatin-binding interactomes 
were analyzed and the results were visualized as described.  
 
3.3 ChAP coupled to quantitative MS enables the investigation of chromatin-
protein interactomics and provides insights into chromatin modification 
crosstalk 
 
The first steps towards investigating whether, and even more importantly, how posttranslational 
chromatin modifications affect the structure of chromatin and downstream biological processes, 
such as transcription, replication and cell division, is the investigation of the impact modifications 
have on the protein environment of the chromatin loci they mark. Heterochromatin is 
characterized by a tightly packed form of chromatin and thought to be mainly transcriptional 
silenced. However, it is specifically marked by a variety of posttranslational modifications and 
yet, it is not fully understood how and whether these modifications contribute solely to the 
molecular mechanisms of establishment and maintenance of the heterochromatic state. To 
investigate the extend of biological functions correlating with heterochromatin I focused on 
chemical modifications in literature so far associated with this chromatin stage. The following 
chapter introduces the protein-binding interactomes mapped in the context of different histone 








3.3.1 Individual chromatin modification states recruit specific chromatin-binding interactomes 
 
Interactomes associated with 10 different chromatin modifications were characterized. For each 
modification state between 1,117 and 2,785 chromatin-bound proteins, including their isoforms, 
were identified. All analyses together identified more than 6,000 proteins. Of these, close to 500 
were found to be regulated by the chromatin modifications. Each modification state impacted the 
binding properties of a specific set of factors. Moreover, each dataset included several proteins 
that were not known before to associate with specific histone modifications. A comprehensive list 
of factors whose binding to chromatin was impacted by the presence of a certain modification is 
provided in table 3.1. These data shed light on how extensively the chromatin interactomes are 
regulated by histone posttranslational modifications. The individual protein-binding interactomes 




Genome wide high resolution maps revealed that H3K9me1 is mainly associated with 
transcriptional active gene loci (Barski et al., 2007; Wang et al., 2008). The predominant 
absence of H3K9me1 at constitutive heterochromatin has been demonstrated before by using 
chromatin immunoprecipitation (ChIP) and antibody based detection methods in ES cells (Peters 
et al., 2003). In contrast, antibody based staining of MEF cells demonstrated that H3K9me1 is 
located at pericentric heterochromatic regions (Sims et al., 2006). To my knowledge, proteomic 
studies investigating protein interactions to H3K9me1 on a global scale have not been 
performed.  
In this proteomic study, H3K9me1-modified chromatin arrays recruited six and repelled seven 
factors from binding (Figure 3.5 A, Table 3.1). Although H3K9 mono-methylation was mainly 
shown to be linked to gene activation, several factors connected to heterochromatin were 
identified to be specifically recruited by H3K9me1. Among them were the heterochromatin 
protein HP1α (CBX5) and UHRF1. Both are known to be involved in heterochromatin 
establishment and maintenance and have been shown to bind preferentially to K9me3 of histone 
H3 (Lachner et al., 2001; Nady et al., 2011). The splicing co-activator SRRM1 (Blencowe et al., 
1998) was also recruited to H3K9me1-modified chromatin, indicating that not only 
heterochromatin associated factors were recruited.  
To my knowledge UHRF1 is the only factor of the interactome that has been described so far to 
directly interact with H3K9me1 (Nady et al., 2011). Protein interaction analysis using the 
database STRING (Jensen et al., 2009) predicted no protein-protein interactions besides the 
interaction between CBX5 and PRMT5 (Figure 3.5 B, upper panel). Thus, it remains unclear, 
whether the six proteins bind as single factors or form a multi subunit complex.  
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In contrast, the transcription factors NFIB, NFIC, NFIX and E4F1 were significantly repelled from 
binding, as was INO80E, a component of the INO80 chromatin remodeling complex. The 
protein-protein interactions between NFIB, NFIC and NFIX and between INO80E and MCRS1 
were predicted by STRING analysis (Figure 3.5 B, lower panel), suggesting that H3K9me1 
regulated factors are biologically linked, which verifies the specificity of the approach.  
 
 
Figure 3.5 Protein-binding interactomes of H3K9me1 and H3K9me2 chromatin.  
A) H3K9me1 interactome. Proteins are plotted by their log2 SILAC ratios of the forward experiment on the 
x-axis and the reverse experiment on the y-axis. Significantly recruited and depleted proteins are colored 
in blue. False positive proteins are marked in black. B) STRING protein-protein interaction networks of 
factors significantly recruited by H3K9me1 (upper part of the panel) and excluded proteins (lower part of 
the panel). C) H3K9me2 interactome. Data are represented as described in A. D) Protein-protein 
interaction networks from STRING analysis of proteins significantly affected by H3K9me2. Recruited 




proteins are shown in the upper part of the panel, whereas excluded proteins are represented in the lower 




The chromatin-binding interactome of H3K9me2 introduced here is represented by the results of 
the forward experiment only, as data evaluation revealed a non-normal distribution of SILAC 
ratios of chromatin-bound proteins identified in the reverse experiment.  
Chromatin di-methylated at lysine 9 of histone H3 recruited five and depleted eight factors from 
binding (Figure 3.5 C, Table 3.1). As the modification is known to be linked to gene repression 
(Wang et al., 2008), it is not surprising that nearly all factors recruited have been shown to be 
involved in maintenance of a repressive transcriptional state. These proteins comprise CBX5, 
UHFR1, DNMT1 and the putative polycomb group protein SCML2 (Montini et al., 1999). HP1 
proteins, such as CBX5 have been shown to bind to H3K9me2 N-terminal peptides (Jacobs and 
Khorasanizadeh, 2002; Lachner et al., 2001). Also, UHRF1 has been demonstrated to bind to 
H3K9me2/-me3 (Liu et al., 2013). Moreover, UHRF1 was identified to interact with DNMT1, 
(Bostick et al., 2007; Sharif et al., 2007), suggesting a role for UHRF1 in DNMT1 recruitment to 
H3K9me2-marked chromatin regions. A link between CBX5, UHRF1 and DNMT1 was further 
suggested by STRING analysis (Figure 3.5 D, upper panel). There is one published study that 
screened for H3K9me2-binding proteins using N-terminal modified peptides of H3 (Chan et al., 
2009). Comparing the findings of this study to mine, CBX5 was found to be the only overlapping 
factor identified to bind in the context of H3K9me2. 
The transcription factors CEBPD, TFAP4, ATF2 and the zinc finger protein ZBTB43 were 
depleted from binding to H3K9me2 in addition to the transcription factors also excluded from 
binding to H3K9me1-modified chromatin arrays. STRING analysis did not reveal any association 




H3K9me3 is the most intensively investigated repressive histone modification. It marks 
pericentric heterochromatin (Barski et al., 2007; Fischle et al., 2003a; Lachner et al., 2003; 
Wang et al., 2008). In my study, no other modification state affected as many proteins as tri-
methylated lysine 9 of histone H3. Altogether, 59 proteins were specifically recruited and 72 
repelled from binding (Figure 3.6 A, Table 3.1). Previous studies using different methodologies, 
already identify a set of H3K9me3-binding factors comprising among others the different 
isoforms of HP1, CBX1, CBX3 and CBX5 (Lachner et al., 2001), ADNP (Mosch et al., 2011) as 
well as UHRF1 (Karagianni et al., 2008) and MPHOSPH8 (Kokura et al., 2010). Besides single 
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Table 3.1 Proteins recruited and excluded from binding to chemically modified chromatin. 
Proteins are listed according to their enrichment ratios (H/L ratios) starting with the highest value on top. 
Proteins significantly recruited by a certain modification state are written in black, proteins excluded are 
written in blue. Grey marked proteins indicate that the proteins were already found to interact with the 
respective modification in one of the following studies (Bartke et al., 2010; Bluhm et al., 2016; Bostick et 
al., 2007; Engelen et al., 2015; Kunowska et al., 2015; Nady et al., 2011; Nikolov et al., 2011; Oda et al., 
2010; Vermeulen et al., 2010) 
 




SHKBP1 UHRF1 CBX1 GCC2 JADE2 EIF2B5 FAM114A1 SCML2 DNAH8 POLR3H UHRF1 DNAH8 DSC3 
SRRM1 CBX5 UHRF2 CNOT2 KIAA1524 PHF1 CAPN1 LCN1 ORC2 POLR3D DNMT1 LRWD1 CALML5 
ALDH18A1 ACTL8 CBX3 BAG6 LGALS7 FGF2 TALDO1 HDGFRP2 LRWD1 SNC73 SCML2 CBX1 TGM3 
PRMT5 DNMT1 CBX5 RSF1 PHF1 FRMPD3 MIF ZRANB2 ORC3 POLR3G RALGAPA2 CBX5 CSTA 
UHRF1 SCML2 USP3 DYM GBP1 LRWD1 ZGPAT PC4 HMGN5 POLR1C ZHX2 ORC3 CDK2AP1 
CBX5 NFIC SPIN2B DFNA5 SLC25A3 ORC2 HDGF RMND1 ARG1 E2F6 ZBTB33 CHAF1B DNCL1 
MCRS1 CEBPD POGZ PRIC295 MAGOH ORC3 CAST SREK1 ORC5 NFIC USP7 ORC2 TRAM1L1 
NFIB NFIB CHAF1A CNOT1 SHPRH ORC5 PSAT1 USP7 SIRT6 POLR3E ACTL8 POGZ  
NFIX ZBTB43 CHAMP1 IPO11 PFN1 ORC3L WARS ENO1 EIF5 POLR2E ZHX1 CBX3  
E4F1 NFIA CHAF1B KIF11 PRPF40A CBX8 SYAP1 RSRC2 APEX1 ACTL8 ZHX3 ORC5  
INO80E TFAP4 NIPBL CNOT11 SRSF6 PRC1 PARK7 CIR ORC3L USP7 UHRF2 SPIN2B  
TFPT E4F1 SEPT7 XPO1 PGK1 ABCF1 FMNL1 NAP1L4 SYAP1 NOLC1 SEMG1 NIPBL  
NFIC ATF2 SEPT9 FBXL6 SAP18 EIF2S2 ANXA5 RPRC1 PHF1 NAA40 CUEDC1 CHAF1A  
    SIRT6 UBA5 EIF4A3 TOPBP1 POU2F1 PSMD3 RNF213 LMNA MBD2 UHRF2  
    SEPT2 SIRT6 ACIN1 WDR5B TPT1 PHF8 EIF5B NCL ZBTB12 SPIN1  
    SPIN1 RAVER1 PHF21A TCOF1 BCLAF1 INO80C USP3 CHD1 MTA2 CHAMP1  
    ACTL8 GET4 CLIC1 EIF2S3 NBN MYC EIF2S2 SCML2 UBE2D2 ORC3L  
    DNMT1 TTI1 ZC3H11A PRC1 PNP MLXIPL EMG1 ZCCHC10 GATAD2B ADNP  
    ADNP2 CNOT7 RNPS1 EIF2S1 CKB POLG EIF2S1 TADA1 CDK2AP1 MAU2  
    LRWD1 ZKSCAN3 TKT MAFK ALDOC TKT ORC6 RAD51AP1 HYDIN NOLC1  
    USP7 SPTY2D1 PAXIP1 PBX2 GDI2 PGK1 TXLNA   ZNF687 JADE2  
    HMGN5 PSMA7 CHAF1B ELF2 AHCY PNISR GOLT1B   FIZ1 ING5  
    ORC3L POLR3K ISL2 KIF2A EIF4H PHF21A EIF2S3   ZMYND8 PHF5A  
    ORC2 PRC1 E4F1 CDYL2 CXorf38 ZNF580 KIF2A   RBBP7 SF3B1  
    TCHH VWA9 AEBP2 AAR2 ZNF451 RFXANK RAD51AP1   CTSD SHPRH  
    ORC3 CHD1 INO80E PLK1 MAGOH HES1 KIF2C   GATAD2A UBTF  
    UHRF1 TAF11 TFPT RBM7 FAM48A INO80D ABCF1   CHD3 SF3A1  
    RAD51AP1 RECQL SP3 XPO5 VRK3 DHX36 BCR/ABL f.   RBBP7 SF3B4  
    ADNP MED10 NR2C1 KIF5B-ALK DLG3 NCAPD2 TXLNG   PGBD3 PMVK  
    ZHX1 HSP90AB1 HEATR2 EXOC2 FAM134C NCOR2 KIFC1   MTA3 FRMPD3  
    EIF5 TPI1 ZMYM1 RPLP2 NACA NEIL2 ZNF598   BLMH SF3A3  
    ORC5 CENPF SP1 NOLC1 TMPO CHTOP PDIA5   CHD4 SEPT10  
    MIER2 SETX ZNF629 SPATA5L1 CEBPD ZC3H14 NFIX   RBM4 SF3B2  
    EMG1 CKAP2 NFIB OXSR1 GOLGB1 SNRPD3 C19orf47   NCOA6 SEPT9  
    SEPT6 PFN1 ZNF770 NPM1 FMNL1 SRSF6 NFIA   ZBTB4 PGK1  
    MPHOSPH8 MED16 CD3EAP RPRC1 SARS SAP18 POLR1B   POGZ SEPT6  
    ATRX GTF3C4 POLR1E PCMT1 ATL3 PNN PKP2   RBBP4 C9orf78  
    MAU2 HSPA9 KMT2C JADE2 LMNA DDX21 ANKRD12   MECP2 LSM2  
    KIFC1 GTF3C5 PRDM10 YKT6 ARPC2 MAGOH BRCA1   MTA1 USP3  
    SMCHD1 LDHB POLR1A EPPK1 ALDH18A1 RPL7L1 E4F1   SEMG2 EIF4G1  
    SEPT8 ZBTB1 PARD3 TINF2 UIMC1 SF3B4 ANKRD32   BACH1 EIF5  
    CDYL MARK2 POLR1B NAP1L1 CBR1 SNRPB2 BARD1   CHAMP1 ING4  
    SCML2 PRDX1 ESRRA UBL4A ASNS PURB AMY1A   WHSC1 RAB6A  
    KIF2A LDHA   SYDE1 CPNE1 CGGBP1     POLR3F BRCA1  
    ABCF1 ACTN4   SCYL2 CUL1 MAP4     E2F2 SEPT7  
    EIF2S2 PKM   HTRA1 TADA3 ZNF354A     SIN3A CHD1L  
    MORC2 TKT   MAP2K2 ARHGEF3 SNRPA1     CLOCK JADE3  
    EIF2S1 EEF2   CHERP BPTF ZC2HC1A     POLR1C RAD51AP1  
    EIF2S3 PRDX6   CBFB ARPC4 SF3A3     BHLHB2 BARD1  
    MIER1 PNP   UBTF PES1 ZBED6     RPRD1B BABAM1  
    ELF1 EEF1B2   PCSK9 POM121C PURA     ZNF131 SEPT2  
    CDYL2 PGAM1   C11orf57 LIG4 SF3B2     BRMS1L BRCC3  
    ZC3HAV1 PSMA6   PHF8 SHCBP1 SF3B1     MITF ZBED1  
    JMJD1C ENO1   ACACA MTF2 ANKRD12     ELF1 SDHB  
    LRIF1 G2E3   GTF2E2 POLD3 SF3A1     SAP30 ACACA  
    WHSC1L1 PPIA   TYMS PUM1 RSL1D1     SUPT3H BRE  
    ZNF280D IGHG4   ZHX2 RIOK3 ATRIP     SAP130 CSTA  
    CDKN1A ALDOA   MBTPS1 RSL1D1 ACACA     ARNTL ASF1B  
    ZMYM2 GNB2L1   AEBP2 SMARCA5 BRE     SUDS3    
    RNF213 DSC2   JARID2 CCDC59 BRCA1     CGGBP1    
    ETV6 ANXA1   G2E3 MRPL13 BARD1     ELF2    
    TINF2 SERPINB3     PUM1 ANKRD11     TAF1D    
    INO80D MMS22L     COBL       ZSCAN20    
    PCNA TGM3     MOB4       MAX    
    CACYBP SFN     NFATC2IP       ARID4A    
    TAF1 CDSN     FBXW11       BRMS1    
    TAF5 EPPK1     POP4       AP2A1    
    TAF6 POF1B     PLEKHA4       MLXIPL    
    WDR77 TADA2B     CENPV       ING2    
    CEBPG DSC3     HMGB3       E2F1    
    ZNF644 TF     HMG20A       ING1    
 








    PRMT5 YOD1     DDX5-ETV4 
f. 
      MNT    
    RFX1 CAT     SIN3B       S100A11    
    PAXIP1 GSTP1     TIMP2       HES1    
    WIZ LGALS7     GGNBP2       MLX   
     TAF1A IGHG1     FNBP4       RAD1   
     POLR3E PRDX2     CLASP2       USF1   
     KMT2D FABP5     DDX52       USF2   
     POLR3D CSTA     USP7       ZBTB14   
     ZBTB44 IGKC   
 
IFI16       ATP6V1F   
     ZBTB39 ARG1    FOXN2       ZBTB1   
     POLR3GL DSC1     CLASP1       AP2B1   
     UCHL5 SPRR1A     SUZ12       SYN1   
     INO80 SPRR1B     KAT7       EPPK1   
     ZNF444 IGLC1     TARS       SYT1   
     NCOA6 TGM1     EZH2       ATP6V0D1   
     ACTR8 S100A14     EED       SFN   
   
 
INO80C       USP1       ATP6V1B2   
    POLR3A       KMT2C       LGALS7   
     TFPT   
 
  DNMT1       SV2A   
     PATZ1      MEAF6       
 
  
     ACTR5       WDR5 
 
       
     INO80E       DDIT4    
 
    
     CRCP 
 
    CPNE8          
     NFRKB      ACTL8           
     INO80B       C10orf12           
     TBRG1       BRD2           
     SP3       TWF2           
     EHMT2       RAI14           
     BAZ2A       NS5ATP4A           
    EHMT1       PHF14            
    POLR3C       CCDC138            
    POLR3B       JADE3            
    TIAL1       SVIL            
    POLR3K       LRRFIP2            
    CEBPD       CAPRIN1            
    POLR3F       TOB1            
    HIVEP2       PRKD2            
    POLR3G       IGF2            
    ZNF148       MYL6B            
    CEBPB       ACACA            
    POLR1D       UHRF1            
    POLR3H       BAZ1B            
    POLR2H       KRI1            
    POLR2E       CDSN            
    KLF16       IGKC            
    POLR1C       IGF1            
    ZNF282       DEFA3            
    POLR2K                    
    POLR2L                    
    POLR1A                    
    CYR61                    
    POLR1B                    
    NFIX               
 
   
    ZMYM1               
 
   
    NFIC               
 
   
    TAF1B               
 
   
 
  FAM129B 
 
                 
 
  PHF20L1 
 
                  
 
  NFIB 
 
                  
 
  NFIA 
 





  E4F1 
 




factors, protein complexes were also recruited by H3K9me3. In agreement with previous findings 
(Bartke et al., 2010; Vermeulen et al., 2010), several members of the human ORC complex were 
found in the dataset. Additionally, a set of factors not shown to bind to H3K9me3-modified 
chromatin before was identified. For example, four out of the five subunits of the septin complex 
were found. Protein-protein interaction analysis using the STRING database predicted an 
indirect connection of SEPT2 to CBX5 via ADNP (Figure 3.6 B). Moreover, this analysis 
predicted a network including most of the proteins specifically recruited by H3K9me3, thus 
validating the approach in terms of specificity and known biological context. Furthermore, the 
STRING analysis indicated recruitment of factors completely new in the context of H3K9me3 
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binding and therefore argued for a gain in knowledge using chromatin arrays over e.g. histone 
peptides for identification of histone PTM-binding proteins.  
Proteins depleted from binding seemed to be organized in complexes as well. For example, 
seven subunits of the INO80 complex and several members of the BRAC1-core RNA 
polymerase II complex were prevented from binding. These findings appeared to be directly 
connected, as 57 of the 72 factors excluded from binding to H3K9me3 are included in an 




The mono-methylation of lysine 27 of histone H3 has been shown to have a higher prevalence at 
active promoters compared to silent ones (Barski et al., 2007). Other studies mapped the 
modification to be significantly present in heterochromatin (Jacob et al., 2010). Chromatin affinity 
purification using H3KC27me1 modified chromatin revealed 19 factors significantly recruited and 
68 excluded from binding (Figure 3.7 A, Table 3.1). Among them, four members of the CCR4-
NOT transcription complex, which is a key regulator of gene expression (Collart, 2016), were 
found (Figure 3.7 C). Other proteins identified are also involved in positive regulation of gene 
expression. These include the chromatin assembly factor RFS1 (LeRoy et al., 1998; Shamay et 
al., 2002) and GCN1L1 (Marton et al., 1997). Also recruited were the deacetylase SIRT6, the 
ribonucleoprotein RAVR1, which acts as a splicing co-repressor and thereby modulates 
alternative splicing events (Gromak et al., 2003; Plafker and Macara, 2000), and the proteins 
XPO1 and IPO11 that function in nuclear export and import, respectively (Kudo et al., 1997). 
Surprisingly, three of the identified factors, DYM, GET4, and GCC2, are involved in processes 
connected to the Golgi apparatus and are known to locate to the cytoplasm (Dimitrov et al., 
2009; Mariappan et al., 2010; Reddy et al., 2006).  
Factors excluded from binding to H3KC27 mono-methylated chromatin feature a broad range of 
enzymatic activities and thus functional diversity. For instance, there were proteins depleted 
from binding that promote transcription such as GTF3C5, GTF3C4 or POLR3K and proteins 
connected to RNA polymerase II activity such as TAF11 and MED10. Many factors are 
connected to cytoskeleton associated functions i.e. PFN1, CKAP2, PRC1 and CENPF. 
Enzymatically active proteins included for example the pyruvate kinase PKM, the hydrolase 
YOD1 that can remove conjugated ubiquitin from proteins, and the G2/M-phase specific E3 
ubiquitin protein ligase G2E3. Two members of the 20S proteasome were identified as well. 
Even though there was a high diversity of expelled factors, protein-protein interactions predicted 
by STRING indicated that 34 of them are connected to one another (Figure 3.7 B). 






Figure 3.6 Protein-binding interactome of H3K9me3-modified chromatin.  
A) H3K9me3 interactome. Proteins are plotted by their log2 SILAC ratios of the forward experiment on the 
x-axis and the reverse experiment on the y-axis. Proteins significantly recruited and excluded from binding 
to chromatin are colored in blue. False positive proteins are marked in black. B) STRING protein 
interactome of proteins significantly recruited by H3K9me3. C) STRING protein-protein interactions of 
factors significantly excluded by H3K9me3.  




The di-methylated state of H3KC27 has been shown to be linked to transcriptional repression 
and localizes to heterochromatin and enhancers (Barski et al., 2007; Wang et al., 2008). 20 
factors were recruited whereas 23 factors were repelled from binding to H3KC27me2-modified 
chromatin (Figure 3.7 D, Table 3.1).  
Several PHD finger proteins were recruited to H3KC27me2. Prominent examples are (i) the 
PHF21A protein, which is a component of the BHC co-repressor complex, (ii) the PHF15 
(JADE2) protein, which is part of the HBO1 complex that displays histone H4 acetylation activity 
and (iii) PHF1, a protein, which is a component of the polycomb group. Remarkably, eight of the 
enriched factors are related to the spliceosome. SRRM1, MAGOH, EIF4A3, and SRRM2 are 
known to interact with the assembly intermediate C of the spliceosome complex, while the 
proteins SRSF6, PRPF40A, RNPS1 and SAP18 interact with the spliceosome at different stages 
of assembly. Interestingly, SAP18 is also part of the (chromatin) repressor complex SIN3, 
suggesting a crosstalk between the two processes. Known associations among the recruited 
proteins are shown in figure 3.7 E, upper panel. 
RNA splicing occurs either co-transcriptionally or immediately after transcription. Surprisingly, 
contrary to recruitment of spliceosomal factors, several subunits of the RNA polymerase I were 
excluded from binding to H3KC27me2. In addition, INO80, a component of the remodeling 
complex INO80, was also excluded from binding to H3KC27me2.  
INO80 was additionally excluded from H3K9 mono- and tri- methylated chromatin. A similar 
binding profile was observed for the nuclear factors NFIB and E4F1 that were besides 
H3K9me1/-me2/-me3 also excluded from H3KC27me2. These findings support a linkage of 
biological functions facilitated by H3K9me1/-me2/-me3 and H3KC27me2 and indicate the 
exclusion of these factors from most heterochromatic regions. In general, the fact that several 
factors were regulated the same way by different modification states (Table 3.1) support the 
existence of a set of factors generally associated with the establishment and maintenance of 
certain chromatin stages. 
An example of proteins underlying opposed regulation by different modifications is CHAF1B, a 
member of the chromatin assembly complex 1 (CAF-1). The protein was excluded from binding 
to H3KC27me2 but enriched by H3K9me3.  
STRING analysis indicated that a protein complex comprised of the transcription factors SP1, 
SP3, ESRRA and NR2C1 was significantly depleted from H3KC27me2-modified chromatin 
arrays (Figure 3.7 E, lower panel). Another interaction among expelled proteins was identified 
between MLL3, a H3K4 methyltransferase, and the protein PAXIP1, which is involved in DNA 
damage response and transcriptional regulation (Wang et al., 2010).  
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Figure 3.7 Protein-binding interactomes of H3KC27 mono- and di-methylated chromatin.  
A) H3KC27me1 interactome. Proteins are plotted by their log2 SILAC ratios of the forward experiment on 
the x-axis and the reverse experiment on the y-axis. Proteins that are significantly recruited or depleted 
from binding to chromatin by the modification are colored in blue. Proteins that were identified as false 
positive are marked in black. B) Protein-protein interaction network of proteins significantly excluded by 
H3KC27me1 predicted by STRING. C) STRING protein interactome of factors significantly recruited by 
H3KC27me1. D) H3KC27me2 interactome. Data are represented as described in A. E) STRING predicted 
protein interactome of factors significantly regulated by H3KC27me2. Recruited factors are shown in the 




The histone modification H3K27me3 is mainly present at silent promoters and is known to be 
related to gene silencing (Barski et al., 2007; Ringrose and Paro, 2004; Wang et al., 2008). 
Performing ChAP with H3KC27me3-modified chromatin arrays revealed that 22 proteins were 
recruited and 37 proteins were excluded from binding to this modification in the context of 
chromatin (Figure 3.8 A, Table 3.1).  
Protein-protein interaction analysis using STRING predicted three multi subunit complexes 
among the proteins recruited to H3KC27me3. The complex encompassing the highest number of 
proteins is formed by several translation initiation factors, connected to the chromo domain 
protein CDYL2 (Figure 3.8 B, upper panel). A second complex is formed by the members of the 
ORC complex that was also shown to be recruited to H3K9me3-modified chromatin (Figure 3.8 
B, upper panel). In a recent study, members of the ORC complex were shown to bind to both 
modification states, H3K9me3 and H3K27me3, in the context of mononucleosomes (Bartke et 
al., 2010). TOPBP1, which is required for DNA replication (Makiniemi et al., 2001), was also 
recruited but not shown to be in association with the ORC complex. A third complex was formed 
by the proteins PRC1, KIF2A and two members of the repressive polycomb group, CBX8 and 
PHF1 (Figure 3.8 B, upper panel). The polycomb group proteins are well studied and known to 
interact with H3K27 methylation states (van Kruijsbergen et al., 2015), therefore they were 
expected to bind to H3K27me3-modified chromatin.  
The protein-binding interactome of H3K27me3 was already investigated in the context of 
mononucleosomes (Bartke et al., 2010). CBX8 was the only protein found to be recruited by 
H3K27me3-modified mononucleosomes and in the here presented study. No further overlap was 
observed, as in the context of mononucleosomes factors depleted from binding to H3K27me3 
were not identified.  
Factors like G2E3 and NOLC1 were identified to be excluded from binding to H3KC27me3-
modified chromatin. These factors have been identified in more than one of the chromatin-
binding interactomes, always in the context of exclusion from chromatin binding. Additionally, in 
contrast to H3KC27me2, factors related to the spliceosome are depleted by H3KC27me3, 
demonstrating an opposed protein-binding regulation by different modification states as 




described for other factors before. Other expelled proteins are (i) transcriptional activators, (ii) 
factors functionally related to the cytoskeleton, (iii) proteins with kinase activity. The PHD finger 
proteins PHF8 and PH15 were found to be depleted as well.  
The interactome of H3KC27me3 revealed the recruitment as well as repulsion of transcription 
factors from chromatin, which indicates the possibility of existing fine-tuning mechanisms of 
protein-binding properties mediated by a distinct PTM. 
 
 
Figure 3.8 H3KC27me3 chromatin-binding interactome.  
A) H3KC27me3 interactome. Data are represented as described in figure 3.7 A. B) STRING predicted 
protein-protein interaction networks of factors significantly recruited (upper part of the panel) and depleted 




Similar to all other investigated mono-methylation marks it was shown that H4K20me1 is linked 
to gene activation and co-localizes with H3K9me1 in vivo (Barski et al., 2007; Wang et al., 
2008). 19 factors were enriched while 35 factors were excluded from binding to H4K20me1-
modified chromatin (Figure 3.9 A, Table 3.1). Two components of the INO80 complex were 
recruited as well as the nucleosome assembly protein NAP1L4 and the RNA polymerase subunit 
gamma-1. Several factors involved in transcriptional repression were found to be recruited as 
well. Among them I identified PHF21A, HES1 and CIR1 (Figure 3.9 B, upper panel). 
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Protein-protein interaction analysis using STRING indicated that two complexes were depleted 
from binding to mono-methylated H4K20 (Figure 3.9 B, lower panel). The larger protein complex 
predicted by STRING consists of 18 proteins. 16 of these proteins are spliceosomal factors, 
mainly connected to the C complex. The second protein network includes members of the 
BRCA1-A complex, BARD1, BRCA1 and BRE, which are responsible for the maintenance of 
genome stability. The proteins ACACA and ATRIP have been shown to associate with this 
complex as well (Figure 3.9 B, lower panel). Altogether, the predicted STRING interactome 





Tri-methylated H4K20 has been shown to localize to heterochromatin and is connected to 
transcriptional repression (Barski et al., 2007; Schotta et al., 2004; Wang et al., 2008). 
Performing ChAP 32 factors were enriched and 11 factors excluded from binding to H4K20me3 
chromatin (Figure 3.9 C, Table 3.1). The modification recruited the ORC complex together with 
its binding components LRWD1 and APEX1. With the exception of APEX1 the complex was also 
recruited to tri-methylated H3K9 and H3KC27 (Table 3.1). The co-purification of the ORC 
complex with all three methylation sites has been shown before (Vermeulen et al., 2010). 
Additionally, STRING analysis predicted protein-protein associations between several recruited 
translation initiation factors (Figure 3.9 D, upper panel), which were also recruited to chromatin 
by H3KC27me3. This complex showed additional association with two taxilin proteins connected 
to the hydrolase USP3, which is known to deubiquitinate monoubiquitinated target proteins, such 
as histone H2A and H2B. Several kinesin family members in association with DNAH8 and PHF1 
formed a third complex predicted by STRING (Figure 3.9 D, upper panel).  
H4K20me3 excluded several factors from binding to chromatin that have been shown to be 
excluded by other modification states investigated in this study as well. For instant, besides 
H4K20me3 all three methylation states of H3K9 excluded factors of the NFI gene family and the 
protein E4F1. The heterodimer BARD1-BRCA1 was excluded from binding to H4K20me1 as well 
as H4K20me3. Additionally, an identical regulation pattern was identified for a third protein, 












Figure 3.9 Chromatin-associated protein interactomes of histone H4K20 mono- and tri-methylation.  
A) H4K20me1 interactome. Log2 H/L ratios of proteins identified in the forward experiment are plotted on 
the x-axis and of the reverse experiment on the y-axis. Proteins that are significantly recruited or depleted 
from binding to chromatin arrays are colored in blue. False positive proteins are marked in black. B) 
STRING interactome of proteins significantly enriched (upper part of the panel) and excluded (lower part 
of the panel) by H4K20me1. C) H4K20me3 interactome. Data are represented as described in A. D) 
STRING protein-protein interaction network of proteins significantly recruited (upper part of the panel) and 
depleted (lower part of the panel) by H4K20me3.  




Arginine 3 of histone H4 is symmetrically di-methylated by PRMT5, a methyltransferase that is 
part of the repressive MB2/NURD complex. I found this complex recruited by H3K9me1 and 
depleted with H3K9me3 (Table 3.1). According to the literature, H4R3me2 was expected to be a 
mark associated with heterochromatin (Le Guezennec et al., 2006; Zhao et al., 2009). Nine 
factors were recruited to H4R3me2-modified chromatin and 11 factors were found to be 
excluded from binding (Figure 3.10 A, Table 3.1). Surprisingly, six of the recruited factors are 
DNA-directed polymerases, suggesting an association to transcriptional activity for H4R3me2. 
Additionally, two transcription factors and the protein SNC73 were recruited, supporting the 
assumption that this modification is rather associated with transcriptional activity and therefore 
unlikely to be linked to pericentric heterochromatin. This assumption is further supported by the 
fact that H4R3me2 excluded the proteins ACTL8, USP7, SCML2 and RAD51AP1 from binding 
to chromatin, as all proteins have been shown to be recruited by H3K9me3, a well-studied 




ChAP was performed with chromatin arrays containing truncated histones H3 that were missing 
the first 20 N-terminal amino acids (Figure 3.10 B). This experiment gave indications of protein 
binding to H3 influenced by the unmodified histone tail.  
The experiment revealed 71 factors with a higher affinity to the wt H3, and thus these proteins 
were depleted from binding to chromatin when the N-terminus of H3 was missing (Table 3.1). 
USP7, DNMT1, ACTL8, and UHRF1 were found to be depleted by H3Δ1-20, which was not 
surprising as they have been demonstrated to be highly enriched in the context of several ChAP 
experiments with methylated H3 tails (Table 3.1). Other proteins excluded from binding to H3Δ1-
20 were JADE3 (PHF16), several factors of the polycomb group, such as SUZ12, and the 
helicase SMARCA5. All these proteins are known to be associated with chromatin in the context 
of PTMs of the H3 N-terminus and therefore are not unlikely to be excluded from binding to 
H3Δ1-20 containing chromatin.  
The proteins CDSN, IGKC and the histone methyltransferase KMT2C (MLL3) were found to be 
depleted by H3Δ1-20 as well as by chromatin arrays containing methylated H3. This finding 
indicates that these proteins preferentially associate with chromatin in presence of the 
unmodified H3 tail.  
Interestingly, the N-terminal tail of H3 seems also to have a role in prevention of protein binding 
to chromatin. I identified 45 proteins that were significantly recruited to chromatin containing 
tailless histone H3 (Figure 3.10 B, Table 3.1). Most likely, these proteins showed enrichment in 




consequence of a better accessibility to the globular domain of H3 or other parts of the 
nucleosome that might be sterically blocked by the presence of the H3 N-terminal tail.  
 
 
Figure 3.10 Chromatin-binding proteins regulated by H4R3me2 and H3Δ1-20.  
Proteins are plotted by their log2 SILAC ratios of the forward experiment on the x-axis and the reverse 
experiment on the y-axis. Proteins that are significantly recruited or depleted from binding to chromatin by 
the modification are colored in blue. Proteins that were identified as false positive are marked in black. A) 
H4R3me2 protein-binding interactome. B) H3Δ1-20 interactome.  
 
Methylated DNA (meCpG) 
 
Chromatin arrays carrying methyl at position 5 of the cytosine pyrimidine ring within CpG 
stretches of the underlying DNA template recruited 42 factors and depleted 47 factors 
significantly from binding to nucleosomal arrays (Figure 3.11 A, Table 3.1). As DNA methylation 
has mainly been described as a repressive mark, I expected to find an overlap with factors also 
regulated by other repressive marks. Surprisingly, the only overlap of recruited factors was found 
between meCpG and H3K9me3. Among the overlapping nine factors were UHRF1, DNMT1, 
SCML2, USP7 and ACTL8. None of the factors regulated by H3KC27me3 or H4K20me3 were 
regulated by methylated DNA (Table 3.1). 19 of the factors recruited by meCpG were predicted 
by the STRING database to be associated with each other (Figure 3.11 B). Among these 
proteins are chromo domain helicase binding proteins, metastasis associated 1 family members, 
the methyl CpG binding protein 2 and zinc finger proteins.  
In the context of mononucleosomes affinity purification was performed with methylated DNA 
using a DNA template based on the 601 sequence (Bartke et al., 2010) similar to what was used 
in the here presented study. Five out of nine recruited factors that have been identified to be 
recruited in that study, namely, MECP2, MBD2, MTA2, CHD4, GATAD2A, were recruited by 
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DNA methylated oligonucleosomal arrays as well. The proteins MAX, USF2, BHLHB2 and USF1 
were depleted from binding to both, mono- and oligonucleosomal arrays. 
Protein-protein interaction analysis of excluded proteins indicated that only ten proteins were not 
associated with the predicted network (Figure 3.11 C). Several factors of the ING2 complex were 
excluded from binding including ING1 and its associated factor SFN. An additional complex was 
predicted by three proteins connected to the V-ATPase. DNA-dependent RNA polymerase and 
transcriptional activators were depleted from binding, supporting an association with gene 
silencing. The overlap observed among proteins excluded from meCpG and H3K9me3 binding is 
unique to polymerase subunits, namely POLR3F and POLR1C. 
 
 
Figure 3.11 Protein-binding interactome of chromatin containing methylated DNA.  
A) Protein-binding interactome of meCpG containing chromatin. Log2 scaled H/L ratios of proteins 
identified in the forward experiment were plotted on the x-axis and the reverse experiment on the y-axis. 
Factors determined as significant outliers are marked in blue. False positives are marked in black. B) 
STRING protein-protein interaction analysis of factors significantly recruited by meCpG. C) Protein-protein 
network of proteins significantly depleted from meCpG chromatin predicted by STRING. 
 




3.3.2 The methylation degrees of lysine residues affect protein binding to different extends  
 
The functional significance of different methylation degrees of lysine residues within histones is 
still under discussion. The lower methylation degrees, mono- and di-methylation, might act as 
platforms that enable the establishment of the respective higher methylation state, leading to the 
tri-methylation mark that affects downstream processes. Alternatively, each of the three 
methylation degrees has their own biological significance and thus lead to distinct functional 
outcomes themselves. 
In the following section I compared the protein-binding interactomes of different methylation 
degrees of H3K9, H3K27 and H4K20 to obtain more insights on how individual methylation 
degrees regulate chromatin-binding properties of individual factors and protein complexes.  
 
 
Figure 3.12 Overlap of proteins regulated by the methylation degrees of H3K9.  
A) Venn diagram of all factors significantly regulated by mon-, di- and tri-methylation of H3K9. B) Bar plot 
of proteins regulated by at least two modification states of H3K9. Log2 scaled SILAC ratios are plotted on 
the y-axis. Gene names are plotted on the x-axis. 
 
Mono-, di- and tri-methylation of H3K9 
 
Each of the methylation states of H3K9 recruited and repelled a specific set of factors from 
binding to the modified chromatin arrays (Figure 3.5, 3.6, Table 3.1). Remarkably, the number of 
factors regulated by H3K9me3 was 10 times higher than those regulated by H3K9me1 and 
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H3K9me2. In fact, mono- and di-methylation of H3K9 affected the binding behavior of 13 
proteins, whereas H3K9me3 had an impact on 131 proteins. The overlap of significantly 
regulated factors is shown in figure 3.12 A. A set of five proteins, CBX5, UHRF1, NFIB, NFIC, 
and E4F1 was affected by all three modification states. These proteins were regulated the same 
way. They were either recruited to all modification states or excluded from binding to chromatin 
(Figure 3.12 B). Several proteins displayed an overlap between two of the modification states 
(Figure 3.12). With the exception of one factor, PRMT5, all proteins were regulated in the same 
direction by the overlapping methylation states. PRMT5 is the only factor found to display an 
opposed binding profile, as the protein was significantly recruited to H3K9me1 but repelled from 
binding to H3K9me3 (Figure 3.12 B).  
 
Mono-, di- and tri-methylation of H3K27 
 
The three different methylation states of H3KC27 affected different protein interactomes, 
indicating the specificity of each modification state on protein-binding properties to chromatin 
(Figure 3.7, 3.8, Table 3.1). Notably, none of the modified lysine residues within histones 
investigated in this study demonstrated such a high divergence of protein binding regulated by 
different methylation degrees. The different H3K27 methylation states have been shown to 
localize to different genomic regions, with a greater diversity than H3K9 and H4K20 methylation 
states (Rosenfeld et al., 2009). Contrary to H3K9 methylation, not a single factor was found to 
be regulated by all three methylation states of H3KC27 (Figure 3.13 A). An overlap of 
significantly regulated proteins was observed only between two of the H3K27 methylation states 
(Figure 3.13 A). The three factors, LGALS7, PFN1 and TKT were significantly affected by 
H3KC27me1 and H3KC27me2 and displayed an opposed binding profile to chromatin. All three 
were significantly repelled from binding to H3KC27me1-modified chromatin while H3KC27me2 
significantly recruited these proteins (Table 3.1). JADE2 and the protein PRC1 also showed an 
opposed binding to chromatin in the context of different H3K27 methylation states. I also 
observed PHF1, AEBP2, EPPK1 and G2E3, to exhibit an opposed binding profile, thus, recruited 
and depleted from binding by two different H3K27 methylation states (Table 3.1). 
 
Mono- and tri-methylation of H4K20 
 
For H4K20 only mono- and tri-methylation states were investigated. Significantly regulated 
proteins of both modification degrees showed a high divergence (Figure 3.9, Table 3.1). An 
overlap was observed for only three factors, including ANKRD12, BRCA1 and BARD1 (Figure 
3.13 B). All three proteins were excluded from binding independently of the H4K20 methylation 
state investigated.  




Taken together, only a small set of common factors was observed to show the same binding 
profile to chromatin containing different modification degrees of a certain methylation site. The 
H3K9 methylation degrees showed an exceptionally high overlap of factors regulated the same 
way (Figure 3.12 A, Table 3.1). At least 70 % of H3K9me1 and of H3K9me2 regulated proteins 
were found to display the same binding profile as to H3K9me3. These findings suggest a 
functional link between the lower modification states and H3K9me3.  
In contrast, diverse examples of proteins affected by the modification degrees of H3K27 and 
H4K20 highlighted the varying effect methylation degrees can have on the regulation of 
chromatin-binding interactomes that was not given for the H3K9 methylation states.  
 
 
Figure 3.13 Overlap of significant proteins regulated by different methylation states.  
A) Venn diagram of proteins significantly regulated by mono-, di- and tri-methylation of H3KC27. B) Venn 
diagram of proteins significantly regulated by H4K20me1 and H4K20me3.  
 
3.3.3 Two chromatin modifications in trans do not only constitute the sum of their single 
counterparts but demonstrate an independent impact on chromatin-binding interactomes 
 
Crosstalk between histone modifications is referred to as the influence one modification has on 
the biological impact of a second one. It is mainly observed between two chemical modifications, 
resulting in changed chromatin-binding properties for a limited number of factors (Lee et al., 
2010). 
I hypothesized that crosstalk of two modifications does not only affect individual proteins but 
changes chromatin-binding properties of proteins on larger scale. Thus, I assumed that 
       75           Results 
 
chromatin modification crosstalk is a process of its own functional significance that extends the 
variety of chromatin regulating mechanisms.  
In order to investigate chromatin modification crosstalk I extended the approach and applied 
ChAP by combining two posttranslational chromatin modifications. On one end I incorporated 
two modifications in trans, i.e. on different histones within one nucleosome. To this end we 
investigated the communication between modifications of H3 and H4. On the other end, I 
analyzed crosstalk between histone PTMs and DNA methylation in the context of chromatin 
arrays. 
 
3.3.3.1 Chromatin arrays carrying a combination of H3K9me3 and H4K20me3 result in a specific 
protein interactome  
 
To take advantage of the possibilities provided by the oligonucleosomal arrays I decided to 
investigate histone modification crosstalk between H3 and H4. Crosstalk in trans cannot be 
investigated using modified N-terminal peptides of histones, as it requires a nucleosomal 
context. Such analyses have not been done before on a proteomic scale. The combination of 
H3K9me3 and H4K20me3 was chosen as these modifications co-localize in pericentric 
heterochromatin in vivo and seem to be functionally linked (Mikkelsen et al., 2007; Schotta et al., 
2004; Sims et al., 2006).  
Performing ChAP using chromatin arrays carrying both modifications, H3K9me3 and H4K20me3 
in combination (H3K9me3|H4K20me3), resulted in a protein interactome displaying 18 factors 
significantly enriched and 39 factors significantly repelled from binding to chromatin (Figure 3.14 
A, Table 3.1). Interestingly, the interactome of the double modification was not just the sum or 
the average of the interactomes obtained with the individual modifications H3K9me3 and 
H4K20me3 (Figure 3.14 B). While all proteins specifically recruited by the double modification 
were also specifically recruited by at least one of the individual modifications, 
H3K9me3|H4K20me3 had a strong impact on exclusion of protein binding to chromatin. Here, 
overlapping proteins excluded from binding by H3K9me3|H4K20me3 and the individual 
modifications were rare and in fact only represented 5.1% of all excluded proteins. Thus, most 
factors excluded by the double modification were uniquely depleted from binding to chromatin 
only in presence of both, H3K9me3 and H4K20me3. 
STRING analysis indicated that proteins repelled from binding to H3K9me3|H4K20me3 
essentially clustered in four main protein complexes (Figure 3.14 C). Five members of the septin 
complex, four members of the HBO1 complex, responsible for the bulk of histone H4 acetylation, 
at least seven factors involved in splicing as well as several components of the BRCA1-A 
complex were identified. Interestingly, the components of the BRCA1-A complex, BARD1 and 
BRCA1, had been found to be excluded from binding to H4K20me3 as well (3.9 D, lower panel, 




Table 3.1). These proteins are located in the background of the H3K9me3 interactome. In 
contrast, the members of the septin complex were significantly enriched by H3K9me3-modified 
chromatin (3.6 B, Table 3.1), demonstrating an opposed binding profile in the context of the 
double modification. These findings motivated me to investigate the binding profiles of proteins 
affected by all three modification states in more detail.  
 
 
Figure 3.14 Protein-binding interactome of H3K9me3|H4K20me3-modified chromatin.  
A) H3K9me3|H4K20me3 interactome. Proteins are plotted by their log2 SILAC ratios of the forward 
experiment on the x-axis and the reverse experiment on the y-axis. Significantly recruited and depleted 
proteins are colored in blue. False positive proteins are marked in black. B) Venn diagram of factors 
significantly regulated by H3K9me3, H4K20me3 and H3K9me3|H4K20me3. C) STRING protein-protein 
interaction network of proteins significantly depleted from binding to H3K9me3|H4K20me3 chromatin. 
 
3.3.3.2 The double modification H3K9me3|H4K20me3 indicates positive and negative crosstalk 
 
The communication between different chemical chromatin modifications can occur on several 
levels. A modification can either promote or prevent the addition or the removal of a second 
modification. Furthermore, a modification can promote or prevent functional properties of a 
       77           Results 
 
second modification, e.g. the promotion or blockage of protein binding to chromatin and thereby 
functional consequences associated with these proteins.  
The latter I investigated in the context of H3K9me3 and H4K20me3. Potential crosstalk was 
addressed by comparing the protein-binding profiles affected by the single modifications to the 
binding profile obtained with H3K9me3|H4K20me3. I started with proteins found to be 
significantly recruited or excluded from binding to the three different chromatin species (Table 
3.1).  
Considering only proteins significantly recruited by H3K9me3|H4K20me3 I found all proteins 
recruited by at least one of the single modifications as well (Figure 3.15 A). This finding 
suggested that protein recruitment in the context of H3K9me3 and H4K20me3 is defined by the 
presence of the individual modifications. The combination of both PTMs had no effect on protein 
recruitment independent H3K9me3 and H4K20me3.  
Next, proteins significantly excluded from H3K9me3|H4K20me3 were compared to proteins 
excluded by the single modifications (Figure 3.15 B). Surprisingly, only 2 of the factors excluded 
by H3K9me3|H4K20me3 were also found to be excluded by one of the single modifications, in 
fact by H4K20me3.  
When comparing H3K9me3|H4K20me3 excluded factors to significantly enriched factors of the 
two single modifications I found an overlap of 7 proteins (Figure 3.15 C). USP3, RAD51AP1 and 
EIF5 were recruited to both single modifications. Additionally, the members of the septin 
complex recruited by H3K9me3 were excluded by the double modification. These findings show 
for the first time that the presence of two modifications in trans result in an inverse binding 
pattern of proteins to chromatin. The combination of both PTMs had an opposing effect on 
protein binding in comparison to the individual modifications, H3K9me3 and H4K20me3. 
 
I was wondering whether this effect was limited to a small number of H3K9me3|H4K20me3 
excluded proteins. Therefore, I compared the SILAC ratios of all H3K9me3|H4K20me3 
significantly excluded proteins with proteins identified in the experiments of H3K9me3- and 
H4K20me3-modified chromatin (Figure 3.16 A). Indeed, 32 of H3K9me3|H4K20me3 significantly 
excluded factors displayed an opposed binding affinity to chromatin compared to the individual 
modifications, indicating negative crosstalk between H3K9me3 and H4K20me3. 
 
So far I only considered proteins that were significantly affected by the modifications. As I found 
proteins opposingly regulated by the double modification I was questioning whether this effect is 
limited to proteins excluded from binding. Proteins significantly recruited to 
H3K9me3|H4K20me3 showed no crosstalk. Therefore, I decided to extend the analysis and 
included proteins displaying an H/L ratio larger than log2 1.5 in the H3K9me3|H4K20me3 
dataset. These proteins were not significantly recruited to the double modification but showed an 




increased affinity to the modified chromatin arrays. 18 of these proteins displayed opposed 
binding compared to the single modifications (Figure 3.16 B), indicating also positive crosstalk 
between H3K9me3 and H4K20me3. Notably, almost all factors affected are in association with 
transcriptional activity, such as the DNA-directed RNA polymerase III subunits and the 
transcription factors NFIA and NFIC.  
 
 
Figure 3.15 Comparison of significant protein binding to chromatin affected by H3K9me3, 
H4K20me3 and H3K9me3|H4K20me3.  
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A) Venn diagram of proteins recruited to chromatin by all three modification states. B) Venn diagram of 
proteins excluded from binding to chromatin by all three modification states. C) Venn diagram of proteins 
significantly recruited to H3K9me3 and H4K20me3 and excluded from binding to H3K9me3|H4K20me3 
chromatin. 
 
Taken together, the data showed three effects of H3K9me3 and H4K20me3 crosstalk. In the first 
category, the double modification had “no effect” on protein binding. “No effect” refers to the 
finding that the protein-binding properties were similar over all three modification patterns. In the 
second category, negative crosstalk between H3K9me3 and H4K20me3 was observed. 
Negative crosstalk was defined as decreased protein-binding affinities in the context of the 
double modification but enriched affinities with individual modifications. In the third category, 
H3K9me3 and H4K20me3 showed positive crosstalk. Positive crosstalk was given when the 
double modification displayed increased protein-binding affinities, while the individual 
modifications displayed decreased binding affinities.  
 
3.3.3.3 Communication of histone and DNA modifications is indicated by positive and negative 
crosstalk 
 
In many model organisms DNA methylation and histone PTMs have been found to be linked (Du 
et al., 2015) in the context of co-localization at certain chromatin regions, but also in terms of 
crosstalk. This made the combination of H3K9me3 and meCpG attractive to prove, whether the 
crosstalk observed between H3 and H4 is also given in the context of further combinations, i.e. 
DNA methylation and posttranslational histone modifications.  
 
The analysis of the meCpG protein-binding interactome revealed an overlap of factors also 
significantly affected by the H3K9me3 interactome (3.17 B, Table 3.1). It appeared that a set of 
nine proteins is similarly regulated by H3K9me3 and meCpG, suggesting that these two 
modifications may be involved in the same regulation pathways. This argument was in 
agreement with a strong association between these chromatin modifications described in the 
literature (Du et al., 2015; Fuks et al., 2003; Lehnertz et al., 2003; Liu et al., 2013).  
 
In consequence, I wanted to characterize in more detail, how the combination of both, histone 
posttranslational modifications and DNA methylation, regulates the chromatin-binding 
interactome. I wanted to investigate potential crosstalk, as seen with the combinatorial readout 
of H3 and H4 methylation. Therefore, ChAP experiments were performed using 
oligonucleosomal arrays carrying both H3K9me3 and CpG-methylated DNA.  
 





Figure 3.16 Crosstalk between H3K9me3 and H4K20me3.  
A) Negative crosstalk between H3K9me3 and H4K20me3. Log2 scaled SILAC ratios of proteins 
significantly repelled from binding and displaying negative crosstalk are indicated on the y-axis. There 
gene names are indicated on the x-axis. B) Positive crosstalk affected by H3K9me3 and H4K20me3. 
Proteins displaying an H/L ratio larger than log2 1.5 in the dataset of the double modification and 
displaying positive crosstalk are plotted as described in A). 
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The protein-binding interactome obtained from ChAP using chromatin arrays carrying both 
modifications, H3K9me3 and meCpG, in combination (H3K9me3|meCpG), displayed 7 factors 
significantly excluded from binding to chromatin but no factors significantly recruited (Figure 3.17 
A, Table 3.1). The comparison of significantly affected proteins of all three datasets, H3K9me3, 
meCpG and the combination of both modifications, revealed an overlap of one factor, CDK2AP1, 
which was recruited to meCpG-modified chromatin and excluded from binding to 
H3K9me3|meCpG-modified chromatin (Figure 3.17 B). The opposed binding behavior to 
chromatin indicated negative crosstalk between meCpG and H3K9me3.  
Despite the results of the significance test, an unusual high number of proteins displayed a 
higher affinity to H3K9me3|meCpG than to unmodified chromatin arrays, whereas the number of 
depleted proteins was similar to other ChAP-MS experiments (Figure 3.17 A). The possibility 
that this effect resulted from experimental variability is low, as only proteins displaying an 
increased H/L ratio are affected in both replicates. The high number of recruited proteins shifted 
the overall distribution towards high H/L ratios (Figure 3.17 A). With this large number of 
enriched proteins significant outliers could not be determined by the described significance test 
(section 3.2). However, considering the increased H/L ratios of both replicates, 
H3K9me3|meCpG-modified chromatin clearly displayed an impact on binding of a very large 
number of proteins to chromatin.  
 
 
Figure 3.17 Chromatin-binding interactome of H3K9me3|meCpG in comparison to the individual 
modifications.  
A) H3K9me3|meCpG interactome. Protein enrichment ratios are plotted as described in figure 3.14 A. B) 
Venn diagram of proteins significantly regulated by H3K9me3, CpG-methylated DNA and 
H3K9me3|meCpG-modified chromatin.  
 




The combinatorial readout of H3K9me3|meCpG has already been performed in the context of 
mononucleosomes (Bartke et al., 2010). In comparison to the interactome revealed with 
chromatin arrays no overlap of significantly excluded factors was observed. Considering the 40 
factors displaying the strongest enrichment to H3K9me3|meCpG chromatin and comparing 
these to the factors enriched with H3K9me3|meCpG mononucleosomes, an overlap of five 
factors was observed, namely UHRF1, CBX3, MBD2, MTA2 and CHD4. All five proteins have 
been shown to be enriched by at least one of the single modifications in the context of chromatin 
arrays as well.  
 
In order to investigate positive and negative crosstalk I extended the analysis to proteins that 
showed no significance but increased and decreased binding affinities to H3K9me3|meCpG. 
Thus, all proteins displaying an H/L ratio larger than log2 3.5 and smaller than log2 -2 in the 
H3K9me3|meCpG dataset were included in the analysis. 
Next to CDK2AP1, I found 14 more proteins showing a decreased binding affinity to 
H3K9me3|meCpG and an increased affinity to at least one of the individual modifications (Figure 
3.18 A). The binding profiles of these proteins indicated negative crosstalk between H3K9me3 
and meCpG. These proteins included USP3 and UBTF, which displayed negative crosstalk 
between both, H3K9me3 and meCpG and also H3K9me3 and H4K20me3. Other proteins 
affected were NUMA1, a component of the nuclear matrix, CENPF, which is involved in 
kinetochore function and chromosome segregation, the histone acetyltransferase KAT7 and the 
nucleolar protein NCL. 
CpG-methylated DNA and H3K9me3 also showed positive crosstalk (Figure 3.18 B). The 
majority of affected factors are known to promote transcriptional activity. Interestingly, there was 
an overlap of 5 factors that displayed positive crosstalk between H3K9me3 and H4K20me3 as 
well. NFIA, NFIC, PRDM10 and the polymerase subunits POLR3A and POLR3H showed 
positive crosstalk between both investigated combinations of chromatin modifications. 
Additionally, three components of the chromatin remodeling complex INO80 and several 
transcription factors showed positive crosstalk in presence of H3K9me3 and methylated DNA. 
 




Figure 3.18 Crosstalk of H3K9me3 and CpG-methylated DNA.  
A) Negative crosstalk of H3K9me3 and meCpG. Log2 SILAC ratios are plotted on the y-axis. Gene names 
are plotted on the x-axis. Proteins with a SILAC ratio less than log2 -2 were considered for the analysis. B) 
Positive crosstalk of H3K9me3 and meCpG. SILAC ratios and gene names were plotted as described for 
A). Proteins with a SILAC ratio greater than log2 3.5 were considered for the analysis. 




3.4 Annotation analysis functionally correlates chromatin marks  
 
High resolution maps based on genome wide analyses of chemical chromatin modifications 
provided insights into the distribution of these marks (Barski et al., 2007; Mikkelsen et al., 2007; 
Wang et al., 2008). Distinct modification patterns have been shown to correlate with certain 
chromatin states, leading to the assumption that a functional correlation between modifications 
exists. To investigate a functional correlation of chromatin modifications based on the protein 
interactomes (3.3), I applied gene annotation enrichment analyses. These analyses resulted in 
identification of overrepresented biological processes and functions related to individual 
chromatin modification marks. 
 
As general strategy, significantly enriched and repelled proteins of a certain modification mark, 
introduced in chapter 3.3, were considered individually for gene annotation enrichment analyses. 
Gene names were mapped to associated biological annotations using the functional annotation 
chart of the online software package DAVID (Huang da et al., 2009a, b). Results represented in 
the following chapter were obtained by using default statistic parameters of DAVID with the 
exception of the EASE score (enrichment) cutoff that was set to 0.05 to increase stringency. 
Annotation categories included in these analyses were GO terms for molecular functions (MF) 
and biological pathways. For the annotation of cellular pathways, the databases 
Panther_Pathways, KEGG_Pathway, BBID, Biocarta and Reactome_Pathway were screened. 
GO term annotation MF was performed including all terms. For each annotation term category 
two output lists per modification state were generated. One list of enriched annotation terms for 
recruited proteins (↑) and one for proteins excluded from binding (↓). Terms were only 
considered for enrichment analysis when at least two genes were assigned to a particular 
annotation term. Only significantly enriched annotation terms (matching the EASE score) were 
included in further analyses. 
To enable global comparison of individual modification marks, the enriched annotation terms of 
recruited and depleted proteins of each chromatin modification mark were correlated by 
determining Pearson product-moment correlation coefficients (Pearson correlation coefficient). 
Modification marks showing a strong linear association of P-values of annotated terms displayed 
a high correlation coefficient. To compare annotated terms that were not enriched in each 
dataset missing P-values were set to 1. 
 
Correlation coefficients obtained for enriched biological pathways are displayed in a heat map 
(Figure 3.19 A). Three clusters of strong correlation between modification states were observed. 
The largest cluster includes the datasets of recruited proteins of H3K9me3, H4K20me3, 
H3KC27me3 and H3K9me3|H4K20me3, indicating a comparable impact on biological functions. 
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All four chromatin modification marks have been shown to co-localize to pericentric 
heterochromatic regions and to be absent from transcriptionally active chromatin (Barski et al., 
2007; Wang et al., 2008). Thus, functional similarities between these modifications might trigger 
related biological outcomes.  
A second cluster of correlation coefficients was obtained for enriched biological pathways for the 
datasets of H3K9me3 and H3KC27me2 depleted and H4R3me2 recruited proteins (Figure 3.19 
A). These findings were additionally supported by a strong correlation of H3K9me3 and 
H3KC27me2 depleted and H4R3me2 recruited proteins by annotation enrichment analyses of 
GO terms of MF (Figure 3.19 B). The results clearly indicated an antagonistic regulation of 
biological functions impacted by these modification marks. These biological functions are 
depleted by H3K9me3- and H3KC27me2-modified chromatin and given with H4R3me2-modified 
chromatin. On the individual protein level, I found several DNA-dependent RNA polymerase 
subunits excluded from binding to H3K9me3- and H3KC27me2-modified chromatin, while they 
were recruited by H4R3me2, suggesting transcriptional activity of chromatin regions marked with 
H4R3me2.  
Another antagonistic regulation is highlighted by the third cluster of correlation coefficients 
obtained for enriched biological pathways of proteins recruited to chromatin modified at 
H3KC27me2 but depleted from binding to H3K9me3|H4K20me3 and H4K20me1 (Figure 3.19 A). 
All datasets were connected to the spliceosome, with the particularity that H3KC27me2 attracted, 
while the presence of H3K9me3|H4K20me3 and H4K20me1 excluded spliceosomal activity. 
This was attributed to the binding properties of several spliceosome associated factors that were 
shown to be opposingly regulated by H3KC27me2 compared to H3K9me3|H4K20me3 and 
H4K20me1 (section 3.3).  
 
Correlation of P-values obtained from annotation term enrichment of GO terms MF pointed to a 
relation between the datasets of H4K20me1 recruited factors and factors depleted from binding 
to chromatin by H3K9me1/-me2, H3KC27me1/-me2 and H4K20me3 (Figure 3.19 B). These data 
suggested an antagonistic regulation of biological functions of H4K20me1 in comparison to the 
mono-methylation states of H3K9 and H3K27, which is surprising as they have been shown to 
be located at the same type of genomic regions (Barski et al., 2007; Mikkelsen et al., 2007; 
Rosenfeld et al., 2009; Wang et al., 2008). The correlation of opposed binding profiles of 
proteins to chromatin of H4K20me1 and the modifications H3K9me2, H3KC27me2 and 
H4K20me3 in contrast, is in agreement with previous findings. In genome wide distribution 
profiles H4K20me1 had its significance at transcriptional active sites whereas H3K9me2, 
H3KC27me2 and H4K20me3 accumulated at transcriptionally silenced regions (Barski et al., 
2007; Mikkelsen et al., 2007; Rosenfeld et al., 2009; Wang et al., 2008).  





Figure 3.19 Annotation enrichment analyses of biological pathways and GO terms of molecular 
functions.  
Significantly enriched (↑) and repelled proteins (↓) of all investigated chromatin modifications (section 3.3) 
were included in the analyses. Protein lists (enriched or excluded) resulted from the respective 
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modification states were applied to annotation term enrichment analysis. P-values of enriched annotation 
terms resulted from the modified Fisher's exact test performed by DAVID (Huang da et al., 2009a, b) were 
taken as input for calculation and visualization of Pearson correlation coefficients. P-values of annotated 
terms that displayed no significance were set to 1. A) Pearson correlation coefficients (Corr) of enriched 
pathway terms annotated to proteins recruited and excluded from binding to modified chromatin are listed 
on the y- and x-axis. Positive correlation is indicated in red shades while negative correlation is indicated 
in blue shades. B) Pearson correlation coefficients of enriched GO terms of molecular functions. Data are 
represented as described for A. 
 
Notably, for both datasets of meCpG, proteins recruited and excluded from binding to chromatin, 
displayed a strong correlation (Figure 3.19 B). The functional classification of meCpG is still 
controversial. In recent years, more and more evidence has accumulated that connects 
methylated DNA with transcriptional activity (Hu et al., 2013; Jin et al., 2012; Wu et al., 2010). 
However, meCpG has been mainly correlated with transcriptional inactivity (Breiling and Lyko, 
2015). In my analyses, proteins depleted as well as recruited to meCpG-modified chromatin 
were associated with similar biological functions, supporting a role for methylated DNA in the 
context of transcriptional activation as well as repression.  
 
In summary, the results of gene annotation enrichment analyses of different modification 
patterns, based on significantly enriched and depleted proteins, suggested four groups of 
functionally related modification patterns. H3K9me3, H4K20me3, H3KC27me3 and the double 
modification H3K9me3|H4K20me3 showed a strong correlation in the context of annotated 
pathway terms, suggesting a functional link between these modifications. Furthermore, the 
analyses indicated an opposing functional background for H4R3me2 compared to H3K9me3 and 
H3KC27me2. The fact that H3K9me3 and H3KC27me2 are associated with transcriptional 
inactivity and that H4R3me2 recruited several subunits of the polymerase (Table 3.1) strongly 
indicates that H4R3me2 is associated with transcriptional activity. The correlation analyses of 
enriched annotated terms also implied that H4K20me1 impacts protein binding to chromatin and 
associated functionalities opposed to H3KC27me2. This finding is based on the inverse 
regulation of binding properties of spliceosomal factors (Table 3.1, Figure 3.7 E, upper panel, 
Figure 3.9 B, lower panel). Next to H3KC27me2, also H3K9me1/-me2, H3KC27me1 and 
H4K20me3 seem to trigger opposed biological functions than H4K20me1. A last group of 
modifications that seemed to be functionally linked, constituted H3K9me1/-me2, H4K20me3 and 
to a lesser extend meCpG. These modification states showed a correlation of terms annotated to 









3.5 Protein-protein cross-linking of the chromatin-binding interactome  
 
My results to that point demonstrated that chromatin affinity purification coupled to mass 
spectrometry is a powerful method for the identification of chromatin-associated factors. It allows 
determination of chromatin-binding interactomes in the context of different chromatin 
modifications and combinations thereof. The method allows studying the impact of chromatin 
modification patterns on recruitment and exclusion of protein binding to chromatin in addition to 
crosstalk effects of modifications (3.3). Yet, the approach does not provide information about 
factors that primarily bind to chromatin and factors that piggypack on other factors for 
association. To address the hierarchical binding pattern of chromatin-associated proteins we 
extended ChAP-MS by protein-protein cross-linking of the chromatin-binding interactome. A 
workflow combining ChAP, chemical cross-linking and mass spectrometry was established. This 
allowed the mapping of specific protein-protein interaction sites and thereby providing structural 
information of binding patterns of chromatin-associated factors and multi protein complexes. 
 
3.5.1 Protein-protein cross-linking on assembled chromatin arrays 
 
To identify physical interaction sites of specific chromatin-associated factors chemical cross-
linking was applied. Chemical cross-linking results in permanent connections of protein 
interaction sites. Thus, proteins assembled in a non-covalent complex that are in close proximity, 
spanning the reach of the cross-linker, can be covalently linked.  
In this study we used bis(sulfosuccinimidyl) suberate (BS3), a chemical cross-linker with a 
spacer arm length of 11.4 Å. It is a homobifunctional cross-linker that reacts with primary amines 
in the side chains of lysine (K) residues and the N-terminus of polypeptide chains resulting in 
stable amide bonds (Sinz, 2006). The appropriate BS3 concentration for efficient cross-linking 
was determined by titrating the cross-linker to affinity purified protein complexes bound to 
recombinant chromatin arrays (M. Nikolov, MPI-bpc). We used a concentration of 200 µM BS3 
to sufficiently cross-link specific chromatin-binding interactomes.  
 
The complete workflow established for cross-linking of chromatin-binding interactomes is 
summarized in figure 3.20. Briefly, specific chromatin-binding interactomes were obtained by 
ChAP. Biotin-tagged 12mer chromatin arrays were assembled as described before and validated 
for sufficient saturation levels (Figure 3.21). The ChAP workflow was extended by the addition of 
BS3 during affinity purification. Cross-linking was found to be most efficient when a small 
concentration of BS3 (20 µM) was already added to the pull down while chromatin arrays were 
still incubated with nuclear extract. The specific chromatin-binding interactomes were cross-
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linked after protein-bound chromatin arrays were separated from nuclear extract and unspecific 
bound proteins were washed away. 
 
 









An important step of the purification procedure is the removal of proteins cross-linked to 
streptavidin of the magnetic beats used for the chromatin pull-down. To exclude such cross-links 
and cross-links occurring between the streptavidin beads themselves from the analysis, the 
cross-linked chromatin-binding interactome was separated from magnetic beats. Therefore, the 
biotin-tagged DNA of the chromatin arrays was degraded by the nuclease benzonase resulting 
in the release of histone octamers and associated proteins from magnetic beads.  
 
I prepared a negative control that allowed direct comparison of cross-linked with non-cross-
linked samples, to prove that ChAP coupled with cross-linking enabled efficient and specific 
cross-linking on-beads of chromatin-associated proteins (Figure 3.22). 
 
 
Figure 3.21 Quality control of reconstituted nucleosomal arrays.  
(A) Agarose gel electrophoresis of free DNA and reconstituted nucleosomal 12mer arrays. (B) AvaI 
digestion of nucleosomal 12mer arrays shown in (A). The saturation level of the nucleosomal arrays is 
above 90%. M defines the DNA size marker. 
 
The identification of cross-links from complex protein mixtures is challenging since cross-linked 
species are underrepresented. Therefore, it is necessary to reduce the complexity of the sample 
and enrich for cross-linked species before mass spectrometric measurements.  
Separation of cross-linked and non-cross-linked species was performed by size exclusion 
chromatography (SEC) on the protein as well as on the peptide level. On the protein level, SEC 
elution profiles monitored by UV absorption at 215 nm featured 6 peaks (Figure 3.22 A, left 
panel). The protein mixture of chromatin associated factors was separated and several fractions 
were pooled according to eluted peaks. Cross-linked proteins eluted within the first three peaks 
from the column, visible by SDS-PAGE and Western blot analysis (Figure 3.22 A, middle and 
right panel). The analysis of elution fractions by SDS-PAGE validated the separation of proteins
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according to their size and indicated the presence of large protein aggregates by a diffuse 
separation pattern of proteins (Figure 3.22 A, middle panel). The success of cross-linking was 
additionally demonstrated by upwards shifted signals of histone H3 as detected by Western blot 
analysis using an antibody against H3 (Figure 3.22 A, right panel). Fractions comprised of cross-
linked material were used for further analyses. Proteins were digested in-solution using the 
protease trypsin.  
 
 
Figure 3.22 Enrichment for protein-protein cross-links by size exclusion chromatography (SEC).  
Elution profiles (monitored by UV absorption) of proteins associated with unmodified chromatin that were 
separated according to their size using a Superdex 200 column (left panel). The protein contents of 
displayed peaks were analyzed by SDS-PAGE (middle panel) and Western blot analysis using apolyclonal 
α-H3 antibody (right panel). SDS-PAGE gels were stained with silver nitrate. Mw defines the molecular 
weight marker. (A) BS3 treated chromatin-associated proteins. (B) Negative control. All experimental 
steps of the negative control were performed equally to the cross-link experiment but the sample was not 
treated with BS3.  
 




The negative control displayed a similar elution profile. Proteins started to elute with a shift of 0.1 
ml (Figure 3.22 B, left panel), indicating larger protein complexes in the cross-linked samples. 
Elution fractions were pooled according to the cross-linked experiment (Figure 3.22 A, left 
panel).  
 
The cross-linked protein samples treated with proteases were composed of three 
subpopulations of peptides, (i) cross-linked peptides, (ii) single peptide chains and (iii) non-
cross-linked peptides. Single peptide chains can either be linked to a cross-linker reacted with 
water or ammonia (mono-links) or with a cross-linker that reacted with both ends of the same 
peptide (loop cross-links). Cross-linked peptides can occur as intramolecular bonds within one 
protein molecule (intra-cross-links) or as intermolecular bonds between two different protein 
molecules (inter-cross-links) (Figure 3.23 B) that are able to create high-molecular weight 
aggregates (Tran et al., 2016). Leitner and colleagues demonstrated that SEC at the peptide 
level of samples treated with cross-linkers facilitates the identification of cross-linked peptides by 
MS (Leitner et al., 2012). To ensure comprehensive detection of cross-linked peptides by MS, 
trypsinized protein mixtures were enriched for cross-linked peptides by another SEC step. The 
elution of peptides started with the void volume, indicating the presence of large peptides and 
the separation of cross-linked peptide aggregates from smaller peptide species. Elution fractions 
were pooled according to eluted peaks. Each of the resulting samples was analyzed by LC- 
MS/MS on a QExactive mass spectrometer. The majority of cross-linked peptides identified in 
the samples resulted from the first two peaks of the elution profile, additionally indicating a 
successful separation of cross-linked and non-cross-linked peptide species. 
 
 
Figure 3.23 Chemical cross-links of peptides using the cross-linker BS3.  
A) Chemical structure of bis(sulfosuccinimidyl) suberate (BS3). B) Cross-linked peptide species that can 
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3.5.2 Protein-protein cross-links of complex protein samples are specifically detected by the 
search algorithm pLink in combination with a reference database 
 
One of the major challenges in XL-MS is the identification of cross-linked peptides and proteins. 
The main reason is due to the fact that obtained MS spectra do not correspond to one peptide 
but to all possible combinations of a cross-linked peptide pair. The consequence is a dramatic 
increase of the database used for the search associated with increased risk of random 
assignments and higher false discovery rates. These increases are exponential with the number 
of proteins included for the search. Thus, it is necessary to determine those proteins having a 
high probability to be detected in the search. These proteins will constitute the reference 
database.  
 
To define a specific database, protein identification from MS measurements, were obtained 
using the MaxQuant software (Cox and Mann, 2008; Cox et al., 2011). Only proteins detected by 
at least 3 “razor and unique peptides” were included. The most abundant proteins were 
determined by dividing the number of detected peptide counts by their molecular weight.  
To increase specificity of cross-link identification a FDR of 0.01 was set for the search using the 
pLink software (Purcell et al., 2007).  
To test the specificity of protein-protein cross-link identification using pLink, I applied the 
algorithm to the mass spectra obtained from the negative control that should not show any 
cross-links. In total three pLink analyses were done, each time using a reference database 
including either the most 100 abundant proteins, the most 150 or all proteins identified in the 
sample. Depending on the size of the reverence database that was used between 13 and 21 
cross-links were identified. Three of those cross-links were also found to be positive 
identifications in the cross-linked sample and were excluded from further analysis. As the 
restriction settings for the detection of cross-linked peptides in combination with purification and 
enrichment strategies still included the identification of false positives the filtering stringency for 
the dataset was increased. 
Therefore, the median of the pLink scores of all spectra that were identified for the negative 
control was determined. Spectra identified for the cross-linked samples displaying a score less 
than this median were excluded from further analyses. In total I found 0.6% false positive 
spectra that had to be excluded from further analysis. As the interest of investigation was 
focused on the identification of the binding hierarchy of proteins associated with chromatin, 
ambiguous spectra were generally excluded from analyses.  
To further validate the specificity of cross-links I mapped the identified intra-cross-links of 
proteins against available crystal structures. The spacer arm of BS3 is 11.4-Å long. Lysines have 
a flexible side chain of 6-Å. Therefore, the two Cα atoms of specifically cross-linked lysines 




should be within a 24-Å distance. I selected the proteins Poly [ADP-ribose] polymerase 1 
(PARP1) and DNA topoisomerase 2-alpha (TOP2A) from the dataset as they displayed several 
intra-cross-links and for both proteins crystal structures were available. 
Using the Xlink Analyzer software (Kosinski et al., 2015; Pettersen et al., 2004) cross-links of 
PARP1 were mapped to the crystal structure of PARP1 with the PDB code 4DQY (Langelier et 
al., 2012). The crystal structure includes the amino acid sequences 6-91, 224-359, 531-575, 
584-644, and 662-761. Hence, only 5 out of 20 cross-links could be mapped to the structure. All 
5 cross links displayed a distance below 24-Å (Figure 3.24 A) validating the specificity of the 
detected cross-links. The same analysis was performed with the identified intra-cross-links of the 
human DNA topoisomerase 2-alpha (TOP2A), using the 2.9-Å resolution structure with the PDB 
code 4FM9 (Wendorff et al., 2012). This structure includes the amino acid sequences 433-1092 
and 1124-1190 of the protein. Here, 5 out of 13 cross-links could be mapped. Only one cross-
link featured a distance longer than 24-Å (33-Å). This cross-link is spanning the DNA-binding 
domain (Figure 3.24 B), which might be conformationally changed when TOP2A is not bound to 
DNA. Both, PARP1 and TOP2A are DNA-binding proteins (Figure 3.24) but have been identified 
to be cross-linked to proteins that themselves are directly cross-linked to one of the histones of 
the histone octamer (Figure 3.26 A).  
 
 
Figure 3.24 Protein-protein cross-links in the context of three-dimensional protein structures.  
Identified intra-cross-links of Poly [ADP-ribose] polymerase 1 (PARP1) and DNA topoisomerase 2-alpha 
(TOP2A) were mapped to corresponding crystal structures using the Xlink Analyzer software (Kosinski et 
al., 2015; Pettersen et al., 2004). The tertiary protein structure is shown in purple. Cross-links are 
represented as blue bars when the distance is below 24-Å and in red when the distance is more than 24-
Å. DNA bound by the protein is indicated by a golden alpha helix surrounding the sugar backbone in blue. 
A) Crystal structure of human PARP1 (PDB code 4DQY (Langelier et al., 2012)) demonstrating the 
position of all identified cross-links corresponding to the amino acid sequence of the shown structure. B) 
2.9-Å resolution structure of human TOP2A (PDB code 4FM9 (Wendorff et al., 2012)). The position of 
identified cross-links corresponding to the amino acid sequence is shown. 
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In conclusion, with one exception I could demonstrate that all mapped cross-links lie within a 24-
Å distance, suggesting that these cross-links are specific. The analysis of the negative control in 
parallel enabled the identification of false positive cross-links and therefore reduced the false 
positive rate. With the identification of only 0.6% false positive spectra, that were excluded from 
the dataset, and the mapping of identified cross-links to crystal structures as positive controls, it 
was shown that the stringency of data filtering is sufficient to provide reliable cross-link 
identifications. 
 
3.6 ChAP-MS coupled with XL provides information of the binding hierarchy 
beyond primary binding proteins recruited to chromatin 
 
ChAP-MS in combination with cross-linking was applied to unmodified nucleosomal arrays. For 
each experiment more than 200 protein species were identified. To ensure specificity and 
integrity of cross-link identification three different databases were used for pLink searches. The 
databases either comprised the top 100 abundant proteins, the top 150 or all positive identified 
proteins of one experiment. All together I obtained 1363 spectra with 521 different cross-link 
sites from two biological replicates. 45.7% of all identified cross-links localized to the 
nucleosome core particle. 
 
Protein-protein cross-links of the core nucleosome 
 
238 cross-links were identified within the core nucleosome, annotated in 792 spectra. These 
represented 464 inter- and 328 intra-cross-links. Most of these cross-links were mapped to the 
lysine-rich N-terminal or C-terminal tails of the histones (Figure 3.25 A). These terminal tails of 
the histones are thought to be unstructured, flexible and protrude outwards from the nucleosome 
core particle (Figure 1.1). It is known that the tails interact with the DNA wrapped around the 
nucleosome (Angelov et al., 2001; Mutskov et al., 1998) as well as with acidic patches of 
nucleosomes in close proximity (Davey et al., 2002; Dorigo et al., 2004; Luger et al., 1997). 
Hence, it is very likely that each of the histone tails can be temporarily in close proximity to each 
other.  
As consequence, lysines far apart from each other in the crystal structure of the core 
nucleosome can come in close proximity and therefore can be cross-linked by BS3. This might 
explain that only 57 of all protein-protein cross-links identified within the core nucleosome were 
shorter than 24-Å whereas 174 of the cross-links were longer than 24-Å (Figure 3.25 B). In 
particular for histone H3 many cross-links were observed with a distance above 24-Å. As shown 
in figure 3.25 A cross-links to histone H3 were mainly found within the N-terminus of the protein. 
Similarly, for the histones H2A, H2B and H4 cross-link sites were concentrated within the 




unstructured domains of the proteins (Figure 3.25 A). Therefore, no conclusion regarding 
structural information can be drawn from the cross-links obtained for the histone octamer. 
 
 
Figure 3.25 Protein-protein cross-link analysis of the core nucleosome.  
A) Cross-links identified for the core nucleosome. The map was created using xiNet (Combe et al., 2015). 
Intra-cross-links are represented by purple lines. Inter-cross-links are colored in green. Red loops indicate 
that the same peptide was cross-linked to itself (multimerization). B) Histogram of cross-link distances of 
all identified cross-links within the four histone proteins mapped onto the crystal structure of the core 
nucleosome (PDB_1KX5 (Davey et al., 2002)) using the Xlink Analyzer software (Kosinski et al., 2015; 
Pettersen et al., 2004). Distances below 24-Å are labelled in blue. Distances longer then 24-Å are colored 
in red.  
 
Protein-protein cross-links of chromatin-associated factors 
 
In order to address the hierarchical binding patterning of chromatin-associated proteins and their 
physical interaction sites all filtered spectra of identified cross-links were uploaded to xiNET 
(Combe et al., 2015). The information of these spectra is summarized in a node-link diagram 
(Figure 3.26 A). 75 proteins were found to be cross-linked. Eight of them displayed only intra-
cross-links, whereas all others exhibit at least one inter-cross-link (Figure 3.26 A). As cross-links 
covalently link proteins in close proximity, it was not surprising that 238 cross-links out of 521 
different cross-link sites were identified within the histone octamer. 18 proteins showed a direct 
physical interaction to at least one of the core histones (Figure 3.26 A). Accordingly, these 
proteins were identified as primary binders to chromatin. A subset of these proteins was found to 
be cross-linked to a second protein. For instance, the protein HP1BP3 was cross-linked to 
histone H3 as well as to SMARCA5. Thus, this approach allowed the identification of secondary 
binders to the core nucleosome, in this case SMARCA5 (Figure 3.26 A). This result clearly 
demonstrate that SMARCA5 can be recruited to chromatin via HP1BP3 when not binding 
directly to chromatin by itself. The same is true for RPL6 and RREB1 as they were also identified 
to be cross-linked to HP1BP3. The protein SMARCA5 itself was cross-linked to a second 
protein, HSPA5, that can be considered as a tertiary binder to the core nucleosome. This protein 
again is connected to a multi subunit complex of proteins identified to be cross-linked to each 
other (Figure 3.26 A). 
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Not all cross-linked proteins could be assigned to one of the core histones. A protein complex of 
SNRNP200, HLTF, DNMT1, KDM2A, BAZ1B and HNRNPC was cross-linked to each other. In 
this case, the connector to chromatin was either not identified or the complex was directly bound 
to DNA via one of the proteins, for instance, such as DNMT1.  
 
To prove that I cross-linked proteins with a biological background to chromatin that show 
expected functional associations, I investigated the 75 proteins identified to be cross-linked 
using the STRING database (Figure 3.26 B). Only six proteins were not included in the protein-
protein map drawn by STRING, verifying the biological association of those proteins. The 
physical interaction sites of the four largest protein complexes of cross-linked proteins (Figure 
3.26 A) were compared to the protein-protein interactions shown by STRING (Figure 3.26 B). 
Altogether, 17 protein-protein interactions overlapped between the two maps (Figure 3.26). For 
instance, the protein-protein interactions between the core histones as well as to histone H1 
proteins have been also predicted by STRING. STRING also showed interactions between 
histone H2A and TOP2A. The complex of UBF1, TOP1, PARP1 and OGT1 was found in both 
maps as well.  
Taken together, I could demonstrate that the established workflow is suitable for (i) identification 
of chromatin associated proteins, (ii) identification of physical interactions between proteins and 
proteins with the nucleosome, (iii) giving insights into the binding hierarchy of chromatin-
associated proteins and their complexes, and (iv) identification of discrete interaction (cross-link) 
sites within proteins.  





Figure 3.26 Interaction network of cross-linked factors associated with chromatin.  
A) Node-link diagram of identified cross-links of chromatin-associated proteins. The network map was 
drawn in xiNET (Combe et al., 2015). Proteins are indicated by a node while cross-linked partner proteins 
are connected by a straight line between two nodes. Intra-cross-links are indicated by a loop connected to 
the respective node. Core histone proteins are marked in red. A large number of identified cross-links for a 
certain protein pair is roughly indicated by a grey shadow around the connection line between the two 
proteins. B) Protein-protein interaction network of known and predicted protein-protein interactions of the 
set of proteins found to be cross-linked in A. The network was generated by the database STRING 
(Jensen et al., 2009) using the default settings of the database.  
 
 




This study is based on a strategy combining recombinant homogenously modified chromatin 
arrays and quantitative mass spectrometry in order to characterize the protein-binding profiles in 
the context of 12 different histone modification patterns. This thesis work has established 
comprehensive lists of proteins whose binding to nucleosomes is regulated by histone 
modifications specifically found at heterochromatin. The raw proteomic data were analyzed by 
using a statistical approach, which allowed the comparison of different interactomes side by 
side. Conclusions were drawn regarding the biological functions, which are actively regulated by 
histone posttranslational modifications. Furthermore, the approach was extended by the 
incorporation of two different histone modifications in combination. For the first time, the 
crosstalk between one modification on H3 and one on H4 was analyzed on a global scale. Also, 
positive as well as negative crosstalk between histone modifications and methylated DNA was 
investigated. Lastly, a new approach combing chromatin affinity purification, cross-linking and 
mass spectrometry was developed to characterize the hierarchy of physical protein-protein 
interactions within a chromatin-binding interactome.  
 
4.1 Individual chromatin-binding interactomes are comparable based on 
significant enrichment cutoffs 
 
Affinity purification using 12mer chromatin arrays resulted in a high number of recruited proteins. 
In fact, I found between 1,117 and 2,785 proteins associated with chromatin depending on the 
incorporated modification. Most of the proteins were binding to the chromatin arrays 
independently of the histone modification state. To define these modification specific regulated 
factors the binding of proteins to modified and unmodified chromatin arrays were quantitatively 
determined and compared by their relative enrichment levels (SILAC ratio). Proteins significantly 
affected by a modification were identified by applying a statistical scoring function (“significance 
A”) (Cox and Mann, 2008) to the distribution of log SILAC ratios in the corresponding 
experiment. Assuming a symmetric Gaussian distribution of variables (i.e. log SILAC ratios) this 
function calculates and scores the probability that a random individual variable has a defined 
distance from the mean of the distribution, which identifies it as a significant outlier. In average, 
approximately 3.5% of chromatin-bound proteins appeared to be directly affected by a chromatin 
modification. 




The advantage of this statistical tool is a fold enrichment cutoff calculated based on the protein-
binding properties of each individual experiment. Thus, significantly affected proteins could be 
determined independently of the variations introduced by the many experimental steps during 
sample preparation, stringently required for direct comparison of proteins affected by different 
histone modifications.  
The drawback of this statistical tool is the requirement for a Gaussian distribution with small 
variance. In fact, when the binding properties of a very large number of proteins are affected by 
the underlying chromatin modification the set of SILAC ratios will spread out around the mean of 
the Gaussian distribution. In consequence, even the data indicate a very large number of 
proteins displaying an increased binding affinity to the modified chromatin arrays, no significant 
outlier will be determined.  
Such a case was observed for H3K9me3|meCpG-modified chromatin. More than 30% of 
chromatin-bound proteins appeared to be affected by the double modification. In consequence, 
significant outliers could not be determined. Thus, for the interactome of the double modification 
H3K9m3|meCpG significantly recruited proteins could not be determined, (Figure 3.17 A). 
Hence, proteins recruited to H3K9m3|meCpG chromatin were not comparable to proteins 
significantly impacted by other modification states. 
 
4.2 Interactomics of chromatin-binding proteins provide new insights into the 
functional impact of individual chromatin modifications 
 
The complex language of posttranslational histone modifications is interpreted by proteins 
having reader domains. These histone-interacting domains, by recognizing their target sites, are 
thought to facilitate the recruitment of effector proteins and their connected biological functions 
to specific chromatin loci. The PTMs investigated here have a considerable impact on the 
composition of chromatin-bound proteins in the context of recombinant chromatin arrays. I 
investigated the protein-binding profiles in the context of 10 individual chromatin modifications. 
The first general conclusion from these datasets is the confirmation that PTMs as well as 
methylated DNA, promote and inhibit protein binding to chromatin. Second, independent of the 
methylation site and the degree of methylation, protein recruitment and exclusion from chromatin 
were regulated specifically, as shown by individual chromatin-binding interactomes for each 
modification. Although in the literature all investigated modification states were associated with 
heterochromatin, and therefore to be expected to have a certain overlap in regulated factors and 
functionality, a high diversity of factors was impacted by the different modification states. These 
factors display a limited set of common factors overlapping only partially between the different 
modification states. The observations support the notion of the existence of a histone PTM 
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language, guiding different biological functions, dependent on the underlying chromatin 
modification pattern, to specific genome loci (Jenuwein and Allis, 2001; Strahl and Allis, 2000). 
 
Mono-, di- and tri-methylation of H3K9 
 
The three methylation degrees of H3K9 show a strong contrast in numbers of proteins they 
significantly regulated. Considering all modification patterns investigated, H3K9me3 modulated 
the binding properties of the largest set of proteins. In contrast, H3K9me1/-me2 impacted the 
lowest number of proteins (Table 3.1). The finding indicates that lower methylation degrees of 
H3K9 affect chromatin in a more subtle way, likely regulating a more restricted set of functions.  
At least 70 % of the proteins affected by H3K9me1/-me2 were also affected by H3K9me3 
(Figure 3.12 A), suggesting a functional link between H3K9me1/-me2 and the tri-methylation 
state. The common functions regulated by these modifications might be heterochromatin 
establishment and maintenance. This assumption is supported by the facts that first, the 
methylation degrees of H3K9 are known to be involved in heterochromatin formation and 
maintenance (Loyola et al., 2009; Towbin et al., 2012). Second, in my study I found the well 
characterized human HP1α (CBX5) and the heterochromatic protein UHRF1 to be recruited to 
chromatin by all three modification degrees (Table 3.1). Both proteins have been previously 
shown to bind to the different H3K9 methylation degrees and are primarily involved in 
heterochromatin formation and maintenance (Lachner et al., 2001; Nady et al., 2011).  
Another common feature of the three H3K9 methylation degrees was the significant decrease in 
chromatin binding of transcription factors of the NFI gene family as well as E4F1 (Table 3.1). 
These factors correlated with the regulation pattern of polymerase subunits in the context of 
several modifications (Table 3.1). More precisely, the heterochromatic PTMs H3K9me3, 
H3KC27me2 and H4K20me3 repelled part of these transcription factors together with 
polymerase subunits from binding to chromatin (3.7 E, lower panel and 3.9 D, lower panel) 
whereas H4R3me2 specifically recruited polymerase subunits and NIFC (Table 3.1). 
Additionally, analysis using the database STRING predicted the factors of the NFI gene family to 
be in association with polymerase subunits (Figure 3.6 C). These findings suggest that the 
transcription factors of the NFI gene family work in the context of transcriptional activation and 
thereby support the heterochromatic context of the H3K9 methylation degrees. 
 
The low number of H3K9me1/-me2 regulated proteins raises the question whether these 
modification degrees have their own biological significance or mainly function as substrates 
necessary for the establishment of H3K9me3 as suggested before (Loyola et al., 2009; Towbin 
et al., 2012). Indeed, my data implicate that H3K9me1/-me2 do not autonomously promote 
functional outcomes and are related to H3K9me3. This supports the suggestion of H3K9me1/-




me2 being substrates for establishment of H3K9 tri-methylation. However, the independent 
genomic distribution of the modification degrees indicates the contribution to various chromatin 
related functions (Barski et al., 2007; Mikkelsen et al., 2007). Therefore, it cannot be ruled out 
that the lower methylation states of H3K9 act in concert with other modification sites to promote 
downstream functions at chromatin regions free of H3K9me3.  
 
Mono-, di- and tri-methylation of H3KC27 
 
In comparison to H3K9, the characteristics of the three methylation degrees of H3KC27 feature 
three main distinctions. First, there was not a single factor found to be commonly regulated by all 
three methylation degrees of H3KC27 (Figure 3.13 A). Second, the factors regulated by each of 
the modification degrees were highly divergent in functionality. Third, chromatin binding of 
several factors was regulated in an antagonistic manner by two of the H3KC27 methylation 
degrees (Table 3.1). These observations indicate a specific biological significance for each of 
the methylation degrees. This point of view agrees with previous findings demonstrating that the 
different H3K27 methylation states are located in different regions of the genome, with a 
diversity much greater than for H3K9 and H4K20 methylation marks (Rosenfeld et al., 2009).  
 
The mono-methylation of H3KC27 recruited several components of the CCR4-NOT complex, 
which has been shown to be involved in transcription initiation and elongation (Collart, 2016). In 
this context the complex was shown to control H3 and H4 acetylation and H3K4 tri-methylation 
(Peng et al., 2008), indicating a role for H3K27me1 in transcriptional activation. This would be in 
agreement with the fact that H3K27me1 is enriched in gene bodies of actively transcribed genes 
(Barski et al., 2007; Wang et al., 2008). The CCR4-NOT complex has also been shown to act in 
the cytoplasm, regulating mRNA translation as well as degradation. Surprisingly, there are three 
more proteins recruited to H3KC27me1 that also show cytoplasmic localization. These proteins 
seem to be associated with a correct organization of the Golgi apparatus and transport 
processes between the Golgi apparatus and the endoplasmic reticulum or endosomes (Dimitrov 
et al., 2009; Mariappan et al., 2010; Reddy et al., 2006). It is unclear how these proteins are 
related to H3K27me1. These proteins might represent cytosolic contaminants found in the 
nuclear extracts due to the method used for the preparation of the extracts (Dignam et al., 1983). 
I think this is not very likely. First of all, light and heavy nuclear extracts were prepared 
individually. Secondly, for each of the two extracts three individual preparations were performed 
and pooled in order to average potential abnormalities introduced by experimental handling. 
Thirdly, some of the cytoplasmic proteins identified in this study were also identified by affinity 
purification in the context of N-terminal histone peptides using HeLa nuclear extracts (Vermeulen 
et al., 2010). From my point of view these facts demonstrate the improbability of contaminants in 
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the nuclear extracts used for this study and support the discovery of so far cytoplasmic classified 
proteins as positive identifications. 
 
Remarkably, 40% of the proteins recruited to H3KC27me2 chromatin are spliceosomal proteins. 
A link between regulation of alternative splicing and chromatin modifications has already been 
described (Luco et al., 2011; Luco et al., 2010; Zhou et al., 2014). The nucleosome density and 
consequently the presence of histone modifications was found to be higher over exons 
compared to introns (Schwartz et al., 2009; Tilgner et al., 2009). The presence of histone 
modifications is thought to locally impact alternative splicing by either, recruitment of splicing 
factors to the transcription site, or by marking alternative exons and/or the surrounding 
chromosomal regions and influencing the elongation rate of polymerase II and therefore splice 
site choices. The presence of H3K9me3 and HP1γ was shown to slow down polymerase II 
resulting in increased inclusion of transcribed alternative exons (Saint-Andre et al., 2011). In 
contrast, hyperacetylation of H3 and H4 increased the elongation rate of polymerase II and 
favored skipping of alternative exons (Hnilicova et al., 2011). 
H3K27me2 was not extensively investigated in the context of alternative splicing so far but have 
been found to be specifically enriched on exons, with the strongest presence at low expressed 
exons, also shown for H3K27me3 (Andersson et al., 2009; Spies et al., 2009).  
The finding that most of the factors recruited by H3KC27me2 are associated with the 
spliceosome strongly correlates this modification site with splicing activities and implicates an 
active functional association. Contrary to the literature, in my study an association with the 
splicing process was exclusively found for H3KC27me2. As chromatin structure and recruitment 
of effector proteins by distinct histone modification patterns seem to correlate with alternative 
splicing it is very likely that the presence of H3K27me2 at certain chromatin regions might 
contribute to splice sites selection or even promote splicing events by slowing down 
transcriptional elongation as shown in the context of H3K9me3.  
 
H3K27me3 is one of the best studied chromatin modification that is catalyzed by the repressive 
multi-subunit complex PRC2 (Schuettengruber et al., 2007). Several polycomb group proteins, 
the components of the PRC2 and PRC1 complexes, have been shown to co-localize with 
H3K27me3 and directly targeting this modification mark (Morey and Helin, 2010; 
Schuettengruber et al., 2007). Surprisingly, the H3KC27me3 interactome characterized here did 
not show an increased affinity for most of the polycomb group proteins expected to bind this 
mark. While I only found CBX8 and PHF1, which were significantly recruited by H3KC27me3, the 
majority of the polycomb proteins were identified below the P-value that was set for statistical 
significance or they were not quantified. The mechanisms that recruit the PRC complexes to 
their target genes are not fully understood yet, but they are thought to contain specific and 




complex elements, i.e. DNA, RNA and DNA-associated proteins (Morey and Helin, 2010). Those 
elements might have been absent from the chromatin template or the nuclear extracts. The 
preparation of nuclear extracts used for the ChAP experiments were based on high salt 
extraction of isolated nuclei followed by the removal of the insoluble chromatin fraction by 
centrifugation (Dignam et al., 1983). Thus, proteins displaying a very strong affinity to the 
chromatin, which resists to high salt treatment, might have been lost or reduced together with 
the chromatin during nuclear extract preparation.  
 
Histone H4 methylation sites 
 
The interactomes of H4K20me1 and H4K20me3 showed high divergence (Figure 3.9, Table 3.1) 
since only an overlap of three factors were found to be regulated by both modification degrees. 
These factors were excluded from binding to the modified chromatin templates (Figure 3.13 B).  
 
In contrast to most of the other investigated PTMs, H4K20me1 recruited predominantly factors 
associated with positive regulation of transcription (Figure 3.9 B, upper panel, Table 3.1). Among 
them are members of the INO80 remodeling complex, which have been shown to be excluded 
from binding to chromatin by H3K9me1/-me3 and H3KC27me2 histone modifications. In addition, 
an antagonistic regulation was observed of splicing associated factors: while H3KC27me2 
recruited several spliceosomal factors, H4K20me1 excluded 16 factors mainly associated with 
the C spliceosomal complex (Figure 3.9 B lower panel, Table 3.1). The data are indicative of a 
connection of H4K20me1 to transcriptional activity and euchromatin, which would be in 
agreement with previous findings that found H4K20me1 located at gene bodies (Barski et al., 
2007; Vakoc et al., 2006). Additionally, H4K20me1 has been shown to be involved in regulation 
of many cellular processes like genome stability, DNA replication, mitosis, and transcription 
(Beck et al., 2012; Lv et al., 2016). The broad spectrum of biological functions linked to 
H4K20me1 is in good agreement with the variety of functions connected to the proteins 
regulated by H4K20me1 as well as the stronger differences and smaller similarities to the other 
histone modifications investigated here. 
 
The second modification in this study that showed a unique protein-binding regulation when 
compared to the other modifications was H4R3me2. Although this modification was expected to 
be in association with heterochromatin (Le Guezennec et al., 2006; Zhao et al., 2009), six of 
nine recruited proteins were polymerase subunits. Additionally, several proteins that were 
recruited to H3K9me3, the hallmark of pericentric heterochromatin, were excluded from binding 
to H4R3me2 (Table 3.1). These findings strongly suggest an association of H4R3me2 with 
transcriptional activation. In agreement, it was shown that dependent on the methyltransferase 
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that set the di-methylation of H4R3, either PRMT1 or PRMT5, H4R3me2 can be associated with 
transcriptional activation or repression, respectively (Barrero and Malik, 2006; Le Guezennec et 
al., 2006).  
 
4.3 Protein-binding interactomes of modified chromatin arrays display only 
moderate overlap compared to those revealed with different modified 
templates 
 
In recent years several laboratories have made attempts to identify proteins specifically 
associated with distinct histone modifications by using templates such as N-terminal histone 
peptides, mononucleosomes and chromatin arrays (Bartke et al., 2010; Bluhm et al., 2016; 
Engelen et al., 2015; Kunowska et al., 2015; Nikolov et al., 2011; Oda et al., 2010; Vermeulen et 
al., 2010).  
 
In the core of H3K9me3, the proteins CBX5, CBX3 and POGZ were identified in six independent 
studies (including this one) using different templates, cell lines and organisms (Bartke et al., 
2010; Bluhm et al., 2016; Engelen et al., 2015; Kunowska et al., 2015; Nikolov et al., 2011; 
Vermeulen et al., 2010). This high level of convergence suggests a strong affinity to chromatin 
for these proteins, which is in contrast to the finding that the interaction of POGZ and CBX5 
weaken the interaction of CBX5 to chromatin (Nozawa et al., 2010). Overall, nearly half of the 
proteins I found to be recruited by H3K9me3 were identified at least in one of the published 
studies mentioned above.  
The overlap of H3KC27me3 recruited factors with published data was much lower. Common 
factors were CBX8 and several members of the ORC complex (Bartke et al., 2010; Vermeulen et 
al., 2010). The ORC complex seems to have a very strong affinity for heterochromatic 
modifications as the complex was also recruited to H3K9me3 and H4K20me3, which was 
observed using N-terminal histone peptides and mononucleosomes as well (Bartke et al., 2010; 
Vermeulen et al., 2010).  
Next to the ORC complex I found another common feature of H3K9me3, H3K27me3 and 
H4K20me3 that had not been described before. The interactomes showed the recruitment of 
several eukaryotic translation initiation factors (Table 3.1). This was unexpected since these 
factors function in translation initiation within the cytoplasm and were previously shown to be 
absent from the nucleus (Bohnsack et al., 2002). As already discussed earlier, it is unlikely but I 
cannot rule out that such observation could be attributed to contaminations of the nuclear 
extracts by cytosolic proteins. Notably, several translation initiation factors were also found as 
background binders in the context of peptide pull-downs of H3K9me3, H3K27me3 and 




H4K20me3 (Vermeulen et al., 2010), indicating that these factors seem to be general 
constituents of (HeLa) nuclear extracts. The functional association of the translation initiation 
factors to the heterochromatic modifications H3K9me3, H3K27me3 and H4K20me3 in contrast 
remains to be in investigated.  
 
Most of the differences observed are likely attributed to the different types of templates used in 
the previous studies. In contrast to N-terminal histone peptides, chromatin arrays are formed by 
an underlying DNA sequence and histone octamers. Thus, chromatin arrays allow the 
identification of proteins that require a binding platform consisting of more than one interaction 
site that can be provided by e.g. the globular domain of a histone, the DNA or a second 
nucleosome in the case of inter-nucleosome binding of histone modification in trans. The latter 
binding mode can also not be addressed using mononucleosomes.  
Some of the differences can also likely be attributed to the different experimental procedures 
used in the different studies. For example, nuclear extracts derived from different organism and 
cell types have been used, different mass spectrometer devices with varying sensitivity, the 
number of technical and biological replicates, and statistical evaluations contribute to divergent 
protein identifications.  
 
However, in comparison to the interactomes of defined posttranslational chromatin modifications 
published so far, the number of proteins we found to be affected using modified chromatin arrays 
is much larger. Only a moderate overlap was observed between my thesis work and the studies 
available in the literature (Table 3.1). This is especially true regarding proteins showing 
decreased affinities to a certain modification state. Thus, the data presented here offer a close to 
comprehensive list of factors whose binding to chromatin is affected by posttranslational 
modifications comprising also the excluded proteins, which in previous studies have been 
essentially kept out of focus. These extended dataset provide not only new functional relations of 
histone modifications but also enables the investigation of chromatin modification crosstalk. All 
these facts validate the gain of additional information provided with the here presented study and 
strongly support the usage of a more complex template closer to the native form of chromatin.  
 
4.4 Individual heterochromatic marks display positive as well as negative 
functional correlation 
 
Since all investigated modification states have been shown to be associated with 
heterochromatin and transcriptional repression (Table 1.1) I expected a certain level of overlap 
of regulated factors. However, due to the vast number and diversity of proteins regulated by the 
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individual chromatin modifications, it turned out to be very challenging to draw any general 
conclusions. Therefore, the functional relationship between individual modifications was 
investigated by using gene annotation enrichment analyses. These analyses showed positive as 
well as negative functional correlation of chromatin modifications and highlighted groups, which 
appeared to be functionally linked. 
H3K9me3, H4K20me3, H3KC27me3, and H3K9me3|H4K20me3 showed a strong correlation in 
the context of annotated pathway terms (Figure 3.19 A), suggesting a functional link between 
these modifications. All these modifications have been shown to localize to pericentric 
heterochromatin and to be involved in transcriptional repression (Barski et al., 2007; Fischle et 
al., 2003a; Lachner et al., 2003; Ringrose and Paro, 2004; Schotta et al., 2004; Sims et al., 
2006; Wang et al., 2008). This observation is consistent with the strong correlation on one hand 
and validates the analytical approach on the other hand.  
Negative functional correlation was observed between H4R3me2 and the two modification states 
H3K9me3 and H3KC27me2. While H4R3me2 recruited several polymerase subunits these 
factors were excluded from binding to H3K9me3 and H3KC27me2, strongly suggesting an 
association of H4R3me2 with transcriptional activity. H4R3me2 has been found in the context of 
both, transcriptional activation and repression as described earlier. 
Additionally, H3KC27me2 displayed a negative correlation to H4K20me1. While H3KC27me2 
showed an increased binding affinity for several spliceosomal factors, in turn H4K20me1 
significantly excluded factors associated with the spliceosome from binding to chromatin. This is 
the first time that such functional relationship between both modifications is described and 
suggested that H4K20me1 might mark sequences at the gene bodies with decreased splicing 
activity, while H3KC27me2 might promote splicing events as suggested in chapter 4.2.  
Besides H3KC27me2, H3KC27me1, H3K9me1/-me2, and H4K20me3 also displayed negative 
correlation to H4K20me1 (Figure 3.19 B), which indicate a unique biological significance for 
H4K20me1 compared to the other investigated modification patterns.  
 
4.5 Combinatorial readout in trans provides new insights into crosstalk between 
chemical chromatin modifications 
 
The identification of proteins binding in the context of the combination of modifications is still 
challenging despite vast technical developments. Thus, the multivalent interactions of chromatin-
binding proteins with combinatorial histone modification patterns were only touched upon in a 
limited number of studies. Here, I took the opportunity offered by our chromatin system to 
investigate the effect of combinatorial readout of H3K9me3 and H4K20me3 as well as H3K9me3 
and CpG-methylated DNA on a global scale. Both combinations of chromatin modifications were 




shown to be not only functionally linked but also displayed co-occurrence in several model 
organisms (Du et al., 2015; Mikkelsen et al., 2007; Schotta et al., 2004; Sims et al., 2006). 
 
The data collected highlight three general effects of combinatorial readout that were observed 
for both combinations, H3K9me3|H4K20me3 and H3K9me3|meCpG.  
In the first category, the double modification appeared to have “no effect” on protein-binding 
regulation. “No effect” was determined for the majority of proteins and referred to the finding that 
the protein-binding properties were similar over all three modification patterns, the two single 
modification sites and the combination thereof. These findings suggest that the regulation of 
protein recruitment to chromatin essentially relies on single modification sites.  
In the second category, I observed antagonistic binding properties for several proteins when 
comparing the double modification to the single ones. In the context of the double modification, 
the decrease in binding of factors that were found otherwise to be enriched with the individual 
modifications was defined as negative crosstalk. In relation to H3K9me3 and H4K20me3 
negative crosstalk was observed for several members of the septin family and spliceosomal 
factors, ASF1B, EIF5 and EIF4G1 (Figure 3.16 A). These findings give insights into the extent of 
consequences brought about by crosstalk. The effects of positive and negative crosstalk were 
not only limited to individual proteins but also were applied to entire protein complexes. Thus, it 
seems that not only direct binding proteins but also secondary interacting proteins were affected 
by crosstalk. Additionally, individual factors displayed negative crosstalk between H3K9me3 and 
meCpG as well as H3K9me3 and H4K20me3, namely USP3 and UBTF (Figure 3.16 A and 3.18 
A). 
Opposed binding was also determined in the reverse direction: crosstalk was considered as 
positive when the double modification displayed increased protein binding, while the individual 
modifications displayed decreased binding to chromatin. Several polymerase subunits and 
members of the NFI family displayed positive crosstalk between both H3K9me3 and meCpG as 
well as H3K9me3 and H4K20me3. Additionally, each of the modification combinations showed 
individual transcription factors that were affected. Recently, positive crosstalk was shown in 
context of H3 methylation and H4 acetylation. It was shown that the presence of H4K5ac next to 
H3K4me3 enhances the binding of BPTF and p300 to nucleosomes by at least seven-fold, 
probably mediated by simultaneous binding of the PHD and the bromodomain (Nguyen et al., 
2014). 
 
In the present study, conclusions about the binding mechanisms of single factors could not be 
drawn, as the experimental design does not allow determining whether a given protein binds 
directly or indirectly to the chromatin arrays. However, it appeared that positive crosstalk of 
chromatin modifications, mainly located at pericentric heterochromatin, tends to recruit factors 
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and protein complexes in association with transcriptional activity and thus, might be involved in 
the reversion of transcriptional repression at defined chromatin regions.  
Proteins showing negative crosstalk are inconclusively transcriptional repressors or in 
association with heterochromatin. In the context of negative crosstalk there seemed to be a 
trend of excluding factors or protein complexes involved in mitosis and proteins associated with 
the cytoskeleton in presence of one of the here investigated double modifications 
H3K9me3|meCpG and H3K9me3|H4K20me3. 
 
4.6 Protein-protein cross-linking coupled to MS maps the binding hierarchy of 
chromatin-bound proteins 
 
So far the identification of specific protein interactions using affinity purification based strategies 
coupled with cross-linking and mass spectrometry were challenging, mainly because of the lack 
in database engines capable to search for cross-links against large databases, which has 
restricted cross-linking approaches to the study of small protein complexes for a long time.  
Now, with important technological developments of recent years, it has become possible to set 
up a workflow that combines proteomic and protein-specific XL-MS. This offers the possibility to 
analyze topological information of the protein interactome associated with chromatin. As I have 
demonstrated, both the protein-binding interactome as well as the hierarchy of protein binding to 
chromatin can be analyzed.  
 
With the established workflow I found 75 cross-linked chromatin-associated proteins. As cross-
links covalently link proteins that are in close physical proximity, the proteins directly cross-linked 
to histones were considered as primary interactors. 18 of the cross-linked proteins showed a 
direct physical interaction to at least one of the core histones (Figure 3.26 A) while 20 factors 
were identified as indirect binders, not cross-linked to histones, but recruited to the chromatin 
arrays via primary binders. The remaining identified proteins could not be assigned to one of the 
core histones. The connecting factors may have not been detected or, alternatively, these 
proteins are recruited to chromatin by interacting with the DNA.  
STRING analysis of cross-linked proteins confirmed the biological association of these proteins 
and came as a support regarding the specificity of the cross-links and of the approach on a more 
general way (Figure 3.26 B).  
 
In contrast to the fact that more than 1000 proteins were identified to bind to the chromatin 
arrays using ChAP-MS, only a small number of proteins were found to be cross-linked. This low 
number might be attributed to limited availability and accessibility of interaction mediating 
sequences qualified for cross-linking. In brief, the BS3 cross-linker, which comprises two amine 




reactive groups separated by a spacer arm of 11.4-Å in length, reacts with primary amines in the 
side chains of lysine (K) residues and the N-terminus of polypeptides (Sinz, 2006; Tran et al., 
2016). Thus, only interacting protein surfaces exhibiting two lysines within a distance of 24-Å can 
be cross-linked. As a consequence, interaction interface that do not have lysines matching this 
criteria cannot be cross-linked, which result in the impossibility to identify actual interactions. 
This limitation may account, at least in part, for the rather small number of cross-linked proteins 
which were identified. Moreover, BS3 tend mostly to react with easily accessible lysine residues 
localized at the surfaces of protein complexes, since diffusion within the rather hydrophobic 
globular part of complexes is hindered by its hydrophilic nature (Huang et al., 2004). As a 
consequence, this may lower the number of cross-links and therefore reduce the number of final 
interacting partner identified. Additionally, the two enrichment steps on the protein as well as the 
peptide level by size exclusion chromatography are known to lead to loss of biological material. 
 
Another limitation is related to on-bead cross-linking. Streptavidin coated beads that were used 
in this workflow have the potential to cross-link purified proteins to the beads itself, potentially 
leading to false positive identifications. To overcome this issue, the underlying biotinylated DNA 
of the cross-linked sample was degraded, which resulted in the release of histone octamers and 
their associated proteins from the beads. 
 
In conclusion, we established a robust workflow that allows the highly specific identification of 
protein-protein cross-links in the context of chromatin affinity purification. The workflow enables 
the mapping of specific protein-protein interaction sites on one hand and provides information 
regarding the hierarchy of protein binding with each other and to chromatin on the other hand. 
The workflow identifies the abundant chromatin-interacting proteins and therefore has a strong 
potential for the investigation of physical protein-protein interaction sites of protein interactomes 
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5 Conclusions and future perspectives 
 
I have shown here, that ChAP-MS is suitable for the elucidation of the interactomes of single and 
complex chromatin modification patterns. My results provide a step towards functional 
characterization of individual modifications deposited on an oligonucleosomal chromatin 
template. Each of the modification patterns studied here regulated a specific set of factors, 
underscoring their distinct biological significance. The protein interactomes of individual 
modifications have revealed novel functional associations of specific marks. This was shown for 
H3KC27me2 that recruits several splicing factors, H4R3me2, which appears to have mainly 
impact on the recruitment of polymerase subunits and H3KC27me1, which was associated with 
transcriptional initiation and elongation by the CCR4-NOT complex. The assignment of biological 
functions to the different chromatin-binding interactomes on a global scale allowed the 
identification of novel relationships between individual modifications and indicated positive and 
negative functional correlation of PTMs. One example is the inverse regulation of the binding 
properties of several spliceosomal factors by H3KC27me2 and H4K20me1.  
My work shows that combinations of different modifications in the context of chromatin can 
reveal important aspects of the nature and the complexity of the language of histone PTMs. 
Indeed, the combinatorial experiments presented here identified a subset of factors regulated 
only in presence of two modification sites. Thus, my experimental design gives novel, 
unpredicted insights into mechanisms of crosstalk between two chromatin modifications. Both, 
H3K9me3 and meCpG as well as H3K9me3 and H4K20me3 display positive as well as negative 
crosstalk, which underlines the importance of testing further combinations of modifications 
whose co-occurrence have been proved in vivo already.  
The performed experiments have proven to provide new insights into specific functions and 
regulation mechanisms of individual histone modification patterns. Extending this approach to 
euchromatic marks would significantly increase the knowledge of pathways underlying 
epigenetic regulations. Furthermore, ChAP-MS can determine the protein-binding interactomes 
in the context of distinct biological circumstances by using e.g. a native DNA sequence instead 
of an artificial one or cell extracts from different cell types, organisms or different developmental 
stages. 
The new cross-linking approach we have established provides a workflow for the identification of 
specific protein-protein interaction of chromatin-bound proteins. I expect this method will 
contribute to our understanding of the hierarchy of protein recruitment and deliver detailed 
information of physical interactions sites, allowing the identification of protein domains involved 
in protein-protein interactions. Expanding the workflow to modified chromatin arrays will in the 
near future provide insights into the formation of protein complexes in the context of different 
chromatin modification patterns.  
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Appendix 1 Proteins significantly recruited or excluded by one of the chromatin modification patterns investigated by chromatin affinity 
purification. The gene names, the uniprot identifier (Protein IDs) and the normalized heavy to light ratios of the forward (F) and the 
reverse (R) experiments are shown as reported by MaxQuant for each chromatin modification state. 
 
 



























































AAK1 D6W5G0 0.75 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.24 0.27 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
AAR2 Q9Y312 1.05 1.48 0.77 1.11 0.94 0.40 1.27 NaN 0.95 0.86 0.64 1.21 0.89 0.72 1.03 0.23 1.60 0.87 NaN NaN 0.77 1.31 NaN NaN 1.26 0.57
AARS H3BPK7 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.24 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ABCF1 H3BPK7 0.91 2.13 0.50 0.85 4.99 0.28 0.89 NaN 0.91 0.49 1.60 0.26 0.42 0.57 1.18 1.40 1.78 0.25 5.02 0.19 0.74 0.63 0.92 1.63 0.67 0.41
ACACA B2ZZ90 0.23 7.76 0.15 2.31 0.70 0.49 0.45 0.73 1.05 0.41 0.30 1.37 1.22 0.43 1.02 2.03 0.57 0.59 0.44 1.27 0.11 2.62 0.74 0.56 0.44 0.72
ACACB O00763 NaN NaN NaN NaN NaN NaN NaN NaN 0.13 0.81 NaN NaN NaN NaN NaN NaN 0.54 NaN 0.62 1.24 NaN NaN 0.68 0.82 0.31 0.46
ACIN1 Q9UKV3-5 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ACIN1 E7EQT4 7.62 1.91 0.50 1.46 1.04 0.67 0.73 0.94 2.27 0.33 1.12 0.93 1.92 0.57 2.49 1.55 1.08 0.53 1.74 3.87 0.54 1.45 1.96 1.84 0.36 0.44
ACTL8 Q9H568 0.16 1.89 1.45 1.11 2.28 0.81 1.04 NaN 2.09 0.95 1.60 0.93 2.30 0.49 4.56 0.10 4.26 0.21 29.52 0.02 2.54 0.55 18.41 0.06 0.54 3.09
ACTN4 O43707 0.80 0.90 2.13 NaN 0.88 0.71 0.37 2.19 1.29 0.50 NaN NaN NaN NaN NaN NaN 0.80 NaN 0.56 1.92 0.47 0.39 0.83 0.40 NaN NaN
ACTR5 Q9H9F9 0.40 0.34 2.21 0.49 0.77 1.51 1.14 0.77 0.69 2.29 1.35 1.04 0.25 3.79 0.20 1.28 0.50 2.40 9.93 0.21 2.89 0.52 1.10 1.62 NaN NaN
ACTR8 Q9H981 0.60 0.46 2.03 0.58 0.75 1.42 1.37 NaN 0.70 2.28 1.33 1.21 0.27 4.17 0.21 1.49 0.51 2.37 12.93 0.20 2.77 0.53 1.05 1.42 3.04 0.47
ADNP B2RBM8 0.52 0.59 0.79 0.79 0.69 1.05 0.73 0.73 0.74 0.92 0.94 0.76 1.03 1.18 0.88 0.23 2.82 0.22 55.25 0.01 3.69 0.16 0.99 1.55 1.61 0.18
ADNP2 Q6IQ32 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 3.46 0.19 19.12 0.09 0.93 0.34 1.10 NaN NaN NaN
AEBP2 B3KXA1 NaN NaN 0.57 NaN 0.60 1.14 NaN NaN 0.50 NaN 0.30 NaN NaN NaN NaN 0.29 1.73 0.49 4.10 0.84 3.03 0.34 NaN NaN NaN 1.21
AHCY P23526 NaN 0.20 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.39 NaN 0.03 1.01 0.33 1.76 1.06 1.16 0.99 1.01 NaN NaN
ALDH18A1 P54886-2 3.74 NaN NaN 1.18 NaN NaN NaN NaN NaN NaN NaN 0.56 NaN 0.27 1.91 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ALDOA P04075 0.24 0.15 2.09 NaN NaN NaN 0.13 2.58 NaN NaN NaN NaN NaN NaN 0.26 0.46 NaN NaN 0.22 1.86 NaN NaN 0.94 0.41 NaN NaN
ALDOC B7Z3K9 NaN 0.18 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.21 NaN NaN NaN NaN NaN NaN NaN
AMN1 B7Z7J3 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.93 NaN 0.37 0.48 0.15 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
AMY1A Q6NSB3 NaN NaN NaN NaN 0.06 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ANKRD11 Q6UB99 0.67 NaN 0.09 NaN 0.53 2.29 0.66 NaN 1.86 0.46 0.99 1.27 NaN 1.16 NaN 0.23 0.73 1.19 3.16 0.48 0.89 1.36 1.57 0.66 NaN NaN
ANKRD12 Q6UB98-2 NaN NaN 0.25 2.26 0.27 2.24 NaN 0.77 1.37 0.44 1.08 0.73 0.48 2.50 NaN 0.15 0.59 1.18 NaN NaN 0.76 1.10 NaN NaN 1.06 NaN
ANKRD32 B4DR33 0.68 0.45 NaN NaN 0.46 5.60 1.95 NaN 1.58 2.00 1.59 1.05 1.08 2.79 0.70 0.64 1.58 1.59 2.20 1.45 0.96 4.50 1.86 1.63 1.65 2.39
ANXA1 Q5TZZ9 0.23 0.15 NaN NaN NaN NaN 0.21 NaN NaN 0.64 NaN NaN NaN NaN 0.37 NaN NaN NaN 0.21 2.04 NaN NaN 0.90 0.18 NaN NaN
ANXA5 P08758 NaN 0.16 NaN NaN NaN 0.56 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.36 NaN NaN NaN 1.10 NaN NaN NaN
AP2A1 O95782-2 0.93 1.39 0.79 0.70 1.35 0.78 1.58 NaN 0.66 1.11 0.74 NaN 1.46 0.62 0.63 0.45 1.18 1.05 1.86 1.19 0.97 1.22 0.41 NaN 2.45 0.70
AP2B1 A8K916 1.04 1.70 0.68 0.88 1.80 1.03 1.58 0.75 0.78 1.31 0.72 0.87 1.21 0.69 0.70 0.18 1.60 1.37 1.92 1.48 0.66 1.64 0.20 NaN 2.38 0.73
APEX1 Q5TZP7 0.63 0.32 1.12 1.21 13.73 0.36 NaN NaN 2.43 0.75 1.60 0.68 NaN 0.40 0.54 3.17 2.21 0.81 0.45 1.47 0.69 1.33 NaN NaN NaN 1.22
ARG1 P05089 NaN NaN 0.69 0.47 NaN 0.09 0.07 NaN NaN NaN 0.08 0.54 NaN NaN 0.17 0.39 NaN NaN 0.16 NaN 0.67 0.12 NaN NaN NaN 3.95
ARHGEF3 E7EU49 0.52 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.38 0.44 0.10 NaN 1.26 NaN NaN NaN 1.61 NaN NaN NaN NaN
ARID4A P29374 NaN NaN 0.76 NaN 0.57 2.39 NaN 1.07 1.08 0.96 1.21 0.74 0.52 NaN NaN NaN 0.94 0.93 20.33 0.49 0.79 1.16 0.71 5.80 0.00 NaN
ARNTL B2RCL8 0.50 0.81 1.25 0.72 1.14 1.11 1.16 1.02 1.05 1.33 0.95 1.03 0.80 1.54 0.47 1.53 1.06 1.10 1.56 0.47 1.10 0.95 0.44 1.77 1.23 0.54
ARPC2 Q53R19 3.78 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.97 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ARPC4 P59998 0.49 1.82 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.71 0.56 0.49 0.36 NaN NaN 0.69 3.52 NaN NaN 2.30 2.61 NaN NaN
ASF1B Q9NVP2 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.67 NaN NaN NaN 29.25 NaN NaN NaN NaN
ASNS P08243-2 NaN 0.29 NaN NaN NaN 1.31 NaN NaN NaN NaN NaN NaN NaN NaN 0.77 0.38 1.02 NaN 0.49 NaN NaN NaN 0.93 0.55 NaN NaN
ATF2 A4D7U9 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.99 NaN NaN
ATF2 F5H629 NaN NaN NaN NaN NaN NaN NaN 0.87 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
  
 



























































ATF2 P15336-5 0.28 0.37 NaN NaN 0.49 0.94 0.63 0.59 0.56 1.10 0.71 0.64 NaN NaN 0.06 NaN 0.39 1.13 3.35 0.21 1.08 0.37 0.83 1.02 NaN NaN
ATF2 P15336-8 NaN NaN NaN NaN 0.46 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ATL3 Q6DD88 NaN 0.24 0.60 NaN NaN 0.29 NaN NaN 0.81 NaN NaN NaN NaN NaN NaN 2.15 2.21 NaN 0.94 NaN NaN 1.05 NaN NaN NaN NaN
ATP6V0D1 B2R7M1 1.15 1.51 NaN NaN NaN 1.02 NaN NaN NaN NaN NaN NaN 1.04 0.99 0.78 0.18 NaN NaN NaN NaN NaN NaN 0.13 NaN NaN NaN
ATP6V1B2 P21281 0.97 0.80 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.82 0.62 0.78 0.38 NaN NaN NaN NaN NaN NaN 0.12 NaN NaN NaN
ATP6V1F A4D1K0 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.21 NaN NaN NaN
ATRIP Q8WXE1-2 0.85 0.81 0.32 NaN 0.70 0.66 NaN NaN 0.84 NaN 0.96 NaN 0.84 0.45 0.62 0.36 0.81 0.79 NaN 0.38 0.46 0.61 NaN NaN 1.67 NaN
ATRX A4LAA3 0.65 0.48 0.33 0.55 0.39 0.40 0.34 0.49 0.48 0.50 0.44 0.55 0.51 1.07 0.67 0.35 1.41 0.20 1.25 0.13 0.85 0.25 0.50 0.32 0.45 0.39
BABAM1 M0R0I0 0.84 0.40 NaN 3.17 NaN NaN NaN NaN 1.34 0.55 NaN NaN NaN 0.89 NaN 0.25 NaN NaN 0.63 4.44 0.23 2.81 NaN NaN NaN NaN
BACH1 Q6ICU0 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 3.74 0.17 0.94 NaN 3.68 0.37 NaN NaN
BAG6 B0UX83 1.79 0.50 0.61 1.03 0.99 0.31 1.27 0.32 0.84 0.72 0.72 0.40 2.43 0.95 1.53 0.21 1.34 0.52 NaN NaN 0.93 1.07 NaN NaN 1.52 0.40
BARD1 F6MDH7 0.64 0.37 0.11 4.55 0.23 2.99 0.75 0.75 1.02 0.67 0.97 0.77 0.60 1.09 0.59 1.17 0.74 0.84 0.63 1.22 0.19 2.47 1.04 0.64 0.64 0.92
BAZ1B Q9UIG0-2 0.07 5.41 1.21 0.93 1.31 1.00 0.98 0.86 0.93 1.19 1.04 1.10 1.08 1.38 0.67 1.02 1.10 0.96 1.60 2.27 1.00 1.07 1.39 1.81 0.56 1.38
BAZ2A J3QK86 NaN NaN 0.54 0.77 0.34 1.11 NaN NaN 0.72 0.48 0.85 0.58 0.50 NaN NaN NaN 0.34 1.83 NaN NaN 0.60 0.94 NaN NaN 0.83 NaN
BCLAF1 E9PK91 0.23 0.24 NaN NaN NaN NaN 0.81 NaN NaN NaN NaN NaN NaN NaN 2.21 NaN NaN NaN NaN NaN NaN NaN NaN 1.41 NaN NaN
BCLAF1 Q9NYF8-2 9.47 0.39 3.98 3.10 0.69 0.83 0.80 1.37 0.85 0.66 4.28 2.20 NaN NaN 0.98 0.78 0.89 0.97 1.13 1.31 0.58 0.72 1.38 1.51 0.68 0.79
BCR/ ABL f . A9UEZ6 0.91 NaN NaN NaN 4.19 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.11 NaN NaN NaN
BCR/ ABL f . P11274-2 1.12 0.65 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.92 0.13 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
BHLHB2 Q6IB83 0.62 0.59 0.56 0.36 0.46 0.55 0.46 0.36 0.45 0.50 0.43 0.47 NaN NaN 0.68 1.19 0.39 0.45 1.78 0.26 0.40 0.51 0.32 1.34 0.68 0.30
BLMH Q13867 NaN NaN NaN NaN 0.47 NaN 0.17 NaN 40.10 NaN 0.73 NaN NaN NaN NaN 11.03 5.54 NaN 0.45 0.77 NaN NaN 4.60 NaN NaN NaN
BPTF E9PE19 NaN NaN NaN NaN NaN 0.74 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.71 0.66 NaN NaN NaN NaN
BPTF F5GXF5 NaN NaN NaN 0.06 0.56 0.32 NaN NaN 0.34 0.20 0.31 0.32 NaN NaN NaN NaN 0.32 0.27 NaN NaN 0.25 0.33 NaN NaN NaN 0.58
BPTF F5H176 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.40 NaN NaN NaN NaN 0.86 0.79 NaN NaN NaN NaN
BPTF Q12830 0.29 1.33 0.54 0.79 0.64 0.67 0.57 0.58 0.93 0.45 0.72 0.63 0.37 1.10 0.61 0.75 0.70 0.64 2.01 0.39 0.63 0.61 1.04 0.71 0.74 0.44
BPTF Q12830-2 0.22 NaN NaN NaN NaN 1.32 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.03 NaN NaN 0.88 0.91 NaN NaN NaN NaN
BRCA1 Q3LRH8 0.86 0.39 0.31 4.37 0.25 2.39 0.78 0.65 1.09 0.62 0.95 0.85 NaN 1.03 0.43 0.12 0.75 0.91 1.18 1.10 0.23 2.40 1.11 0.47 0.62 0.72
BRCC3 P46736-2 0.55 0.21 NaN NaN 0.42 1.68 0.43 NaN 1.37 0.48 0.75 0.88 0.61 0.88 0.33 0.27 0.98 0.65 NaN 0.29 0.17 2.71 NaN 0.38 0.64 0.79
BRD2 H0Y6K2 0.29 3.05 1.22 1.45 1.29 2.47 1.13 1.42 1.26 1.38 1.15 2.12 0.83 2.19 0.87 1.67 1.44 1.55 1.39 1.80 1.30 2.09 1.86 1.94 1.09 1.76
BRE Q9NXR7-4 0.48 0.26 0.21 3.04 0.42 1.66 0.61 NaN 1.46 0.45 0.75 0.70 0.61 NaN 0.41 0.12 0.97 0.63 0.63 0.47 0.15 3.33 0.53 0.25 0.59 0.62
BRMS1 Q9Y3T1 0.59 0.81 1.51 1.22 0.71 2.90 1.53 1.53 1.35 1.64 1.29 1.06 0.46 NaN NaN 1.89 1.07 1.44 10.22 0.23 1.04 1.55 0.64 4.30 NaN NaN
BRMS1L B3KU43 0.80 1.03 1.51 1.56 0.81 3.14 1.74 1.25 1.68 1.92 1.66 1.33 0.63 3.27 0.51 0.87 1.30 1.77 6.12 0.36 1.22 2.08 0.82 4.80 3.32 0.97
C10orf 12 Q8N655 0.25 2.70 NaN NaN 0.79 0.65 NaN NaN NaN NaN 0.61 NaN NaN NaN 0.96 0.59 NaN 0.66 1.74 2.39 0.94 0.39 1.09 1.90 0.54 NaN
C11orf 57 Q6ZUT1 NaN 2.82 2.96 0.88 1.45 1.13 1.50 2.01 1.41 1.62 0.69 2.60 NaN NaN NaN NaN 1.37 2.17 NaN 1.86 1.19 2.08 1.17 1.62 1.14 2.26
C19orf 47 Q8N9M1-2 NaN NaN NaN NaN 0.46 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.86 6.53 0.33 0.51 0.24 NaN NaN NaN NaN
C9orf 78 Q9NZ63 NaN 1.16 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.18 NaN NaN NaN NaN 0.37 NaN NaN NaN NaN NaN
CACYBP Q9HB71-3 1.44 NaN NaN NaN 1.13 0.59 0.65 NaN 1.12 0.71 0.61 0.66 0.68 0.86 1.42 0.65 0.52 NaN NaN NaN 0.67 0.68 NaN 0.86 NaN NaN
CAPN1 P07384 NaN 0.05 0.38 0.49 0.27 0.19 0.31 0.33 0.34 0.67 NaN NaN NaN NaN 0.37 6.16 1.45 0.76 NaN NaN 0.55 0.66 NaN NaN NaN 0.45
CAPRIN1 Q14444-2 NaN 4.34 NaN NaN NaN NaN 0.50 NaN NaN NaN NaN NaN NaN NaN 2.29 1.32 NaN NaN NaN NaN NaN 0.57 NaN NaN NaN NaN
CAST B7Z468 NaN 0.11 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CAST E7EVY3 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CAT P04040 NaN NaN NaN NaN NaN NaN 0.10 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.08 NaN NaN NaN NaN NaN NaN 1.01
CBFB Q13951 0.85 2.02 1.19 0.78 0.71 1.23 NaN NaN NaN NaN 0.24 1.06 NaN NaN 1.09 NaN 0.54 1.24 7.90 0.12 1.02 1.10 0.71 1.46 NaN NaN
CBFB Q13951-2 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.39 0.94 NaN NaN
CBR1 P16152 NaN 0.28 NaN NaN NaN NaN NaN NaN NaN 1.35 NaN NaN NaN NaN NaN NaN NaN NaN 0.43 NaN NaN NaN NaN NaN NaN NaN
CBX1 Q6IBN6 NaN NaN 1.17 0.74 0.77 1.22 0.78 0.79 0.68 1.04 1.04 0.89 1.18 0.62 1.84 0.42 7.84 0.07 26.41 0.16 8.65 0.06 NaN 0.80 2.66 0.32
CBX3 A4D177 0.68 0.50 1.35 0.89 0.87 1.53 1.06 0.99 0.96 1.48 1.32 1.08 1.69 0.78 1.76 0.23 8.64 0.08 16.22 0.01 8.76 0.10 1.55 0.92 2.83 0.25
CBX5 P45973 NaN NaN 0.68 NaN 0.65 0.69 0.46 0.87 0.42 0.97 0.66 0.59 2.29 0.26 4.80 0.14 9.47 0.13 20.30 0.06 10.24 0.08 1.32 0.92 NaN NaN
CBX8 Q9HC52 0.77 NaN 1.23 0.97 1.10 1.26 0.97 1.00 2.61 0.51 3.58 0.39 0.82 1.92 0.53 0.21 1.89 0.61 6.76 0.30 2.31 0.56 2.05 1.16 1.86 0.91
CCDC138 Q96M89 0.26 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.21 0.20 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CCDC59 Q9P031 0.49 NaN 1.16 1.23 1.18 1.23 NaN NaN 1.22 1.03 1.09 1.23 0.87 NaN 0.36 0.33 1.12 0.53 NaN 1.01 1.02 1.43 0.96 1.17 1.43 1.38
CD3EAP A8K818 NaN NaN NaN 0.79 0.61 0.58 0.75 0.59 NaN NaN 1.42 0.61 NaN NaN NaN 6.25 0.32 0.95 5.46 0.44 1.62 0.28 NaN NaN NaN NaN
CD3EAP O15446 1.47 1.84 0.73 0.90 0.62 0.65 1.16 0.79 0.33 2.02 1.49 0.58 NaN NaN 1.22 7.41 0.30 0.94 2.77 0.35 1.54 0.30 NaN NaN NaN NaN
CDK2AP1 O14519-2 NaN NaN NaN NaN 1.31 1.28 NaN NaN NaN 1.40 NaN NaN NaN NaN NaN NaN 0.88 1.51 0.03 NaN 1.04 1.83 5.32 0.11 NaN NaN
CDKN1A Q96LE1 NaN NaN NaN 0.53 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.40 NaN NaN NaN 0.59 NaN NaN NaN NaN
CDSN Q0EFA5 0.08 NaN NaN NaN NaN NaN 0.14 NaN 0.21 0.06 0.25 NaN NaN NaN NaN NaN NaN NaN 0.14 NaN 0.07 NaN NaN NaN NaN NaN
CDYL Q9Y232-2 0.86 0.57 0.47 0.61 0.35 1.16 0.59 0.59 0.64 0.66 0.86 0.50 0.71 0.58 0.96 0.18 1.80 0.23 3.90 0.17 1.89 0.20 1.23 1.06 1.03 0.19
CDYL2 Q8N8U2 NaN NaN 0.86 0.86 0.40 1.53 NaN NaN NaN NaN 1.54 0.47 1.37 1.27 NaN NaN 2.50 0.37 6.51 0.09 2.74 0.25 1.32 0.97 NaN NaN
































































CEBPD P49716 NaN 0.23 1.60 0.91 0.60 2.75 NaN NaN NaN 1.92 1.26 1.32 NaN NaN 0.10 1.23 0.48 2.77 5.85 0.15 1.69 0.92 1.26 1.37 NaN NaN
CEBPG P53567 NaN NaN 1.47 0.79 0.60 NaN NaN NaN NaN NaN 1.11 NaN NaN NaN NaN 2.99 0.60 2.45 NaN NaN 1.85 NaN NaN NaN 2.14 NaN
CENPF P49454 1.08 0.70 1.29 0.70 1.76 0.58 0.17 1.03 1.12 0.69 0.73 1.15 NaN NaN 1.31 0.60 1.74 0.63 0.22 12.26 0.78 1.20 1.18 1.42 0.52 1.52
CENPV Q7Z7K6 1.87 1.97 0.87 0.65 0.88 0.92 0.84 0.80 0.77 0.86 0.78 0.77 0.72 0.97 2.21 4.94 0.73 0.75 1.40 1.22 0.89 0.77 0.92 1.02 0.77 1.14
CENPV Q7Z7K6-3 NaN 2.18 NaN NaN NaN NaN 0.93 0.92 NaN NaN NaN NaN NaN NaN 2.26 NaN NaN NaN NaN 0.83 1.22 1.13 0.75 1.28 NaN NaN
CGGBP1 Q9UFW8 0.71 1.11 0.44 NaN 2.30 0.45 NaN NaN 1.03 0.90 0.96 0.44 NaN NaN 0.45 0.53 1.67 0.35 6.52 0.18 1.32 0.61 0.50 2.13 NaN NaN
CHAF1A D6W625 0.49 1.07 0.96 0.48 1.34 0.83 0.55 0.82 0.41 1.55 0.76 0.92 NaN 0.64 0.86 1.02 4.77 0.12 5.08 0.37 6.15 0.10 1.50 1.54 NaN NaN
CHAF1B B2R7X3 0.58 0.82 0.89 0.41 1.10 0.83 0.54 0.78 0.38 1.54 0.81 0.75 0.71 0.59 0.85 1.61 4.40 0.13 2.30 0.59 7.41 0.07 1.30 1.25 2.10 0.18
CHAMP1 Q96JM3 1.07 0.71 1.09 0.85 1.06 1.04 0.61 NaN 0.77 1.66 1.22 1.35 1.21 NaN 0.63 0.14 6.98 0.18 11.02 0.12 7.92 0.14 4.49 0.54 1.06 0.34
CHD1 O14646-2 1.40 0.47 0.81 0.54 1.32 0.48 0.67 1.82 1.08 0.57 NaN 0.99 NaN NaN 1.33 0.46 1.09 0.45 0.31 6.01 0.54 1.03 0.78 0.95 0.23 1.99
CHD1L Q86WJ1 NaN 0.51 NaN NaN NaN 0.38 NaN NaN NaN NaN NaN NaN NaN 1.35 0.69 0.56 NaN NaN 0.34 0.68 0.31 NaN 0.63 0.40 NaN NaN
CHD3 H7C0J3 NaN NaN NaN NaN NaN 1.15 NaN NaN NaN NaN NaN NaN NaN NaN 0.68 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CHD3 Q12873 0.53 NaN 0.60 0.49 0.59 0.41 0.48 0.46 0.69 0.49 0.68 0.41 0.44 1.34 0.42 0.16 0.38 0.46 4.21 0.28 0.61 0.41 4.32 0.15 0.76 0.22
CHD4 F5GWX5 0.58 1.00 0.80 0.75 0.89 0.66 0.73 0.73 0.91 0.65 0.87 0.71 0.56 1.06 0.79 0.41 1.12 0.52 11.85 0.03 1.31 0.44 3.94 0.19 1.17 0.43
CHD4 Q14839 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.60 0.53 8.52 0.26 2.15 0.32 NaN NaN NaN NaN
CHERP Q8IWX8 1.76 2.12 0.86 1.82 1.60 0.83 0.84 1.16 1.52 1.37 NaN 1.66 NaN NaN 1.26 0.62 1.61 0.94 1.38 1.03 0.88 2.02 1.16 1.13 0.91 1.36
CHTOP Q9Y3Y2-4 2.23 0.46 0.50 1.83 0.81 0.77 0.70 1.02 2.25 0.76 1.31 1.03 1.19 NaN 0.77 0.23 0.92 0.73 3.44 1.26 0.99 1.06 2.32 NaN 0.80 0.49
CIR A0PJI7 NaN NaN 1.43 0.23 NaN NaN NaN NaN 0.65 0.69 NaN NaN NaN NaN NaN NaN NaN NaN 1.09 0.84 NaN NaN 1.05 1.45 NaN NaN
CKAP2 B2RMQ4 3.76 2.14 0.41 0.64 0.53 0.50 0.55 NaN 0.64 0.71 0.72 0.92 0.53 NaN 0.01 0.25 0.53 0.75 0.35 1.36 0.50 0.71 0.87 0.67 0.38 0.52
CKAP2 E9PD90 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.63 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CKB P12277 NaN 0.18 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.30 NaN NaN NaN 0.29 NaN NaN NaN 1.18 0.39 NaN NaN
CLASP1 B7ZLX3 NaN NaN NaN NaN 1.59 0.70 NaN NaN NaN NaN NaN NaN NaN NaN 0.42 0.03 0.75 0.55 NaN NaN 1.40 0.50 NaN NaN NaN NaN
CLASP1 Q7Z460 0.53 3.25 0.69 0.42 1.29 0.52 0.74 0.52 0.87 0.47 0.82 0.35 1.54 0.55 0.54 0.08 0.79 0.51 2.96 0.31 1.04 0.40 0.53 0.67 1.16 0.25
CLASP2 F5H604 0.49 2.66 0.70 0.54 1.54 0.54 0.91 0.68 0.66 0.73 1.01 0.45 1.73 0.60 0.51 0.08 1.04 0.58 1.92 0.25 0.70 0.77 0.69 NaN 1.24 0.45
CLIC1 Q5SRT3 0.18 0.15 NaN NaN NaN NaN NaN NaN 1.79 0.32 NaN NaN NaN NaN 0.25 NaN NaN NaN 0.38 1.79 NaN NaN 1.15 0.31 NaN NaN
CLOCK Q53EU0 1.24 NaN 0.91 NaN 1.62 2.15 1.18 1.14 0.81 1.26 1.25 NaN NaN 2.57 NaN NaN 1.40 1.38 3.10 0.40 1.52 1.38 0.63 2.19 1.67 1.54
CLTC K7EJJ5 NaN NaN NaN 1.51 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CLUH I3L2B0 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CLUH K7EIG1 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CNBP P62633-2 1.04 0.79 1.07 0.57 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.78 2.12 NaN NaN 0.88 0.73 0.50 NaN 1.24 NaN NaN NaN
CNOT1 A5YKK6 0.91 1.60 0.56 0.79 1.01 0.30 1.05 0.34 0.52 0.68 0.46 0.57 1.42 0.33 0.76 0.06 1.17 0.67 2.19 NaN 0.48 0.96 NaN NaN 1.10 0.47
CNOT1 H3BMZ2 1.05 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CNOT10 Q9H9A5 0.87 1.17 0.48 0.66 1.07 0.30 0.86 NaN 0.36 0.64 0.42 0.55 1.16 0.48 0.72 0.18 1.05 0.69 0.82 NaN 0.50 0.84 NaN NaN 0.86 0.51
CNOT11 Q9UKZ1 0.67 0.77 0.71 0.61 0.88 0.40 1.23 0.42 0.52 0.77 0.51 0.46 1.02 0.42 0.63 0.15 1.20 0.72 1.30 NaN 0.56 0.95 NaN NaN 1.33 0.55
CNOT2 B3KTL6 NaN NaN 0.81 0.91 0.85 0.83 NaN 0.95 0.92 0.98 0.82 0.85 0.89 1.33 NaN NaN 0.75 0.96 NaN NaN 0.89 0.78 0.85 0.78 0.72 0.72
CNOT2 F8VV52 0.48 0.97 0.48 0.55 0.87 0.32 1.27 0.32 0.59 0.86 NaN NaN 0.79 0.55 0.53 0.21 0.93 0.61 NaN NaN 0.37 0.86 NaN NaN 0.84 0.52
CNOT3 H7C148 NaN NaN NaN NaN NaN NaN 0.63 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CNOT7 B3KM57 0.86 1.18 0.73 0.75 1.03 0.52 1.19 0.45 0.60 1.02 0.53 0.66 0.94 0.49 0.69 0.06 1.08 0.72 1.87 NaN 0.62 1.08 NaN NaN 1.72 0.57
COBL O75128-3 0.37 1.68 NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.70 NaN NaN 0.32 0.05 NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.39
CPNE1 F2Z2V0 NaN 0.30 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.65 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CPNE8 Q86YQ8 NaN 2.88 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.08 NaN NaN 0.62 1.26 NaN NaN NaN 0.94 NaN NaN
CRCP O75575 NaN NaN NaN NaN 0.44 0.62 0.35 0.75 0.51 0.75 0.67 0.66 NaN NaN 0.34 NaN 0.20 1.42 11.02 NaN 1.44 0.25 NaN NaN NaN NaN
CSTA Q6IB90 NaN NaN 0.55 NaN NaN NaN 0.07 NaN 0.40 NaN NaN 0.57 NaN NaN 0.08 NaN NaN NaN 0.06 NaN 0.08 NaN NaN 0.21 NaN NaN
CTSD P07339 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.18 NaN NaN NaN NaN 0.18 NaN NaN
CUEDC1 J3QLQ8 NaN NaN NaN NaN 1.84 0.61 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.52 NaN NaN NaN 0.76 1.05 13.24 0.16 NaN NaN
CUL1 Q13616 4.92 0.60 1.49 NaN 1.57 1.17 NaN NaN NaN NaN NaN NaN NaN 0.74 NaN NaN NaN 0.99 1.93 0.62 1.24 NaN 1.07 0.92 NaN NaN
CXorf 38 B2RD30 4.76 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
CYR61 B4DI61 12.33 9.81 0.73 0.75 0.61 0.47 0.54 NaN NaN NaN 0.67 0.94 0.36 NaN 9.50 7.97 0.33 NaN 1.11 1.14 NaN 0.55 1.04 0.96 NaN NaN
DDIT4 Q9NX09 0.35 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.39 0.12 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
DDX21 Q9NR30 1.52 3.92 0.33 1.51 1.03 1.03 1.05 NaN 1.51 0.76 1.36 0.66 0.85 1.17 2.92 0.83 0.72 0.81 1.07 1.67 0.75 0.91 2.31 1.25 0.79 1.11
DDX52 Q9Y2R4 0.44 2.36 1.35 1.06 1.11 0.83 0.91 NaN 1.63 0.95 0.95 1.25 1.62 0.77 0.54 0.15 1.00 0.92 1.44 0.94 1.18 1.00 1.65 0.93 0.90 2.38
DDX5-ETV4 f . C1IK54 0.45 NaN NaN NaN 0.11 0.31 NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.17 NaN NaN 0.04 0.28 NaN NaN NaN NaN NaN NaN
DEFA3 Q6EZE9 0.02 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
DFNA5 H7C147 0.17 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
DFNA5 O60443 0.41 0.15 0.66 0.81 0.73 0.25 1.17 0.35 0.54 0.71 0.38 0.52 0.68 0.88 0.34 0.13 1.45 0.53 NaN NaN 0.57 1.03 NaN NaN 1.25 0.49
DHX36 Q9H2U1 1.14 0.77 0.54 1.78 1.00 1.22 0.97 0.58 1.11 0.97 1.68 0.69 0.35 2.24 1.19 0.98 1.10 0.82 1.39 0.61 1.34 0.85 1.09 0.89 1.28 0.51
DLG3 Q92796-3 NaN 0.22 0.62 0.66 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.35 0.36 NaN NaN NaN 0.76 0.51 NaN NaN NaN NaN NaN
DNAH8 H0Y7V4 NaN NaN NaN NaN 116.99 0.85 NaN NaN 1.02 1.04 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 146.80 0.48 NaN NaN NaN NaN
  
 



























































DNMT1 F5GX68 0.19 1.69 1.18 0.42 2.58 0.46 0.60 0.96 0.83 0.78 1.04 0.69 1.45 0.46 4.40 0.28 3.14 0.18 56.86 0.01 1.82 0.38 31.78 0.02 0.38 1.61
DNMT1 P26358 NaN NaN 1.48 0.38 2.75 0.50 NaN NaN NaN NaN 0.95 0.70 1.41 NaN NaN NaN 3.32 0.20 NaN NaN 1.96 0.44 NaN NaN NaN NaN
DNMT1 P26358-2 NaN NaN 1.29 0.36 2.44 0.44 NaN NaN NaN NaN 1.05 0.66 NaN 0.23 NaN NaN 2.92 0.18 215.33 0.01 1.88 0.36 39.19 0.05 NaN NaN
DSC1 Q9HB00 0.08 0.07 NaN NaN 0.13 NaN 0.06 NaN 0.37 0.09 NaN NaN 0.68 1.08 0.08 NaN NaN NaN 0.06 0.13 0.13 NaN 0.17 NaN NaN NaN
DSC2 Q68DY8 NaN NaN NaN NaN NaN NaN 0.21 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
DSC3 A8K6T3 NaN NaN NaN NaN NaN 1.00 0.12 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.11 NaN NaN NaN NaN NaN NaN NaN
DYM J3QSE7 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.16 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
DYM Q7RTS9 0.79 0.91 0.44 0.72 0.91 0.32 1.11 0.34 0.44 0.65 0.45 0.38 0.76 0.51 0.73 0.14 1.28 0.71 0.71 NaN 0.49 0.99 NaN NaN 1.27 0.51
E2F1 Q01094 NaN NaN NaN NaN 0.65 0.50 0.62 NaN 0.46 0.46 0.54 0.74 NaN NaN NaN NaN 0.52 0.36 NaN 0.38 0.51 0.45 0.23 1.85 NaN NaN
E2F2 Q5U0J0 NaN NaN NaN NaN 1.04 0.74 NaN NaN 0.58 NaN NaN NaN NaN NaN NaN NaN 0.65 0.51 NaN NaN 0.57 0.65 0.45 1.49 NaN NaN
E2F6 O75461 0.75 NaN 3.04 1.67 1.61 3.48 2.27 2.24 1.77 3.06 2.02 2.42 1.10 2.77 0.78 0.49 2.47 1.83 2.05 0.13 3.44 1.48 1.71 3.74 5.28 NaN
E4F1 H3BUJ7 NaN 0.51 1.28 0.77 0.34 3.30 0.65 NaN 0.58 2.27 1.28 1.30 0.27 6.34 0.08 4.58 0.21 4.35 12.56 0.10 1.64 0.73 0.93 2.05 NaN NaN
EED O75530 0.29 1.91 0.89 0.64 0.90 0.66 0.65 0.90 0.81 0.74 0.76 0.77 0.50 1.51 1.31 0.76 1.46 0.33 2.34 0.29 1.41 0.35 1.01 1.60 0.71 0.60
EEF1B2 P24534 0.65 0.34 1.08 NaN 0.52 1.02 0.40 2.66 0.76 0.49 0.79 0.61 NaN NaN NaN 0.80 0.33 1.20 0.66 0.87 0.90 0.57 1.35 NaN 1.22 NaN
EEF2 P13639 0.88 0.41 1.39 NaN 1.10 0.97 0.40 NaN 1.35 0.60 1.12 NaN 1.50 0.93 0.74 0.39 1.02 0.85 0.18 1.50 0.61 0.86 0.97 0.38 NaN 0.88
EHMT1 Q9H9B1 0.45 0.51 1.05 0.92 0.68 1.60 0.85 1.06 0.94 1.27 1.14 0.98 2.16 0.74 1.03 0.25 0.38 2.02 8.61 0.20 1.05 0.87 2.20 2.01 2.29 0.34
EHMT2 A2ABF8 0.54 0.56 0.92 0.93 0.72 1.64 0.82 0.95 0.92 1.15 1.11 0.92 2.24 0.73 1.24 0.48 0.37 1.94 7.75 0.23 1.08 0.85 2.24 1.91 1.68 0.28
EIF2B5 Q13144 NaN 0.73 NaN NaN NaN NaN NaN NaN NaN NaN 22.40 0.95 1.34 1.12 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
EIF2S1 Q53XC0 1.52 2.07 1.09 1.30 8.22 0.34 0.89 1.13 1.29 0.76 1.96 0.50 0.55 0.46 1.32 1.23 2.84 0.35 NaN 0.26 0.97 1.00 1.09 2.28 1.57 0.64
EIF2S2 Q6IBR8 0.93 1.39 0.71 0.83 8.30 0.33 1.11 NaN 1.28 0.74 2.18 0.46 0.45 0.43 1.18 2.24 2.71 0.33 2.23 0.28 0.95 1.08 0.90 1.06 1.50 0.53
EIF2S3 P41091 0.82 1.35 1.01 1.02 7.23 0.32 0.88 1.04 1.16 0.67 2.08 0.52 0.79 0.72 1.15 0.98 2.37 0.34 2.61 0.62 0.88 1.03 1.23 1.24 0.95 0.52
EIF4A3 P38919 4.31 0.92 0.48 1.40 0.83 0.61 0.79 0.90 2.11 0.30 1.08 0.97 1.37 0.99 2.02 1.56 1.05 0.56 1.37 2.38 0.58 1.24 1.96 1.34 0.56 0.55
EIF4G1 E7EX73 1.30 1.24 NaN NaN 0.66 0.62 NaN 0.71 1.14 0.38 NaN NaN NaN 0.61 1.50 0.14 0.63 0.74 1.17 1.34 0.35 NaN NaN 0.88 0.62 NaN
EIF4H Q15056 NaN 0.20 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.36 0.56 NaN NaN 0.43 1.00 NaN NaN 0.89 0.87 NaN NaN
EIF5 P55010 NaN 0.40 NaN NaN 15.49 0.26 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.76 0.19 NaN 0.28 NaN 2.89 0.73 0.68 NaN NaN
EIF5B Q8N5A0 NaN NaN NaN NaN 6.17 0.19 NaN 0.86 NaN NaN 0.86 0.62 NaN NaN NaN NaN 0.88 0.21 NaN 0.24 0.39 1.02 NaN 1.53 NaN NaN
ELF1 P32519-2 0.80 NaN NaN 1.02 3.68 0.40 NaN NaN NaN NaN NaN NaN NaN NaN 0.19 3.47 2.27 0.34 3.10 0.24 2.38 0.57 0.47 1.85 NaN NaN
ELF2 B7Z720 0.69 0.40 NaN NaN 3.04 0.66 NaN NaN NaN NaN 1.99 0.55 NaN NaN 0.12 0.73 1.85 0.64 8.91 0.17 2.59 0.55 0.58 2.58 NaN NaN
ELF2 Q15723-1 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
EMG1 Q92979 0.51 0.79 0.84 0.87 7.42 0.27 1.02 0.93 1.61 2.89 1.04 0.62 0.75 0.62 0.53 0.15 2.79 0.25 2.15 0.49 0.72 0.96 1.43 1.85 0.85 NaN
ENO1 P06733 0.18 0.07 3.44 NaN 1.91 0.98 0.25 2.61 1.90 0.36 NaN NaN NaN 1.03 0.16 0.16 0.79 NaN 0.32 1.67 0.46 0.45 1.01 0.27 NaN NaN
EPPK1 P58107 NaN 0.69 1.42 1.10 1.01 0.48 0.13 NaN NaN 0.38 0.70 1.68 0.75 0.41 0.75 0.57 0.63 0.57 NaN 1.30 0.45 0.58 0.16 NaN NaN NaN
ESRRA Q569H8 NaN NaN NaN 0.56 2.28 0.83 0.83 0.95 0.25 3.92 0.78 0.87 NaN NaN NaN NaN 0.80 1.42 4.48 0.22 1.82 0.54 NaN NaN 1.46 0.50
ETV6 P41212 0.57 0.56 1.66 1.44 0.83 2.60 1.27 1.96 0.97 2.56 1.31 1.17 0.78 2.38 0.27 0.71 0.65 2.49 10.92 0.03 1.86 0.84 0.80 1.04 2.01 1.12
EXOC2 Q96KP1 0.88 1.19 0.84 0.95 0.94 0.53 1.13 0.70 0.94 0.99 0.74 1.46 0.77 0.64 0.77 0.21 1.33 1.05 NaN NaN 0.65 1.22 NaN NaN 2.44 0.60
EZH2 Q15910 0.32 1.99 0.77 0.71 1.06 0.94 0.73 0.94 0.87 0.98 0.90 1.03 0.59 1.42 1.34 1.02 1.49 0.45 1.85 0.94 1.38 0.42 1.13 1.69 0.99 0.74
FABP5 E7DVW5 NaN NaN NaN NaN NaN NaN 0.07 NaN NaN NaN NaN NaN NaN NaN 0.08 0.18 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
FAM114A1 Q8IWE2 NaN 0.05 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
FAM129B Q96TA1-2 1.31 1.04 NaN NaN 0.85 0.50 0.80 NaN NaN NaN 1.24 NaN NaN NaN 1.46 0.93 0.29 NaN 0.26 NaN 0.90 1.12 0.92 1.09 0.01 0.56
FAM134C Q86VR2 NaN 0.22 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.62 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
FAM48A B3KNI1 NaN 0.22 0.54 0.41 0.45 0.91 NaN NaN NaN NaN 0.94 0.65 NaN NaN 0.33 NaN 0.50 0.93 NaN NaN 1.16 0.32 NaN NaN NaN NaN
FBXL6 Q8N531 0.68 0.30 0.95 0.54 0.69 0.80 1.09 0.40 0.69 0.64 0.90 0.41 0.42 1.61 0.62 NaN 0.67 0.65 2.90 0.14 0.75 0.67 0.60 1.03 0.49 0.72
FBXW11 B4DH70 NaN 2.12 1.02 0.79 0.61 1.12 0.82 0.81 0.71 1.07 0.80 0.85 0.45 2.58 NaN NaN 0.51 1.11 8.04 0.21 0.91 0.77 1.16 1.11 NaN 0.53
FGF2 D9ZGF5 0.88 1.98 0.50 1.65 0.99 0.84 0.81 NaN 1.21 4.17 4.84 NaN NaN NaN 1.59 4.47 0.82 0.72 0.79 0.41 0.70 0.81 0.86 0.46 0.44 0.76
FIZ1 Q96SL8 0.81 0.39 0.64 0.82 0.46 1.52 0.80 0.77 0.52 0.64 0.71 0.62 0.29 1.40 0.62 6.13 0.28 1.13 9.62 0.04 0.58 0.50 6.84 0.17 1.19 0.30
FMNL1 I6L9I9 NaN 0.15 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.30 0.63
FMNL1 O95466-2 0.86 0.13 0.70 1.00 0.87 0.34 NaN NaN NaN NaN 0.84 NaN NaN NaN 0.62 2.51 1.12 1.00 1.21 0.99 1.05 1.18 NaN NaN NaN 0.60
FNBP4 D3DQS4 NaN 2.29 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.98 0.96 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
FOXN2 Q6IS90 0.42 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.84 1.17 0.78 NaN 0.34 NaN NaN NaN NaN 0.70 NaN NaN NaN NaN NaN
FRMPD3 Q5JV73 0.07 NaN 0.95 0.85 0.29 0.88 NaN NaN NaN 0.04 7.21 0.78 7.64 1.26 0.94 NaN 0.56 0.21 0.38 0.09 0.40 2.45 0.10 NaN 0.33 0.25
G2E3 F5GX24 0.34 0.38 1.30 1.13 1.23 0.81 0.25 2.63 0.56 1.38 0.29 4.19 1.36 1.05 0.76 0.67 1.22 0.79 0.46 12.76 0.94 1.18 2.66 1.57 0.66 1.18
GATAD2A Q86YP4 0.39 0.90 1.01 0.72 0.95 0.84 0.98 0.96 1.01 0.82 0.92 0.85 0.41 1.45 0.67 0.87 0.68 1.10 5.61 0.05 0.69 1.03 4.53 0.15 1.45 0.52
GATAD2B Q8WXI9 0.43 0.85 0.81 0.61 0.85 0.61 0.66 0.72 0.82 0.69 0.76 0.68 0.34 1.32 0.69 0.50 0.58 0.92 5.81 0.03 0.57 0.90 5.07 0.10 0.99 0.42
GBP1 Q5D1D5 NaN NaN NaN NaN NaN NaN 0.04 0.50 NaN 0.25 0.91 NaN NaN NaN NaN NaN NaN NaN 0.10 NaN NaN 0.04 NaN NaN NaN NaN
GCC2 Q8IWJ2 NaN 0.33 1.10 NaN NaN 0.66 1.02 0.21 NaN 0.89 0.78 NaN NaN NaN NaN 0.14 1.77 1.16 NaN 0.13 0.99 1.10 NaN NaN 0.85 1.58
GDI2 Q5SX86 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.71 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.91
GDI2 Q6IAT1 2.61 0.14 1.74 NaN NaN NaN 0.23 NaN NaN NaN NaN NaN NaN NaN 0.71 NaN NaN NaN 0.20 1.37 NaN NaN 0.87 0.26 NaN NaN
































































GGNBP2 A8K3S2 0.44 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.63 0.46 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
GNB2L1 E9KL35 1.08 1.05 NaN NaN 1.24 0.99 0.25 NaN NaN 0.43 NaN NaN 0.64 1.33 1.01 0.23 1.26 NaN NaN 1.02 1.28 1.31 0.68 0.68 1.40 NaN
GOLGB1 Q14789 NaN 0.24 0.08 0.42 0.60 0.12 NaN NaN NaN NaN 0.05 NaN NaN 1.33 NaN NaN 1.12 0.67 NaN NaN 0.67 0.81 NaN NaN 0.97 1.29
GOLT1B G3V1U5 NaN NaN NaN NaN NaN 0.19 NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.04 NaN 1.39 NaN NaN NaN NaN NaN NaN NaN NaN
GSTP1 P09211 NaN NaN NaN NaN NaN NaN 0.10 NaN NaN NaN NaN NaN NaN NaN NaN 0.70 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
GTF2E2 P29084 NaN NaN NaN 0.59 1.47 0.50 0.79 2.24 0.94 1.66 0.57 2.17 0.31 3.64 0.68 0.79 NaN NaN NaN NaN 1.66 0.95 NaN 1.73 NaN NaN
GTF3C4 Q9UKN8 0.81 0.55 0.51 0.55 0.71 0.66 0.51 NaN 0.51 0.89 0.81 0.56 0.53 0.95 0.80 0.33 0.83 0.46 5.58 0.34 1.82 0.17 0.80 NaN NaN NaN
GTF3C5 Q5T7U4 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
GTF3C5 Q9Y5Q8 0.62 0.47 0.45 0.72 0.66 0.53 0.47 NaN 0.37 0.84 0.70 0.51 0.40 1.24 0.68 0.18 0.96 0.37 9.10 0.11 2.15 0.17 0.81 1.55 NaN 0.69
HDGF P51858 NaN 0.10 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
HDGFRP2 Q7Z4V5-2 NaN 0.57 8.74 0.20 0.70 0.77 NaN 0.65 0.78 NaN 0.52 NaN NaN NaN NaN NaN 0.92 0.47 NaN NaN NaN NaN NaN NaN NaN NaN
HEATR2 Q86Y56 1.08 0.72 0.88 0.99 1.21 0.53 1.72 NaN 0.20 1.30 0.42 0.85 1.14 0.98 0.93 0.56 1.86 0.99 0.33 NaN 0.67 1.21 NaN NaN 2.21 0.77
HES1 Q14469 0.79 1.39 2.08 0.44 1.02 1.41 1.23 1.26 0.82 1.50 1.13 1.04 NaN NaN 0.52 0.95 0.79 1.38 NaN 0.22 1.53 0.81 0.44 4.35 3.09 NaN
HIVEP2 P31629 1.30 3.32 0.69 NaN 0.44 1.34 NaN NaN NaN NaN 0.63 0.52 0.55 NaN NaN NaN 0.42 NaN 4.31 0.58 0.73 0.42 NaN NaN NaN NaN
HMG20A Q9NP66 0.12 1.27 1.51 1.00 1.16 1.34 1.07 1.23 1.07 1.59 1.13 1.29 NaN NaN 0.49 0.64 1.09 1.16 0.84 1.42 1.11 1.02 1.01 1.12 1.17 1.90
HMGA1 P17096 2.15 2.37 0.55 0.93 0.93 0.78 0.54 0.54 0.67 0.59 0.91 0.65 0.69 0.76 2.09 2.24 0.92 0.64 1.28 1.31 0.75 0.64 1.37 1.27 0.49 0.90
HMGB3 O15347 0.30 1.62 1.14 1.80 5.09 0.89 1.06 1.57 1.47 0.95 0.46 NaN NaN NaN 0.28 NaN 1.23 0.50 4.72 0.91 1.25 0.81 2.74 1.92 NaN 0.93
HMGN5 Q5JSL0 NaN NaN NaN NaN 18.80 0.09 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 3.10 0.19 NaN NaN NaN NaN NaN 0.70 NaN NaN
HSP90AB1 P08238 1.29 0.95 1.17 1.09 1.25 0.75 0.59 1.67 1.12 0.52 0.70 0.80 0.94 1.35 1.60 1.27 0.96 0.84 0.28 2.48 0.74 0.75 1.11 0.62 1.08 0.72
HSPA9 B7Z4V2 1.19 1.28 0.48 0.59 0.50 0.51 0.48 NaN 0.40 0.55 0.39 0.43 NaN 0.81 1.11 0.97 0.39 0.50 NaN 0.48 0.57 0.31 NaN NaN NaN 2.30
HTRA1 Q05DJ8 0.15 0.24 0.33 0.44 0.34 0.40 0.32 0.61 0.73 0.60 0.32 1.08 0.42 0.34 NaN NaN 0.45 0.83 0.24 NaN 0.39 0.37 NaN NaN 0.29 0.30
HYDIN Q4G0P3 NaN NaN NaN 1.73 0.79 2.22 1.34 1.54 NaN NaN 1.72 1.47 NaN NaN NaN NaN 1.14 1.69 0.78 0.18 1.58 1.39 4.78 0.12 1.03 NaN
IFI16 D3DUZ3 0.26 1.71 0.45 1.04 0.58 0.89 0.44 0.63 0.69 0.69 0.85 0.72 0.49 1.09 0.32 7.31 0.59 0.78 3.99 0.04 0.66 0.68 0.96 0.44 0.87 0.30
IFI16 Q16666 0.29 1.81 0.54 1.12 0.65 0.97 0.55 0.75 0.79 0.79 0.94 0.81 0.57 1.29 0.33 4.45 0.63 0.90 10.65 0.01 0.76 0.78 0.99 0.50 1.13 0.34
IGF1 Q9NP10 0.06 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.04 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
IGF2 E3UN46 0.19 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.34 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
IGHG1 S6B291 NaN NaN 0.99 NaN 0.97 NaN 0.07 NaN NaN NaN NaN 0.90 NaN NaN NaN 0.16 0.71 NaN NaN NaN 0.97 0.74 0.24 NaN NaN NaN
IGHG4 P01861 NaN NaN NaN NaN NaN NaN 0.29 NaN NaN NaN NaN NaN NaN NaN NaN 0.13 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
IGKC Q0KKI6 0.06 NaN NaN NaN NaN NaN 0.07 NaN NaN 0.42 NaN NaN NaN NaN NaN 0.16 NaN NaN NaN NaN NaN NaN 0.28 NaN NaN 0.57
IGLC1 A2NUT2 NaN NaN NaN NaN NaN NaN 0.04 NaN NaN NaN NaN NaN NaN NaN NaN 0.22 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ING1 Q9UK53-2 NaN 1.18 1.37 1.36 0.73 2.89 1.63 1.62 1.39 1.82 1.35 1.12 0.55 2.88 0.47 2.62 1.23 1.39 NaN 0.30 1.05 1.62 0.51 5.21 1.67 NaN
ING2 B2RA15 NaN 0.71 1.53 1.50 0.94 3.35 1.92 2.15 1.69 2.05 1.62 1.44 0.69 3.35 NaN NaN 1.59 1.92 NaN 0.25 1.60 2.09 0.66 6.47 2.70 1.47
ING4 A4KYM7 NaN NaN 0.76 0.81 0.68 0.93 0.73 0.90 1.16 0.88 0.69 1.07 0.52 1.94 0.65 NaN 0.98 0.77 0.36 NaN 0.25 2.33 1.43 2.34 1.02 1.22
ING5 E9PEN0 NaN NaN 1.14 1.15 1.32 1.80 1.10 1.06 1.48 1.03 NaN NaN 0.97 NaN 0.70 NaN 1.81 1.58 0.52 6.29 0.61 3.50 1.95 2.74 1.55 1.48
INO80 Q9ULG1 0.66 0.47 1.56 0.64 0.85 1.46 1.06 0.81 0.65 2.13 1.25 1.07 0.32 3.48 0.33 2.89 0.46 2.07 45.99 0.19 2.55 0.48 1.58 2.30 2.54 1.03
INO80B Q9C086 0.38 0.29 2.49 0.68 0.79 1.97 1.44 0.83 0.73 2.47 1.33 1.12 0.22 3.93 0.26 1.26 0.51 2.56 25.25 0.09 2.89 0.56 1.13 0.80 2.10 0.38
INO80C Q6PI98 0.71 0.40 2.94 0.48 0.80 2.02 1.68 0.97 0.72 3.02 1.50 1.27 0.26 4.42 0.25 1.33 0.55 2.66 18.02 0.07 3.32 0.59 1.08 1.64 2.83 0.47
INO80D Q53TQ3-2 NaN NaN 2.54 0.56 0.82 1.15 NaN NaN 0.72 2.81 1.48 1.42 NaN NaN NaN NaN 0.56 2.04 NaN 0.25 3.22 0.53 NaN NaN NaN NaN
INO80E Q8NBZ0 0.41 0.29 2.36 0.62 0.77 1.85 1.45 0.92 0.64 2.89 1.37 1.26 0.21 4.84 0.25 0.93 0.52 2.59 11.44 0.04 3.09 0.54 1.08 1.59 NaN 0.52
IPO11 Q9UI26 1.27 1.12 0.77 0.95 0.80 0.38 1.15 0.39 0.61 0.77 0.74 1.27 0.91 0.67 1.08 0.14 1.51 0.77 NaN NaN 0.60 1.22 NaN NaN 1.95 0.57
ISL2 Q96A47 NaN NaN 1.47 0.79 1.00 NaN 1.10 NaN 0.56 2.13 0.88 0.96 NaN NaN NaN NaN 0.94 NaN 15.38 0.15 1.88 0.56 0.96 1.32 NaN NaN
JADE2 G3XAA4 0.19 0.37 0.99 1.05 0.87 1.15 8.73 1.31 14.63 0.96 0.77 1.85 NaN 1.35 NaN NaN 0.72 1.12 NaN NaN 0.46 2.27 NaN NaN NaN 1.37
JADE3 Q92613 0.18 2.96 0.59 0.90 0.87 0.90 0.47 1.11 1.04 0.73 1.03 1.50 0.67 1.38 1.44 0.61 0.87 0.69 0.27 4.05 0.21 2.48 1.26 1.80 0.60 0.77
JARID2 Q92833 NaN NaN 0.42 0.96 0.68 0.90 NaN NaN 0.50 0.87 0.18 2.49 NaN 1.09 NaN NaN 0.56 0.83 NaN 0.58 0.64 0.66 1.42 1.15 NaN NaN
JMJD1C B7ZLC8 1.20 NaN NaN NaN 1.26 0.41 NaN NaN NaN 0.78 0.74 NaN 0.65 NaN 0.53 0.06 1.17 0.25 0.02 NaN 0.77 0.40 NaN NaN NaN NaN
KAT7 O95251-4 0.20 1.58 0.43 0.79 0.69 0.61 0.42 0.66 0.78 0.51 0.40 0.72 0.58 0.68 1.09 1.05 0.70 0.64 0.11 4.40 0.26 1.14 1.12 1.12 0.50 0.76
KIAA1524 Q8TCG1 0.97 0.70 0.54 0.76 0.99 0.49 NaN NaN 11.50 0.83 NaN NaN 0.80 1.02 0.76 0.35 1.46 0.75 0.18 NaN 0.59 1.51 NaN NaN 2.77 0.64
KIF11 P52732 1.28 0.94 0.77 1.45 0.67 0.19 1.07 0.38 0.55 0.73 0.40 NaN 0.93 0.75 1.13 0.15 1.31 0.73 NaN NaN 0.65 1.23 NaN NaN 1.11 0.43
KIF2A O00139-1 NaN NaN NaN NaN NaN 0.40 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
KIF2A O00139-2 NaN NaN 0.69 NaN 5.41 0.26 NaN NaN NaN NaN 1.25 0.40 NaN NaN 0.66 0.41 1.97 0.25 1.53 0.58 0.94 0.68 1.14 1.05 NaN 0.58
KIF2C A8K3S3 1.01 0.78 NaN 0.69 4.69 0.23 NaN NaN NaN 0.45 0.79 NaN NaN 0.89 NaN 0.33 1.03 0.48 NaN 0.90 0.61 0.65 NaN NaN NaN 0.45
KIF5B-ALK C1PHA2 NaN NaN 1.16 NaN NaN NaN NaN 0.59 0.28 NaN 0.73 NaN NaN NaN NaN NaN 1.56 NaN NaN NaN NaN NaN NaN NaN NaN NaN
KIFC1 Q9BW19 0.62 0.57 0.37 NaN 2.36 0.20 NaN NaN 0.61 0.25 0.73 0.28 NaN 0.43 0.42 0.12 1.25 0.19 1.86 NaN 0.67 0.37 NaN NaN NaN NaN
KLF16 Q9BXK1 0.82 0.58 1.60 0.87 0.76 2.07 1.18 1.29 0.75 2.05 1.14 1.00 0.31 3.44 0.19 5.06 0.38 2.51 9.97 0.15 3.12 0.38 1.68 1.15 2.05 0.68
KMT2C Q8NEZ4 0.39 NaN NaN NaN 0.54 0.79 NaN NaN 0.38 NaN 0.95 0.88 NaN NaN 0.18 0.22 NaN NaN NaN 0.32 2.04 0.31 0.71 0.76 NaN NaN
KMT2D O14686 0.45 0.65 1.59 0.57 0.95 1.15 0.31 NaN 0.73 1.18 1.19 1.06 0.78 1.25 0.24 0.22 0.46 2.00 NaN 0.44 1.35 0.76 2.10 1.44 NaN 0.10
KRI1 H0YFD2 0.11 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.42 NaN NaN NaN NaN NaN NaN NaN
LCN1 P31025 NaN NaN NaN 0.14 NaN NaN NaN NaN NaN NaN NaN NaN 0.04 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.12 NaN NaN
  
  



























































LDHA P00338 0.34 0.17 1.63 1.45 1.42 1.11 0.45 2.65 1.51 0.58 1.13 1.24 1.24 1.02 0.27 0.22 1.24 1.08 0.78 1.94 0.82 1.00 1.41 0.72 2.07 1.10
LDHB Q5U077 0.99 0.52 1.28 1.04 0.86 0.69 0.42 2.03 1.20 0.52 0.96 1.07 1.15 0.95 0.82 0.22 1.00 0.94 0.51 1.48 0.66 0.84 1.18 0.69 1.77 0.55
LGALS7 P47929 NaN NaN NaN NaN NaN NaN 0.08 NaN NaN 0.20 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.06 NaN NaN NaN
LIG4 P49917 NaN 1.95 1.64 1.27 0.87 1.65 1.30 1.22 0.82 2.19 1.37 1.52 0.65 2.57 NaN NaN 0.82 1.62 4.67 0.16 1.65 1.02 1.06 0.83 2.15 0.78
LMNA P02545 0.69 0.42 1.15 0.57 1.99 0.35 0.72 0.49 1.10 0.86 0.78 1.06 0.96 1.12 0.56 0.62 1.24 0.60 0.07 2.21 0.79 0.97 0.10 0.56 0.19 1.73
LMNA P02545-2 NaN 0.25 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.31 NaN NaN NaN 0.09 1.46 NaN NaN NaN NaN NaN NaN
LMNA P02545-5 NaN NaN NaN NaN NaN NaN NaN 35.49 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
LRIF1 Q5T3J3 NaN NaN 1.54 NaN 1.22 1.22 NaN NaN 0.91 NaN 2.35 1.15 NaN NaN NaN NaN 3.65 0.67 5.72 0.13 2.75 0.38 2.52 NaN NaN NaN
LRRFIP2 A8MXR0 NaN 4.13 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.36 1.04 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
LRWD1 Q9UFC0 0.76 0.71 1.12 1.09 9.82 0.05 1.47 1.05 0.91 1.15 3.02 0.19 0.99 0.93 0.78 0.25 3.16 0.18 3.42 0.61 7.94 0.05 2.90 1.09 1.35 1.11
LSM2 Q9Y333 1.43 0.87 NaN NaN 1.31 0.73 NaN 1.09 NaN NaN NaN NaN NaN NaN 0.95 0.40 NaN 0.77 0.61 1.13 0.07 1.50 NaN NaN 0.63 0.70
MAFK A2VCQ5 NaN NaN NaN NaN NaN 0.28 0.09 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
MAFK A8WFP5 0.87 NaN 0.70 0.67 NaN NaN NaN NaN NaN NaN NaN 0.51 NaN NaN 0.34 1.88 NaN NaN 5.77 0.12 NaN 0.57 2.28 0.49 NaN NaN
MAGOH P61326 8.28 0.92 0.39 1.79 0.76 0.47 0.71 1.01 1.80 0.21 1.13 1.15 NaN 0.41 2.21 0.57 1.20 0.46 NaN NaN 0.48 1.28 NaN NaN 0.42 0.64
MAP2K2 P36507 0.81 0.61 0.84 0.86 0.66 0.48 1.03 0.65 0.77 1.17 0.68 1.85 0.58 0.66 0.75 0.18 1.19 0.97 NaN NaN 0.61 1.02 NaN NaN 2.17 0.68
MAP4 E7EVA0 NaN 0.58 0.54 3.00 1.97 0.82 NaN NaN 1.40 NaN 1.64 0.76 NaN NaN 0.47 0.12 1.23 0.76 3.75 NaN 1.39 0.99 2.56 2.22 NaN NaN
MAP4 P27816-5 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
MARK2 Q7KZI7-8 0.66 0.01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.72 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
MAU2 Q9Y6X3 0.86 0.62 NaN NaN 0.93 1.30 0.92 NaN 1.07 NaN 1.25 0.92 NaN 1.67 1.08 0.28 3.14 0.30 12.24 0.08 4.56 0.21 NaN 0.80 NaN NaN
MAU2 Q9Y6X3-2 NaN NaN NaN NaN 1.38 1.35 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 3.22 0.37 8.03 0.14 1.93 0.26 NaN NaN NaN NaN
MAX Q8TAX8 1.02 1.71 3.10 1.03 1.38 1.89 2.24 1.63 1.66 2.27 1.99 1.67 NaN NaN 0.75 4.76 1.56 1.69 6.02 0.17 2.33 1.37 0.51 2.58 2.48 NaN
MBD2 Q9UBB5 0.38 0.79 1.48 0.71 0.97 1.04 1.00 1.02 1.11 0.89 1.06 0.87 0.33 2.55 0.68 0.32 0.65 1.46 15.14 0.01 0.86 1.17 6.56 0.08 2.02 0.54
MBTPS1 Q14703 NaN NaN NaN NaN 0.35 0.49 NaN NaN NaN NaN 0.32 NaN NaN NaN NaN NaN 0.61 NaN NaN NaN 0.27 0.62 NaN NaN 0.69 0.69
MCRS1 Q96EZ8-3 0.58 0.33 2.31 0.79 1.08 1.26 1.35 1.15 0.89 1.62 1.46 1.22 0.26 5.42 0.37 0.53 0.80 1.57 7.29 0.18 2.37 0.62 1.71 1.12 NaN 0.49
MEAF6 Q9HAF1-2 0.22 1.83 1.12 1.14 0.99 1.27 0.78 1.04 1.07 0.87 1.17 1.51 NaN NaN 0.75 0.65 1.16 1.15 0.70 2.39 0.86 1.77 1.86 2.03 0.88 0.93
MECP2 P51608-2 1.04 1.09 0.50 0.93 0.55 0.91 0.58 0.70 0.88 0.65 0.75 0.71 0.62 0.78 0.60 5.77 0.62 0.98 5.15 0.10 0.77 0.74 3.74 0.32 0.58 0.58
MED10 Q9BTT4 0.67 NaN NaN NaN 0.89 0.54 0.60 NaN 0.60 1.10 0.83 0.76 NaN NaN 0.22 NaN 0.52 0.90 0.22 NaN 1.25 0.53 NaN NaN NaN NaN
MED16 Q9Y2X0-2 0.53 0.64 0.71 0.56 0.84 0.41 0.51 NaN 0.49 0.98 0.82 0.64 0.52 1.13 0.27 0.99 0.52 0.64 1.59 0.47 0.88 0.34 0.74 1.15 NaN NaN
MIER1 Q8N108-19 NaN NaN 0.62 0.66 0.72 1.49 0.80 NaN 0.87 1.05 NaN NaN NaN NaN NaN 0.84 2.15 0.31 2.07 0.09 2.39 0.32 NaN NaN NaN NaN
MIER2 Q8N344 NaN NaN NaN NaN 0.53 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 2.08 0.21 3.85 NaN 2.66 0.20 NaN NaN NaN NaN
MIF I4AY87 NaN 0.09 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.44 NaN NaN NaN NaN NaN NaN NaN
MITF A8K5K3 NaN NaN NaN NaN NaN NaN 1.02 NaN 2.45 1.33 NaN NaN NaN NaN NaN NaN 0.78 NaN 1.75 0.27 NaN 0.63 0.55 2.12 NaN NaN
MLX Q9UH92 0.44 0.72 1.46 0.37 0.99 1.11 1.27 0.86 0.72 1.21 0.98 0.86 0.38 2.25 0.24 0.31 0.77 0.93 10.58 0.21 1.34 0.62 0.25 2.64 2.25 0.34
MLXIPL H7C1V3 NaN 0.58 1.29 0.42 0.75 0.85 NaN NaN NaN NaN 0.72 0.53 NaN NaN NaN NaN 0.68 0.75 NaN 0.12 0.90 0.80 NaN NaN NaN NaN
MLXIPL Q9NP71-3 0.31 0.55 1.38 0.28 0.94 1.04 0.94 0.65 0.60 1.17 0.87 0.80 0.46 2.00 0.22 0.21 0.71 0.83 10.76 0.17 1.11 0.74 0.27 1.85 NaN 0.44
MMS22L E2QRD4 NaN NaN NaN 0.71 0.38 1.24 0.19 NaN NaN NaN 0.98 0.72 0.54 0.90 NaN NaN 0.96 0.67 1.27 0.57 0.26 0.90 0.78 0.70 0.91 NaN
MNT Q99583 0.43 1.20 1.60 0.82 1.14 1.74 1.11 1.11 1.18 1.49 1.19 1.27 0.74 2.24 0.37 6.72 1.26 1.41 3.72 0.23 1.23 1.13 0.33 2.83 2.65 0.51
MOB4 Q9Y3A3-3 0.48 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 32.32 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
MORC2 Q9Y6X9-2 1.04 1.36 NaN NaN 1.77 0.30 NaN NaN NaN NaN NaN NaN NaN NaN 1.08 0.67 NaN 0.35 1.07 1.16 NaN 0.63 1.27 1.22 NaN NaN
MPHOSPH8 Q99549 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 2.07 NaN NaN 12.07 NaN 3.00 0.28 NaN 0.08 2.63 0.22 NaN NaN NaN NaN
MRPL13 Q9BYD1 0.49 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.28 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
MTA1 Q13330 NaN NaN NaN NaN NaN 0.39 NaN NaN NaN NaN 0.68 0.57 0.42 NaN NaN NaN 0.34 1.09 NaN 0.48 0.42 0.95 NaN 0.25 NaN NaN
MTA1 Q13330-3 0.19 0.84 0.99 0.55 0.86 0.69 0.71 0.84 0.85 0.65 0.81 0.73 0.51 1.61 0.51 0.62 0.50 1.17 3.36 0.11 0.50 1.15 2.12 0.23 1.05 0.47
MTA2 O94776 0.45 1.04 1.02 0.71 0.99 0.85 0.76 0.83 0.98 0.76 0.92 0.82 0.42 1.52 0.82 0.65 0.66 1.11 5.90 0.03 0.70 1.05 6.43 0.11 1.34 0.45
MTA3 E7EQY4 0.34 0.91 0.71 0.68 0.77 0.83 0.86 0.80 0.81 0.75 0.79 0.66 0.31 1.77 0.57 0.55 0.67 0.85 8.18 0.04 0.66 0.87 3.02 0.16 1.02 0.51
MTF2 Q9Y483 0.39 1.58 0.84 0.62 0.85 0.97 0.71 0.73 0.85 1.01 0.78 1.11 0.51 NaN 1.39 1.66 1.06 0.81 1.23 0.50 1.08 0.81 0.84 1.94 0.91 0.98
MYC B4E1N7 NaN NaN 3.87 0.90 1.95 2.08 2.31 NaN 1.61 1.76 2.18 2.17 NaN NaN NaN NaN 1.68 1.93 4.29 0.23 2.20 1.41 0.79 1.61 NaN NaN
MYL6B P14649 NaN 5.52 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.64 1.31 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
NAA40 Q86UY6 0.80 0.62 0.80 0.84 0.91 0.95 0.91 0.72 0.80 0.98 0.87 0.84 0.57 1.21 0.89 1.07 0.90 0.77 0.97 0.90 0.89 0.77 0.89 0.97 0.35 2.29
NACA E9PAV3 6.94 0.53 1.73 1.66 1.39 1.01 0.79 NaN 0.42 0.81 1.03 0.93 NaN NaN 0.72 0.37 1.13 NaN NaN 1.59 1.10 1.05 1.37 0.78 NaN NaN
NAP1L1 F8VY35 1.04 2.68 2.06 0.90 2.30 0.84 1.09 1.74 1.85 1.18 0.76 1.98 0.80 1.90 1.95 1.35 2.12 0.71 1.19 1.22 1.85 0.81 2.19 0.45 1.20 1.86
NAP1L4 B7ZAK9 NaN 0.21 4.07 0.69 2.71 0.49 NaN NaN 1.03 1.26 NaN NaN NaN NaN 1.25 0.50 NaN NaN 1.13 0.57 1.01 NaN 1.52 NaN NaN NaN
NBN O60934 NaN 0.17 1.10 1.69 3.36 2.43 2.31 2.33 2.03 2.83 2.09 1.80 0.95 2.48 0.32 0.17 3.19 1.28 0.19 0.38 1.75 1.56 0.49 0.29 2.03 1.61
NCAPD2 B3KMS0 1.41 1.16 0.84 4.23 1.04 0.54 1.07 0.53 0.87 1.04 0.81 0.86 1.05 1.16 1.41 0.70 1.08 1.08 2.40 0.37 0.85 0.77 1.02 0.93 1.30 0.57
NCL P19338 0.60 1.27 0.99 0.86 2.39 0.50 0.62 1.07 1.32 0.77 0.86 1.11 1.21 0.88 1.26 0.34 2.10 0.58 0.26 4.90 0.86 1.93 1.30 0.56 0.31 2.33
NCOA6 Q14686 NaN NaN 1.42 1.30 1.18 1.29 NaN NaN 0.89 2.25 1.01 1.04 NaN NaN 0.35 0.41 0.46 2.12 5.02 0.31 1.88 0.53 1.60 0.15 NaN NaN
NCOR2 C9JE98 0.94 0.58 0.52 NaN 0.51 0.77 0.60 NaN 1.22 0.52 0.95 0.80 NaN 0.89 0.56 0.07 0.63 0.92 NaN NaN 1.02 0.69 NaN NaN NaN NaN
































































NFATC2IP Q8NCF5 0.47 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.45 0.26 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
NFIA B1AKN8 0.60 0.38 0.78 0.49 0.41 1.62 NaN NaN 0.21 0.53 0.84 0.68 0.24 2.93 0.09 2.99 0.18 2.64 69.81 0.15 2.04 0.25 1.04 0.87 NaN 0.26
NFIA Q12857-2 NaN NaN 0.23 0.60 0.44 NaN NaN NaN NaN NaN 0.70 0.48 NaN NaN 0.05 NaN 0.17 NaN 3.42 0.04 1.63 0.27 1.13 0.91 NaN NaN
NFIB O00712-5 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
NFIB Q5VW27 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.43 NaN NaN NaN NaN
NFIB Q5VW28 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
NFIB Q5VW30 NaN 0.37 0.98 0.59 0.43 1.74 NaN 0.64 0.43 NaN 0.83 0.73 0.28 6.29 0.10 7.91 0.19 2.70 17.59 0.08 1.90 0.31 1.07 0.91 NaN NaN
NFIC P08651 0.73 0.85 0.97 0.56 0.40 1.54 0.26 0.27 0.19 0.42 0.84 0.75 0.11 7.60 0.11 11.19 0.19 2.33 16.73 0.01 2.02 0.27 1.41 0.99 NaN 0.20
NFIC P08651-5 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.75 NaN NaN NaN NaN
NFIC P08651-6 NaN NaN NaN NaN 0.54 1.49 NaN NaN NaN NaN 1.03 0.84 NaN NaN NaN NaN 0.28 NaN NaN NaN 2.75 0.39 NaN NaN NaN NaN
NFIX B4DM25 NaN 0.76 1.17 0.80 0.47 2.17 NaN NaN 0.66 NaN 1.02 0.98 0.24 5.04 0.16 NaN 0.28 2.77 19.53 0.14 1.68 0.48 1.52 0.87 NaN NaN
NFIX C9JWJ8 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 6.98 0.63 1.73 0.44 NaN NaN NaN NaN
NFIX D2DXM9 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.24 NaN NaN NaN NaN NaN NaN
NFRKB Q6P4R8-3 0.70 0.44 1.87 0.60 0.88 1.62 1.18 0.87 0.65 2.45 1.27 1.08 0.38 6.92 0.27 0.56 0.48 2.35 36.59 0.02 2.53 0.50 1.35 2.70 1.91 0.32
NIPBL Q6KC79 0.86 0.66 0.58 0.89 0.87 0.78 NaN 0.69 1.01 0.42 1.15 0.73 1.53 0.68 1.95 0.12 3.88 0.13 14.75 0.19 3.86 0.12 NaN 1.06 0.91 0.61
NIPBL Q6KC79-2 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.16 NaN NaN NaN NaN 2.31 0.07 NaN NaN NaN NaN
NOLC1 Q14978-2 0.60 0.61 0.68 1.21 0.91 0.76 0.98 1.23 1.02 0.81 0.65 1.34 0.89 0.73 0.83 0.66 1.21 0.56 1.12 2.64 0.37 1.85 2.18 1.32 0.44 2.62
NOLC1 Q14978-3 NaN NaN 0.90 1.22 1.21 1.11 1.17 1.66 1.38 1.17 0.81 1.48 1.15 1.11 NaN NaN 1.38 0.69 1.21 3.02 0.46 2.39 2.42 1.51 0.38 3.33
NPM1 E5RI98 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
NPM1 P06748 1.11 1.51 1.63 0.97 2.06 0.75 0.84 1.34 1.20 1.02 0.80 1.81 1.14 1.42 1.06 0.47 1.60 1.03 0.57 1.76 1.07 1.66 0.95 0.83 0.98 1.43
NR2C1 H9NIM2 0.43 1.18 0.85 0.60 1.32 1.40 1.34 NaN 0.53 2.23 1.19 0.86 1.21 0.91 0.32 0.20 0.96 1.18 3.06 0.36 2.20 0.58 0.56 0.95 NaN NaN
NS5ATP4A Q09GN0 0.27 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.49 0.18 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ORC2 Q13416 0.66 0.73 1.03 1.03 7.63 0.04 1.18 0.88 0.84 0.94 2.93 0.20 1.07 0.89 0.76 0.19 2.86 0.19 3.24 0.78 7.26 0.08 2.47 1.05 0.82 0.95
ORC3 Q9UBD5-2 0.82 0.83 0.89 0.96 6.95 0.04 1.00 0.87 0.83 0.81 2.39 0.19 1.06 0.79 0.88 0.44 2.41 0.18 2.98 0.83 5.33 0.06 2.79 1.10 0.75 0.97
ORC3L Q9UBD5 NaN NaN 1.85 NaN 6.65 0.16 NaN 0.68 1.47 1.45 2.26 0.24 NaN NaN 0.68 0.10 NaN 0.24 NaN 1.29 6.24 0.25 NaN NaN NaN 0.75
ORC5 A4D0P7 0.59 0.74 1.25 1.14 7.95 0.08 1.48 1.05 0.99 1.07 2.88 0.21 1.00 0.96 0.64 0.41 2.66 0.24 6.95 0.40 6.65 0.08 2.84 1.07 1.34 1.27
ORC6 B3KMP9 0.67 0.60 NaN NaN 4.67 0.16 1.20 NaN NaN 0.82 0.97 0.58 NaN 0.59 0.50 0.07 1.70 0.34 1.09 1.06 NaN 0.49 NaN NaN NaN NaN
OXSR1 O95747 1.88 1.50 NaN NaN 0.66 0.50 0.82 0.86 0.82 1.30 0.69 1.45 0.66 1.07 1.51 0.25 1.21 1.16 NaN NaN 0.64 0.85 NaN NaN 1.51 0.70
PARD3 Q8TEW0-11 1.90 NaN NaN NaN NaN NaN 0.41 0.49 0.33 NaN NaN NaN NaN NaN 0.10 0.16 NaN NaN 1.24 0.25 1.08 NaN 0.48 1.02 NaN 0.79
PARK7 Q99497 NaN 0.12 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.16 NaN NaN NaN 0.21 NaN NaN NaN 0.84 0.39 NaN NaN
PATZ1 Q59HH1 1.01 0.50 0.92 1.34 0.54 1.78 NaN NaN 1.55 1.18 0.73 0.71 NaN NaN 0.57 3.04 0.43 2.06 2.87 0.62 1.10 0.73 1.03 0.90 3.95 NaN
PAXIP1 B4DEQ6 0.63 1.15 2.01 0.54 1.06 1.16 NaN NaN 0.50 1.89 1.20 1.37 0.90 1.72 0.43 0.07 0.51 2.13 6.18 0.25 1.71 0.88 2.02 1.34 0.67 NaN
PBX2 P40425 NaN NaN NaN NaN 2.33 0.51 NaN NaN 0.64 NaN 1.25 0.38 NaN NaN 0.60 3.30 0.93 0.55 12.87 0.10 1.67 0.45 1.23 0.50 NaN NaN
PC4 Q6IBA2 1.04 1.15 7.12 0.83 0.84 0.95 0.98 0.96 0.99 0.92 0.88 0.84 0.87 0.88 0.96 1.43 0.77 0.94 0.98 1.27 0.72 0.95 1.07 1.00 0.87 1.08
PCMT1 H7BY58 1.18 1.40 0.39 0.50 0.38 0.44 0.33 0.23 0.38 0.35 0.54 1.25 NaN NaN 1.22 4.14 0.21 0.67 0.38 0.36 0.26 0.46 0.49 0.37 0.76 0.32
PCNA P12004 0.38 0.61 1.09 0.63 0.68 1.36 0.80 1.07 0.50 1.68 0.85 0.96 0.34 1.78 0.23 1.30 0.45 1.70 3.63 0.09 2.09 0.35 0.93 1.06 1.28 0.41
PCSK9 Q8NBP7 NaN NaN NaN 0.45 0.46 0.51 NaN NaN 0.38 0.44 0.55 NaN 0.62 0.33 NaN 0.77 0.40 0.48 NaN NaN 0.32 0.40 NaN NaN NaN NaN
PDIA5 Q14554 NaN NaN NaN NaN 3.57 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
PES1 B5MCF9 NaN 1.93 NaN NaN NaN NaN NaN NaN NaN NaN 1.25 0.71 NaN NaN 1.92 NaN NaN NaN 1.16 1.42 NaN NaN 1.21 NaN NaN NaN
PFN1 P07737 0.20 0.24 NaN NaN NaN NaN 0.35 1.42 NaN 0.34 NaN NaN NaN NaN NaN NaN 0.85 NaN NaN NaN NaN NaN NaN NaN 0.15 NaN
PGAM1 Q6P6D7 0.30 0.16 NaN NaN NaN 0.88 0.37 2.87 0.31 0.51 NaN NaN NaN NaN 0.24 0.25 NaN 2.91 0.58 1.33 NaN NaN 0.26 NaN NaN NaN
PGBD3 A8K4Q3 NaN NaN 0.99 0.52 0.79 0.63 0.68 0.59 0.78 0.55 0.73 0.79 0.31 1.99 NaN NaN 0.49 0.86 9.50 0.09 0.84 0.65 4.32 0.19 0.85 0.24
PGK1 P00558 0.43 0.12 2.36 NaN NaN 0.72 NaN 4.63 2.16 0.30 NaN NaN NaN NaN 0.53 0.19 1.02 0.61 0.32 2.11 0.39 NaN 1.10 0.22 NaN NaN
PHF1 E9PQT8 NaN NaN NaN NaN 7.63 0.23 NaN NaN 5.32 0.34 9.40 0.21 NaN NaN NaN NaN NaN NaN NaN NaN NaN 2.81 NaN NaN NaN NaN
PHF14 O94880 0.07 2.12 1.45 1.13 1.46 1.30 1.00 1.26 1.03 1.51 1.08 1.29 0.67 3.93 0.50 0.95 1.25 1.24 1.23 2.00 1.11 1.43 1.27 1.95 0.61 1.92
PHF14 O94880-2 0.12 NaN NaN NaN 2.02 1.47 1.25 2.05 1.16 2.45 1.52 2.00 NaN NaN NaN NaN NaN 2.32 NaN 1.97 NaN 1.40 1.36 NaN NaN 1.72
PHF20L1 F8W9L8 NaN NaN NaN 1.23 1.94 1.92 NaN NaN NaN NaN 1.92 2.53 NaN NaN NaN NaN NaN 3.49 5.73 NaN 3.10 2.72 4.29 NaN NaN NaN
PHF21A Q96BD5-2 0.27 0.61 NaN 0.43 0.97 0.52 NaN NaN NaN 0.40 0.55 0.45 NaN NaN 0.43 0.50 0.69 0.45 0.99 0.45 0.67 0.38 NaN 0.80 NaN NaN
PHF5A Q7RTV0 1.51 1.01 NaN NaN 1.62 0.54 0.86 1.37 2.18 0.51 NaN NaN 1.97 0.63 0.84 1.08 2.27 0.52 NaN NaN 0.49 2.55 NaN NaN 0.43 NaN
PHF8 Q9UPP1-2 1.28 2.06 3.05 0.50 1.79 0.54 1.13 1.76 1.63 1.23 0.66 2.50 NaN 3.17 NaN NaN 1.41 0.42 NaN NaN 1.17 0.53 1.28 1.05 0.48 1.90
PKM P14618 0.30 0.26 0.62 1.34 1.57 0.83 0.25 1.77 1.05 0.88 0.81 0.50 0.82 1.97 0.43 0.47 0.67 0.89 0.46 0.97 2.28 0.27 1.17 0.65 0.47 0.92
PKM P14618-2 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
PKP2 Q99959-2 0.49 0.35 0.77 NaN 0.73 11.63 0.71 0.56 0.86 0.86 0.83 0.80 0.61 0.91 0.34 0.22 0.74 1.06 0.47 0.89 0.88 0.60 0.61 0.49 0.87 0.63
PLEKHA4 Q59H51 0.46 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
PLK1 B2R841 1.18 NaN NaN 0.92 0.98 0.63 NaN NaN NaN NaN 0.73 NaN 0.95 0.51 1.12 0.21 0.90 0.65 NaN NaN 0.98 0.66 NaN NaN NaN NaN
PMVK Q6FGV9 1.01 0.65 0.73 0.70 0.54 0.39 NaN NaN NaN NaN NaN NaN NaN 0.59 0.52 0.15 0.80 1.33 NaN NaN 0.41 NaN NaN NaN NaN NaN
PNISR Q8TF01 1.00 1.25 2.45 0.45 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.55 2.12 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
PNN A8K964 9.86 2.15 0.46 1.83 0.91 0.63 1.53 NaN 2.15 0.41 1.26 1.18 1.69 0.63 2.83 1.72 1.29 0.50 1.51 2.20 0.59 1.61 1.78 1.67 0.45 0.51
  
 



























































PNP Q8N7G1 NaN 0.18 NaN NaN NaN NaN 0.39 NaN NaN NaN NaN NaN NaN NaN 0.47 0.59 NaN NaN 0.27 NaN NaN NaN 1.01 NaN NaN NaN
POF1B Q8WVV4 NaN NaN NaN NaN NaN NaN 0.12 NaN NaN NaN NaN NaN NaN NaN 0.15 NaN NaN NaN 0.21 NaN NaN NaN NaN NaN NaN NaN
POGZ Q7Z3K3-5 NaN 0.69 1.51 0.93 1.07 1.35 0.86 NaN 0.59 1.84 1.13 1.16 2.13 1.51 0.77 NaN 5.91 0.11 47.32 0.14 7.48 0.08 5.82 0.79 NaN NaN
POGZ Q7Z3K3-7 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 2.77 NaN 15.19 NaN NaN NaN 6.14 NaN NaN NaN
POLD3 B7ZAQ5 0.51 NaN NaN 0.59 0.42 0.48 NaN NaN NaN 0.84 0.77 0.66 NaN 0.40 0.70 0.45 NaN NaN NaN 1.00 0.58 0.53 1.72 NaN NaN 0.54
POLG E5KNX5 NaN NaN NaN 0.41 0.38 0.38 0.29 NaN 0.73 1.00 0.37 0.51 NaN NaN 0.45 NaN 0.19 0.52 NaN NaN 0.49 0.47 NaN NaN NaN 0.42
POLR1A B7ZKR9 NaN NaN NaN NaN NaN NaN 1.13 NaN NaN NaN NaN NaN NaN NaN NaN 2.76 0.34 NaN NaN 0.37 NaN 0.51 NaN NaN NaN NaN
POLR1A O95602 1.85 2.21 1.02 1.08 0.47 1.98 1.03 0.76 0.39 3.52 1.80 0.75 0.76 1.40 1.15 2.91 0.21 2.19 27.77 0.24 1.94 0.41 0.73 2.40 0.75 0.95
POLR1A B7ZKR9 NaN NaN NaN NaN NaN NaN 1.13 NaN NaN NaN NaN NaN NaN NaN NaN 2.76 0.34 NaN NaN 0.37 NaN 0.51 NaN NaN NaN NaN
POLR1A O95602 1.85 2.21 1.02 1.08 0.47 1.98 1.03 0.76 0.39 3.52 1.80 0.75 0.76 1.40 1.15 2.91 0.21 2.19 27.77 0.24 1.94 0.41 0.73 2.40 0.75 0.95
POLR1B Q9H9Y6 1.94 2.83 1.08 1.06 0.42 2.20 1.21 0.82 0.38 3.98 2.30 1.06 0.40 3.60 1.22 3.63 0.25 2.48 16.97 0.15 2.54 0.54 0.75 2.26 NaN NaN
POLR1C Q96HT3 1.60 1.26 0.70 0.69 0.34 0.94 0.74 0.81 0.47 0.89 0.86 0.68 0.16 2.47 0.70 3.79 0.15 1.70 21.83 0.04 1.54 0.28 0.79 3.44 5.07 0.17
POLR1D Q9Y2S0 NaN 0.82 NaN NaN 0.56 1.12 0.87 0.89 0.56 0.87 0.92 0.76 NaN NaN 0.48 2.13 0.24 1.80 0.05 NaN 1.97 0.36 NaN NaN NaN NaN
POLR1E Q9GZS1-2 NaN 1.67 1.01 1.06 0.51 0.97 1.28 0.89 0.50 3.10 1.75 0.69 0.26 NaN 1.14 NaN 0.31 1.10 5.58 0.12 1.78 0.36 0.74 NaN NaN NaN
POLR2E E5KT65 1.06 0.96 0.74 0.69 0.38 1.00 0.74 0.85 0.47 0.94 0.93 0.70 0.21 2.04 0.39 3.56 0.17 1.63 15.20 0.06 1.67 0.30 0.73 1.89 3.37 0.16
POLR2H C9JLU1 1.41 1.40 0.67 1.01 0.46 0.98 0.83 0.96 0.52 0.93 1.00 0.80 0.20 2.22 0.36 1.39 0.17 1.61 15.42 NaN 1.70 0.30 NaN NaN NaN NaN
POLR2K P53803 NaN NaN NaN NaN 0.45 1.17 0.78 0.95 0.57 1.01 1.03 NaN NaN NaN NaN NaN 0.20 1.99 NaN NaN 1.73 0.39 NaN NaN NaN NaN
POLR2L P62875 1.01 0.92 NaN NaN 0.37 1.01 0.77 0.87 0.55 1.11 0.82 NaN NaN NaN 0.45 1.29 0.15 1.88 NaN NaN 1.85 0.30 0.77 NaN NaN NaN
POLR3A O14802 1.03 0.93 0.36 0.44 0.37 0.54 0.26 0.66 0.45 0.67 0.52 0.52 0.26 1.80 0.44 2.46 0.13 1.25 24.78 0.15 1.15 0.20 1.05 3.00 2.76 0.18
POLR3B Q7Z3R8 1.16 1.02 0.42 0.54 0.36 0.56 0.27 0.67 0.44 0.71 0.51 0.67 0.28 NaN 0.41 1.78 0.14 1.37 4.80 0.21 1.29 0.26 1.19 2.45 NaN 0.25
POLR3C Q9BUI4 0.98 0.91 0.32 0.52 0.36 0.56 0.31 0.71 0.47 0.60 0.50 0.51 0.35 0.78 0.53 1.53 0.14 1.37 9.50 0.34 1.17 0.22 1.04 2.03 2.96 0.21
POLR3D P05423 0.34 0.50 0.45 0.46 0.34 0.58 0.28 0.71 0.46 0.67 0.56 0.54 0.22 1.67 0.34 2.68 0.13 1.21 14.87 NaN 1.16 0.23 NaN 2.19 NaN 0.11
POLR3E Q9NVU0 0.94 0.83 0.30 0.37 0.38 0.54 0.26 0.66 0.45 0.45 0.51 0.53 0.35 1.59 0.41 3.68 0.15 1.21 1.97 0.20 1.06 0.18 1.24 NaN NaN 0.20
POLR3F Q53FI8 1.43 0.82 0.36 0.47 0.31 0.58 0.30 0.79 0.45 0.73 0.45 0.53 NaN NaN 0.37 5.03 0.13 1.41 NaN 0.18 1.25 0.21 0.79 3.01 2.57 0.21
POLR3G D6R9U7 1.56 0.86 0.35 0.40 0.34 0.47 0.34 0.77 0.46 0.73 0.56 0.53 NaN NaN 0.39 1.90 0.18 1.52 11.83 0.32 1.39 0.21 NaN 2.53 NaN 0.17
POLR3GL A6NGX6 NaN NaN 0.29 NaN 0.29 0.52 0.28 0.62 0.44 0.66 0.54 0.59 NaN NaN 0.51 1.17 0.19 1.32 NaN NaN 1.12 0.22 NaN NaN NaN NaN
POLR3H E7ERZ2 NaN NaN NaN NaN NaN NaN NaN NaN 0.85 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
POLR3H Q9Y535 1.52 0.67 0.33 0.45 0.35 0.64 0.33 0.76 0.50 0.75 0.60 0.56 0.15 1.68 0.36 1.62 0.14 1.52 26.33 0.26 1.39 0.20 NaN 3.06 NaN 0.10
POLR3H E7ERZ2 NaN NaN NaN NaN NaN NaN NaN NaN 0.85 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
POLR3H Q9Y535 1.52 0.67 0.33 0.45 0.35 0.64 0.33 0.76 0.50 0.75 0.60 0.56 0.15 1.68 0.36 1.62 0.14 1.52 26.33 0.26 1.39 0.20 NaN 3.06 NaN 0.10
POLR3K Q9Y2Y1 NaN NaN NaN NaN 0.44 0.89 0.37 1.14 0.65 0.90 0.64 0.84 NaN NaN NaN 1.62 0.24 1.66 NaN NaN 1.61 0.27 NaN NaN NaN NaN
POM121C A8CG34 0.51 NaN NaN NaN NaN NaN 0.04 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
POP4 O95707 0.47 NaN NaN NaN NaN 1.06 NaN NaN NaN NaN 0.92 0.93 0.79 0.80 0.52 0.24 0.93 NaN 1.53 1.37 1.28 1.03 0.78 NaN NaN NaN
POU2F1 H0YLB5 NaN 0.16 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.19 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
PPIA A8K486 0.16 0.13 1.79 1.62 1.53 1.02 0.31 NaN 1.40 0.38 1.05 0.94 0.60 0.79 0.21 0.34 0.90 0.64 0.43 NaN 0.73 0.57 0.79 0.47 NaN NaN
PRC1 H9KV59 0.70 NaN NaN NaN 0.54 0.19 NaN NaN NaN NaN NaN 0.33 NaN NaN NaN 0.43 0.52 0.22 NaN 0.58 NaN NaN NaN NaN NaN NaN
PRC1 O43663 0.57 0.79 0.47 0.36 0.72 0.29 0.46 1.30 0.49 0.45 0.63 0.30 0.35 1.35 0.60 0.48 0.80 0.25 1.90 0.32 0.75 0.26 0.42 NaN 0.46 0.26
PRDM10 B7ZL72 NaN NaN NaN 0.49 0.65 0.95 NaN NaN 0.21 1.87 0.67 0.73 0.57 NaN 0.23 NaN 0.41 0.80 98.83 0.13 1.91 0.23 2.67 1.16 NaN NaN
PRDX1 Q06830 0.65 0.32 1.55 1.73 1.64 0.83 0.33 1.87 0.69 0.49 0.79 0.85 0.82 1.13 0.61 1.07 1.31 1.04 0.43 1.01 0.93 0.82 1.00 0.52 0.87 0.57
PRDX2 P32119 0.41 0.16 1.50 NaN NaN 0.88 0.07 NaN NaN NaN NaN NaN NaN NaN 0.39 0.70 NaN NaN 0.21 0.95 0.81 NaN 0.88 0.41 NaN NaN
PRDX6 P30041 0.47 0.22 2.87 2.76 1.07 0.91 0.42 2.67 1.61 0.50 0.74 NaN 0.99 0.87 0.40 0.54 1.16 1.16 0.28 1.77 0.65 0.59 1.13 0.30 1.65 0.64
PRIC295 E1NZA1 1.50 1.05 0.51 0.84 0.70 0.29 1.24 0.36 0.47 0.65 0.48 0.54 0.99 0.64 1.11 0.45 1.02 0.64 0.46 0.39 0.41 0.77 NaN NaN 1.05 0.44
PRKD2 Q8NCK8 0.19 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
PRMT5 O14744 1.00 0.82 0.84 0.60 0.72 0.85 NaN NaN 0.60 0.85 0.90 0.71 2.91 0.28 1.18 0.49 0.33 1.52 1.05 0.81 0.95 0.51 1.15 0.89 NaN 0.28
PRPF40A O75400-2 2.16 1.94 0.38 0.83 0.95 0.47 1.09 0.96 NaN 0.35 1.53 0.66 NaN 0.50 1.07 1.25 1.02 0.39 1.67 NaN 0.46 0.96 1.15 NaN 0.30 0.75
PRPF40A O75400-3 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.92 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
PSAT1 B4DHQ3 NaN 0.11 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.28 1.81 NaN NaN 0.94 NaN NaN NaN
PSMA6 G3V5Z7 0.21 0.18 NaN NaN NaN NaN 0.28 2.39 NaN 0.63 0.50 NaN NaN NaN 0.20 0.04 1.13 0.82 0.49 1.28 1.19 1.07 1.12 0.74 NaN NaN
PSMA7 O14818 0.61 0.30 1.21 NaN 1.02 1.15 0.60 1.40 0.40 0.61 0.99 0.70 1.10 0.69 0.50 0.17 0.71 NaN 0.57 1.07 0.70 0.88 1.06 0.87 NaN NaN
PSMD3 Q6IBN0 0.85 0.64 2.35 0.37 1.07 1.08 NaN NaN 0.71 0.79 NaN 0.84 NaN 2.68 0.76 0.37 1.23 1.12 0.87 0.06 NaN 1.02 NaN 1.02 NaN NaN
PUM1 Q14671 0.76 4.67 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.90 0.29 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
PUM1 Q5T1Z4 0.76 3.89 1.60 NaN 1.30 1.26 1.40 NaN 0.72 0.95 NaN NaN 1.65 0.67 0.92 0.09 1.28 1.34 NaN NaN 0.49 1.35 NaN NaN 1.95 0.97
PURA Q2NLD4 1.73 0.83 0.47 3.16 0.60 2.00 NaN NaN NaN NaN NaN 1.29 NaN NaN 0.90 2.93 0.66 1.64 3.50 0.51 1.65 0.89 4.27 0.86 NaN NaN
PURB Q96QR8 1.32 0.75 0.50 2.54 0.57 2.17 1.09 1.31 1.21 1.49 1.47 1.00 0.45 1.83 0.74 4.17 0.65 1.74 3.11 0.61 1.42 1.08 3.72 0.96 1.12 1.24
RAB6A P20340 0.53 1.72 2.79 17.37 0.81 2.83 NaN NaN 0.70 NaN NaN 0.74 0.86 0.23 0.53 0.15 0.67 NaN NaN NaN 0.15 0.82 NaN NaN NaN NaN
RAB6A Q6FGX3 0.75 1.60 NaN NaN 1.45 2.67 NaN NaN NaN NaN NaN NaN 1.54 0.33 0.24 0.32 NaN NaN NaN NaN 0.33 NaN NaN NaN NaN NaN
RAD1 O60671 NaN NaN NaN NaN 1.23 0.86 NaN NaN NaN NaN 1.20 0.79 NaN NaN NaN NaN 1.00 NaN NaN 0.26 1.55 0.65 0.36 3.77 NaN NaN
































































RAI14 Q9P0K7-2 NaN 3.57 1.03 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.19 NaN 0.49 NaN NaN NaN 0.19 NaN NaN NaN NaN
RALGAPA2 Q2PPJ7-3 0.67 NaN NaN 1.31 NaN NaN NaN NaN NaN NaN 0.88 NaN NaN NaN 1.34 0.14 NaN NaN NaN NaN NaN NaN 35.51 0.19 NaN NaN
RAVER1 E9PAU2 0.88 1.48 0.53 0.73 1.03 0.48 1.11 0.42 0.60 0.73 0.49 0.57 1.19 0.56 0.82 0.43 1.09 0.75 0.75 NaN 0.67 0.96 NaN NaN 1.29 0.50
RBBP4 Q09028-3 0.38 0.67 1.15 0.76 0.99 1.10 0.89 0.95 0.88 1.02 0.99 0.87 0.42 2.03 0.71 2.17 1.11 0.82 4.30 0.08 1.48 0.60 3.37 0.27 1.64 0.55
RBBP7 Q16576-2 0.34 0.69 1.16 0.78 0.92 1.01 0.95 0.95 0.98 0.89 1.03 0.87 0.40 2.26 0.64 1.61 0.77 1.00 12.27 0.03 0.87 0.95 3.85 0.17 1.66 0.56
RBBP7 Q6FHQ0 0.33 0.65 1.28 0.76 0.93 1.01 1.00 1.01 1.10 0.89 1.03 0.85 0.37 2.62 0.66 3.20 0.73 1.14 20.37 0.02 0.80 1.16 5.14 0.16 1.87 0.55
RBM4 A8K9U0 1.64 0.98 0.68 1.27 1.02 1.15 0.87 0.92 NaN 0.89 0.95 0.89 NaN 0.81 1.17 0.55 NaN 0.73 5.52 0.58 1.10 0.96 7.67 0.72 0.84 0.91
RBM7 J3KPD3 0.83 0.63 1.19 1.61 0.95 0.91 1.11 1.08 1.03 1.06 NaN 1.37 0.72 1.22 0.79 0.74 1.08 NaN NaN NaN 1.16 1.11 1.51 NaN NaN NaN
RBM7 Q6IRX3 0.57 0.55 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
RECQL P46063 0.48 0.81 0.33 0.54 0.79 0.68 0.60 NaN 0.51 0.57 0.56 0.43 0.25 1.24 0.62 2.59 0.38 0.81 1.45 0.59 1.11 0.26 1.50 1.15 0.55 0.34
RFX1 P22670 0.71 0.87 0.80 0.89 0.43 1.18 NaN NaN 0.62 NaN 0.90 0.84 0.84 0.59 0.70 0.08 0.45 1.89 11.12 0.14 1.54 0.50 2.16 0.55 NaN 0.53
RFXANK O14593 0.54 1.26 1.03 0.30 0.83 0.58 NaN NaN 0.34 1.10 0.58 0.55 0.25 1.55 0.27 0.43 0.57 0.56 20.68 0.05 1.34 0.26 1.58 0.59 NaN NaN
RIOK3 B4E1Q4 0.50 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.43 0.15 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
RMND1 Q5SZ82 1.11 NaN 4.02 NaN NaN NaN 0.90 NaN NaN 0.80 0.79 0.92 NaN NaN NaN NaN 0.70 0.90 0.92 NaN 0.71 NaN NaN NaN NaN NaN
RNF213 Q63HN8 0.78 0.42 0.72 0.98 NaN 0.17 NaN NaN NaN 0.45 0.74 0.57 1.13 0.42 0.54 0.23 1.28 0.27 NaN 0.32 NaN 0.79 NaN NaN 1.54 0.41
RNPS1 H3BV80 5.57 1.30 0.48 1.49 0.79 0.55 0.91 1.12 2.23 0.39 1.34 1.17 NaN 0.59 1.79 2.26 1.04 0.57 1.08 2.62 0.37 1.71 NaN NaN 0.48 0.54
RPL7L1 R4GMU7 NaN NaN 0.37 1.78 0.95 0.70 NaN NaN 1.72 NaN 0.98 0.62 NaN 0.88 0.86 0.35 1.00 0.50 0.85 0.72 0.60 1.07 1.09 0.66 0.67 1.03
RPLP2 P05387 1.30 1.51 NaN NaN 1.30 0.93 0.93 1.10 1.44 1.16 0.71 NaN NaN 1.01 1.12 0.39 1.02 1.08 1.06 37.48 1.08 1.50 0.66 0.43 NaN 0.72
RPRC1 D3DPS3 1.19 1.71 1.37 0.27 NaN 0.60 NaN NaN NaN 0.58 0.43 1.08 NaN NaN 1.43 1.00 NaN NaN 0.86 0.67 1.47 0.36 0.85 0.78 NaN NaN
RPRD1B Q9NQG5 0.69 0.54 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.80 0.81 0.66 NaN 1.03 NaN 1.58 1.04 1.12 NaN 1.90 1.04 NaN
RSF1 Q96T23-2 NaN 0.60 0.16 0.62 0.41 0.45 NaN 0.48 0.54 0.39 0.35 0.36 0.55 NaN 0.56 NaN 0.42 0.53 0.43 1.43 0.38 0.71 0.07 0.02 0.03 0.36
RSL1D1 O76021 0.64 2.86 0.17 2.10 0.58 0.75 0.57 NaN 1.12 0.40 0.75 0.45 0.70 0.62 2.07 0.60 0.57 0.53 1.15 NaN 0.53 0.60 1.68 0.66 0.26 0.88
RSRC2 Q7L4I2-2 0.60 0.80 2.06 0.22 0.66 0.56 1.47 0.58 0.50 0.35 NaN NaN NaN NaN 0.56 0.93 0.55 NaN 0.68 1.02 NaN 0.70 1.05 0.78 0.37 NaN
S100A11 P31949 NaN NaN NaN NaN NaN NaN 0.17 NaN NaN NaN NaN 0.70 NaN NaN NaN 0.39 NaN NaN NaN NaN NaN NaN 0.34 NaN NaN NaN
S100A14 Q9HCY8 NaN NaN NaN NaN NaN NaN 0.01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
SAP130 H7BXF5 0.55 1.15 1.26 1.26 0.77 2.28 1.47 1.31 1.72 1.35 1.24 1.10 0.60 2.95 0.40 NaN 1.01 1.19 4.46 0.29 0.88 1.47 0.76 4.12 1.49 0.63
SAP18 O00422 11.09 1.94 0.33 1.48 0.76 0.40 0.74 0.86 2.32 0.32 NaN NaN NaN NaN 3.14 2.03 1.17 0.50 NaN NaN 0.54 1.25 1.70 1.73 0.42 NaN
SAP30 O75446 0.71 0.79 1.47 1.38 0.83 3.28 1.73 1.41 1.63 1.92 1.62 1.22 0.64 2.90 0.54 0.82 1.29 1.60 10.80 0.19 1.23 1.77 0.81 4.83 3.45 0.87
SARS Q53HA4 NaN 0.24 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.50 NaN NaN NaN NaN NaN NaN NaN
SCML2 B4DZR9 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.14 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
SCML2 Q9UQR0 0.63 1.53 8.39 0.10 1.02 0.82 NaN NaN 0.96 0.81 0.73 1.13 0.65 0.72 4.14 0.42 2.39 0.26 7.89 0.16 1.43 0.45 16.71 0.03 0.22 2.16
SCYL2 Q6P3W7 1.60 1.60 0.63 0.71 1.04 0.60 0.89 0.26 0.88 1.32 0.62 NaN 1.10 0.65 1.01 0.14 1.16 0.88 NaN NaN 0.58 1.14 NaN NaN 1.91 0.63
SDHB Q0QEY7 NaN NaN NaN 0.50 0.43 0.43 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.25 NaN NaN NaN NaN NaN
SEMG1 P04279-2 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.09 NaN NaN
SEMG2 A8K6Z6 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.31 NaN NaN
SEPT10 E7EW69 NaN NaN NaN NaN 1.52 0.34 NaN NaN NaN NaN NaN NaN NaN 0.96 NaN NaN 1.62 1.89 NaN NaN 0.23 1.77 NaN NaN NaN NaN
SEPT2 Q15019 1.17 1.78 0.69 0.81 1.69 0.31 0.44 0.67 0.88 NaN 0.58 0.62 0.73 0.51 0.76 0.23 2.03 0.13 0.58 0.54 0.11 2.30 0.81 0.89 0.49 0.44
SEPT6 Q8NFH9 NaN NaN 0.65 1.18 1.89 0.35 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 2.33 0.23 NaN NaN 0.40 2.72 NaN NaN NaN NaN
SEPT7 Q16181 1.54 1.59 NaN NaN 1.67 0.30 NaN NaN NaN NaN 0.55 0.40 NaN 0.62 NaN NaN 2.08 0.11 0.61 NaN 0.14 2.00 NaN NaN NaN NaN
SEPT7 A8K3D0 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
SEPT8 B7ZVZ1 NaN NaN NaN NaN 1.72 0.34 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.32 NaN NaN 0.36 NaN NaN NaN NaN NaN
SEPT9 Q9UHD8 1.29 2.84 0.51 0.63 1.59 0.24 NaN NaN NaN NaN 0.59 0.63 0.97 0.26 0.91 0.26 1.56 0.12 NaN NaN 0.14 1.56 NaN NaN 0.57 1.00
SERPINB3 P29508 NaN NaN NaN NaN NaN NaN 0.20 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.30 NaN NaN NaN NaN 0.54 NaN NaN
SETX Q7Z333 0.72 0.83 1.13 0.99 1.27 0.47 0.14 1.02 1.01 1.13 1.19 1.14 1.00 0.74 0.71 0.06 0.89 0.94 0.04 NaN 0.58 0.63 NaN NaN 1.21 0.31
SF3A1 Q15459 2.02 1.00 0.32 2.80 1.58 0.46 0.68 1.07 1.71 0.58 0.98 1.20 1.96 0.61 1.20 1.05 1.82 0.49 0.68 1.49 0.35 2.11 NaN 0.88 0.57 1.22
SF3A3 B3KY12 1.43 1.01 0.33 2.09 1.32 0.43 0.55 1.05 1.63 0.60 0.65 0.85 1.01 0.80 1.18 1.90 1.58 0.41 0.77 0.93 0.31 2.03 0.97 0.87 0.30 1.13
SF3B1 O75533 1.53 1.09 0.26 2.11 1.54 0.37 0.51 1.00 1.53 0.43 0.86 1.05 2.12 0.66 1.25 1.22 1.50 0.38 1.29 1.49 0.32 1.81 1.06 1.12 0.27 1.08
SF3B2 E9PJ04 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.83 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
SF3B4 Q53FG6 1.34 0.70 0.47 NaN 1.17 0.47 0.77 NaN 1.81 0.55 1.00 1.31 1.95 0.82 1.24 2.04 1.54 0.49 1.13 1.05 0.30 1.92 1.08 0.87 0.47 1.12
SFN P31947 0.31 0.14 NaN NaN NaN 0.40 0.16 NaN NaN 0.27 NaN NaN NaN NaN 0.25 NaN 0.65 NaN NaN NaN NaN 0.40 0.13 NaN NaN NaN
SHCBP1 B2RDX0 NaN 1.95 NaN NaN 1.20 0.42 NaN NaN NaN NaN NaN NaN NaN NaN 1.15 NaN NaN 0.37 NaN NaN NaN NaN NaN NaN NaN NaN
SHKBP1 B2R6W9 NaN 2.05 2.61 247.82 NaN NaN NaN NaN 18.49 NaN 8.02 NaN 7.50 NaN NaN NaN NaN 14.85 10.88 NaN NaN 7.93 NaN 12.58 9.65 2.47
SHPRH Q149N8 0.54 0.39 0.55 1.15 1.13 0.80 NaN NaN 2.46 0.28 NaN NaN 0.99 0.71 0.04 2.02 1.25 0.51 0.78 1.63 0.31 1.80 NaN NaN 1.07 0.59
SIN3A Q96ST3 0.60 1.10 1.14 1.43 0.78 2.21 1.22 1.28 1.33 1.39 1.30 0.97 0.75 3.07 0.46 1.51 1.05 1.26 19.35 0.23 0.91 1.50 0.94 6.60 1.65 0.76
SIN3B O75182-2 0.45 NaN 1.51 1.25 1.10 1.37 0.91 1.02 1.68 0.85 1.62 1.18 0.76 3.14 0.56 0.70 1.02 1.40 6.63 NaN 2.23 0.78 1.75 NaN 2.19 0.36
SIRT6 Q8N6T7 NaN 0.36 0.85 0.33 6.34 0.07 NaN 0.57 NaN 0.38 0.52 0.45 1.42 0.25 2.87 0.22 2.54 0.14 2.56 0.16 1.44 0.29 0.87 0.71 0.67 0.38
SLC25A3 F8VVM2 NaN NaN NaN 7.09 NaN NaN NaN NaN NaN 0.27 0.37 NaN NaN NaN NaN NaN NaN NaN 70.06 NaN NaN 0.38 NaN NaN 0.55 NaN
SMARCA5 O60264 0.37 1.62 1.03 1.36 0.88 1.53 0.97 1.09 1.25 1.09 1.26 1.28 0.85 2.11 0.70 1.13 1.00 1.34 2.63 0.54 1.18 1.33 1.94 1.13 0.89 1.07
  
 



























































SMCHD1 A6NHR9 0.54 0.91 0.61 0.97 0.99 0.73 0.58 NaN 0.79 0.65 1.02 0.73 3.26 0.67 1.44 0.17 2.21 0.24 47.25 0.19 3.01 0.19 NaN 1.06 NaN NaN
SMCHD1 L0R6P7 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.78 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
SNC73 Q9UP60 NaN NaN NaN NaN 47.70 NaN 0.06 NaN NaN NaN 0.05 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.12
SNRPA1 P09661 1.80 0.90 0.39 2.21 1.43 0.47 0.65 1.06 1.57 0.58 0.90 0.99 1.68 0.56 1.10 0.99 1.57 0.43 0.94 1.41 0.38 1.79 1.17 1.01 0.44 1.17
SNRPB2 P08579 1.62 0.96 0.37 1.84 1.40 0.47 0.69 1.03 1.53 0.48 0.77 0.89 1.68 0.57 1.06 1.03 1.53 0.43 0.98 1.26 0.41 1.65 1.08 1.07 0.49 1.14
SNRPD3 B4DJP7 1.72 0.87 0.55 2.08 1.24 0.62 0.80 1.11 1.71 0.71 1.10 1.14 NaN 0.67 1.13 1.02 1.43 0.64 0.80 NaN 0.72 1.38 0.73 0.79 0.59 1.22
SP1 G5E9M8 0.84 NaN NaN 0.54 NaN 1.23 NaN NaN 0.30 1.72 0.83 0.61 NaN NaN 0.47 0.49 NaN 1.74 1.34 NaN 2.52 0.24 NaN NaN NaN NaN
SP3 Q8WWU3 0.70 NaN 0.79 0.55 0.79 1.58 0.96 1.01 0.45 1.88 0.94 0.81 NaN NaN 0.39 3.36 0.43 2.14 1.40 0.82 3.09 0.28 1.10 0.70 2.61 0.28
SPATA5L1 Q9BVQ7 1.54 1.33 1.50 NaN 0.89 0.60 NaN NaN 0.97 NaN 0.71 1.46 1.15 0.86 1.11 0.45 0.88 1.20 0.91 NaN 0.82 0.78 NaN NaN NaN NaN
SPIN1 Q9Y657 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 4.88 0.22 3.36 0.38 7.35 0.13 NaN NaN NaN NaN
SPIN2B Q5JZB8 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 7.57 NaN 12.49 0.13 9.55 0.12 NaN NaN NaN NaN
SPRR1A B7ZLF8 NaN NaN 0.04 NaN NaN NaN 0.06 NaN NaN 0.03 0.14 0.18 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
SPRR1B P22528 NaN NaN NaN NaN NaN NaN 0.05 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
SPTY2D1 Q68D10-2 1.07 1.61 0.58 0.62 0.53 1.01 0.49 1.21 1.18 0.77 0.71 0.91 2.42 NaN 1.21 0.62 0.55 0.89 0.65 0.69 0.76 0.52 0.86 0.47 0.67 1.30
SREK1 B3KRJ9 1.25 0.69 2.82 0.21 1.15 0.53 NaN NaN NaN NaN NaN NaN 2.27 0.79 0.96 0.83 1.22 0.54 NaN NaN 0.57 1.04 NaN NaN 0.45 0.70
SRRM1 A9Z1X7 7.44 3.28 0.27 0.72 0.35 0.21 0.34 0.48 0.72 0.15 0.45 0.39 NaN 0.27 1.64 1.39 0.37 0.22 0.78 1.27 0.34 0.42 NaN NaN 0.20 0.27
SRSF6 A8K588 7.33 1.79 0.52 2.00 0.92 0.75 0.97 1.25 2.36 0.31 1.51 1.23 2.06 1.16 1.53 1.63 1.32 0.59 1.63 1.50 0.77 1.38 NaN 0.96 0.33 0.63
SUDS3 Q9H7L9 0.60 0.77 1.45 1.34 0.72 3.05 1.47 1.43 1.51 1.69 1.52 1.10 0.58 3.30 0.41 3.57 1.19 1.47 9.63 0.24 1.11 1.76 0.71 3.53 2.46 1.07
SUPT3H O75486 0.64 0.52 1.02 0.55 0.45 0.97 0.84 NaN 0.58 0.99 0.82 0.77 1.55 0.41 0.44 0.45 0.47 1.02 NaN 0.09 1.53 0.38 0.58 2.32 1.71 0.40
SUZ12 Q15022 0.35 2.04 0.76 0.65 0.89 0.93 0.76 0.98 0.89 0.89 0.92 0.84 0.61 1.37 1.44 1.45 1.33 0.50 1.80 0.89 1.16 0.44 1.07 1.72 1.05 0.67
SV2A A8K6Q3 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.03 NaN NaN NaN
SV2A L8E840 NaN NaN NaN 0.96 NaN NaN NaN 0.83 NaN NaN NaN 1.01 NaN NaN NaN NaN 1.06 1.22 NaN NaN 0.85 NaN NaN NaN 0.83 0.84
SVIL O95425-2 NaN 4.06 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.08 0.62 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
SYAP1 B2RBI2 NaN 0.12 0.88 1.23 NaN 0.17 0.82 NaN NaN 0.78 NaN NaN NaN NaN NaN NaN 1.36 0.90 NaN NaN NaN 1.09 NaN NaN 1.30 0.55
SYDE1 B2RD93 1.00 NaN 2.41 NaN 3.42 0.36 NaN NaN NaN NaN 0.56 1.46 NaN NaN 0.68 0.13 1.17 0.62 1.37 0.75 0.80 1.05 NaN NaN NaN NaN
SYN1 P17600 NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.02 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.18 NaN NaN NaN
SYT1 J3KQA0 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.14 NaN NaN NaN
TADA1 Q96BN2 0.57 0.57 0.75 0.54 0.49 1.11 0.75 NaN 0.54 0.95 0.81 0.72 NaN NaN 0.55 0.30 0.51 0.97 5.32 0.17 1.31 0.40 0.77 1.95 0.33 NaN
TADA2B Q86TJ2 NaN NaN 0.96 0.53 0.49 1.02 0.12 NaN 0.59 0.86 0.94 0.72 0.29 2.07 NaN NaN 0.44 0.96 0.12 0.12 1.39 0.38 NaN 1.07 0.16 NaN
TADA3 O75528 NaN 0.30 1.76 0.83 1.15 1.15 1.20 0.99 0.89 1.45 1.10 0.94 NaN NaN 0.29 1.42 0.94 1.13 1.85 0.76 1.40 0.79 1.22 1.29 1.57 0.92
TAF1 P21675-6 NaN NaN 0.53 0.62 0.51 NaN 0.71 NaN 0.48 0.83 0.67 0.79 NaN NaN 0.18 NaN 0.29 1.34 4.80 0.28 1.47 0.32 NaN NaN NaN NaN
TAF11 Q15544 NaN NaN NaN NaN 0.71 NaN 0.41 1.26 0.61 0.94 0.74 1.04 NaN NaN NaN NaN 0.36 0.52 NaN NaN 1.76 0.42 NaN 0.80 NaN NaN
TAF1A Q15573 NaN NaN 0.46 NaN 0.27 0.96 0.60 0.70 0.42 0.94 0.78 0.67 NaN NaN NaN NaN 0.22 1.33 7.79 0.15 1.02 0.48 0.41 1.36 NaN NaN
TAF1B Q53T94 NaN NaN NaN 1.00 0.84 NaN 0.53 0.78 NaN NaN 0.99 0.75 NaN NaN NaN NaN 0.29 NaN NaN 0.22 NaN 0.40 0.48 NaN NaN 0.98
TAF1D Q9H5J8 NaN NaN 1.91 0.73 NaN NaN 0.72 0.67 0.35 1.03 0.83 0.75 NaN NaN 0.52 NaN 3.21 1.75 9.84 0.22 0.95 0.51 0.51 2.33 NaN NaN
TAF5 Q15542 0.24 1.04 0.44 0.75 0.63 1.10 0.36 0.91 0.49 0.98 0.77 0.87 NaN 2.06 0.15 1.30 0.31 1.40 2.51 0.15 1.50 0.37 1.34 2.18 NaN NaN
TAF6 J3KR72 0.33 0.90 0.41 0.67 0.63 0.83 0.30 0.88 0.45 0.79 0.58 0.88 0.35 1.13 0.14 3.94 0.32 1.43 2.56 0.45 1.33 0.31 NaN 2.36 NaN 0.50
TALDO1 P37837 NaN 0.08 NaN NaN 1.18 NaN NaN NaN NaN 0.37 NaN NaN NaN NaN NaN NaN 1.82 0.67 0.55 NaN NaN NaN NaN NaN NaN NaN
TARS Q53GX7 0.46 2.76 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.54 0.42 1.07 NaN NaN NaN NaN NaN NaN NaN NaN NaN
TBRG1 Q3YBR2 NaN NaN 2.66 0.70 0.86 2.03 3.27 NaN 1.06 2.91 1.70 1.24 0.34 4.99 NaN 1.32 0.49 2.50 6.11 0.10 2.92 0.64 NaN 1.46 NaN NaN
TCHH Q07283 NaN NaN NaN NaN 2.83 0.54 NaN NaN NaN NaN NaN 0.78 NaN NaN NaN 0.86 3.06 0.20 NaN NaN 1.80 0.34 NaN NaN 0.15 NaN
TCOF1 E7ETY2 NaN NaN NaN NaN 0.74 1.46 2.08 1.40 0.67 1.54 2.41 0.62 NaN NaN NaN NaN 0.43 1.06 NaN NaN 1.73 0.52 NaN NaN NaN NaN
TCOF1 E9PHK9 0.94 1.11 0.68 0.93 0.67 0.91 1.34 1.04 0.62 1.36 1.73 0.66 0.32 0.94 0.51 3.86 0.40 0.85 2.11 0.63 1.41 0.47 0.84 1.00 0.80 0.42
TCOF1 Q13428-3 NaN NaN 0.62 0.79 0.70 0.98 1.18 0.90 0.58 1.07 1.51 0.62 NaN NaN NaN 5.82 0.33 0.79 NaN NaN 2.02 0.47 NaN NaN 1.08 0.25
TF Q53H26 NaN NaN NaN NaN NaN NaN 0.11 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
TFAP4 Q6FHM5 0.99 0.42 2.57 1.24 1.09 3.69 1.73 1.59 1.26 2.30 1.93 1.79 NaN NaN 0.08 3.25 0.84 3.84 26.96 0.06 3.54 1.12 2.42 3.00 1.64 NaN
TFPT G5E9B5 0.65 0.36 2.24 0.60 0.64 1.64 1.41 0.91 0.61 2.70 1.34 1.23 0.19 5.94 0.29 1.41 0.50 2.37 NaN 0.06 3.41 0.52 0.99 2.26 4.32 0.42
TGM1 B0AZN7 NaN NaN NaN NaN NaN NaN 0.02 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
TGM3 Q08188 NaN NaN 0.23 NaN NaN NaN 0.18 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.08 NaN NaN NaN NaN NaN NaN NaN
TIAL1 Q01085-2 1.75 1.20 1.07 1.49 1.11 0.98 NaN NaN NaN NaN 1.41 1.34 1.37 1.06 1.37 0.49 NaN 2.35 NaN 1.72 1.15 1.11 NaN NaN 1.03 1.29
TIAL1 Q2TSD2 NaN 1.01 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.14 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
TIMP2 P16035 NaN 2.25 1.29 1.13 NaN 1.65 1.49 1.35 NaN 1.83 1.32 1.39 0.96 NaN NaN NaN 1.19 1.67 NaN NaN NaN 1.58 NaN NaN NaN NaN
TINF2 B4DFJ1 NaN NaN 1.16 1.30 1.16 2.40 NaN NaN NaN 2.61 NaN 1.55 NaN NaN NaN NaN 0.62 2.35 2.44 1.02 1.66 1.50 1.60 2.38 NaN NaN
TKT P29401 0.16 0.10 2.42 NaN NaN 0.44 0.22 1.70 1.37 0.30 NaN NaN NaN NaN 0.23 0.54 0.89 0.63 0.19 2.15 0.62 NaN 0.85 NaN NaN NaN
TMPO P42166 1.71 0.14 0.59 0.24 0.92 0.46 0.61 0.16 0.37 0.73 0.42 0.27 NaN NaN 0.33 2.10 0.42 0.45 0.05 0.89 0.74 0.24 0.08 0.41 0.14 0.52
TOB1 Q2TU63 0.20 NaN NaN NaN NaN 0.75 NaN NaN NaN NaN NaN NaN NaN NaN 0.22 0.08 0.33 NaN NaN NaN NaN NaN NaN NaN NaN NaN
TOPBP1 Q92547 1.66 NaN NaN NaN 2.82 0.59 NaN NaN NaN NaN 2.19 0.47 NaN NaN 0.99 0.15 1.62 NaN 4.50 0.47 2.33 0.35 NaN NaN NaN NaN
































































TPT1 Q5W0H4 NaN 0.16 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.33 NaN NaN NaN 0.83 NaN NaN NaN
TTI1 O43156 1.08 0.75 0.48 0.62 0.87 0.50 1.27 0.46 0.60 0.79 0.67 NaN 0.89 0.82 0.96 0.22 1.26 0.74 1.89 0.32 0.68 1.06 NaN NaN 1.38 0.52
TWF2 D6RG15 NaN 3.42 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
TXLNA P40222 NaN NaN NaN NaN 5.37 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
TXLNG Q9NUQ3 NaN 0.20 NaN NaN 4.14 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
TYMS Q53Y97 0.98 1.14 1.27 1.33 1.11 0.91 NaN NaN NaN NaN NaN 2.08 0.97 0.62 0.77 0.15 NaN 1.20 NaN NaN 0.99 1.29 NaN NaN NaN NaN
UBA5 Q9GZZ9 0.72 0.88 0.60 0.83 1.15 0.75 1.60 0.51 0.62 0.83 0.50 0.51 1.07 0.74 0.69 0.37 1.45 1.02 NaN NaN 0.56 1.31 NaN NaN 1.97 0.60
UBE2D2 P62837 NaN NaN NaN NaN 1.04 0.60 0.23 NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.14 0.45 11.11 0.03 NaN NaN 9.02 0.16 NaN NaN
UBL4A P11441 2.03 0.41 NaN NaN 1.01 0.45 1.24 NaN 1.44 0.67 0.63 NaN 1.91 0.67 1.08 0.14 1.03 0.54 NaN NaN 0.64 1.01 NaN NaN 1.73 0.50
UBTF E9PKP7 0.75 0.75 0.87 1.20 1.22 1.09 0.92 1.43 1.36 1.24 0.73 2.26 NaN NaN 1.44 0.76 1.41 0.80 0.14 4.57 0.45 2.45 NaN NaN NaN NaN
UBTF P17480 0.91 0.87 0.72 1.13 1.14 1.09 0.95 1.23 1.21 1.03 0.86 1.62 1.04 1.17 1.57 1.36 1.22 0.73 0.23 4.10 0.50 2.12 1.36 0.79 0.46 1.97
UCHL5 Q9Y5K5 NaN NaN NaN NaN NaN NaN NaN NaN 0.78 2.69 1.50 1.34 NaN NaN NaN NaN NaN NaN 4.50 NaN 1.96 0.83 NaN NaN NaN NaN
UCHL5 Q9Y5K5-2 0.81 0.39 2.42 0.62 0.75 1.69 1.49 0.86 0.67 2.69 1.43 1.29 0.47 3.50 0.34 1.84 0.54 2.42 9.85 0.11 2.90 0.57 1.31 2.61 4.16 0.32
UHRF1 Q96T88 0.19 6.56 0.85 0.97 1.41 1.03 0.68 1.07 1.51 0.69 1.75 0.69 3.45 0.34 16.08 0.06 3.72 0.26 8.81 0.01 4.06 0.25 31.17 0.02 1.21 1.00
UHRF2 Q96PU4 NaN NaN NaN NaN 3.81 NaN NaN NaN NaN NaN NaN NaN NaN NaN 10.59 NaN 16.02 0.16 8.83 0.14 10.44 0.19 5.97 0.06 NaN NaN
UIMC1 F8VQY2 NaN 0.27 NaN 1.96 0.59 1.10 NaN NaN 1.08 0.40 0.83 0.57 NaN NaN NaN NaN 0.92 0.68 0.38 0.40 0.29 NaN 0.52 0.45 NaN NaN
USF1 B1AQP1 1.03 1.35 1.98 0.83 1.22 1.48 1.68 1.11 1.13 1.73 1.17 1.34 0.59 2.54 0.95 6.52 1.20 1.30 5.16 0.33 1.23 1.29 0.43 6.11 3.28 0.62
USF2 Q15853 0.82 1.56 2.21 0.83 1.32 1.61 1.68 1.21 1.25 1.72 1.31 1.39 0.57 2.84 0.81 4.45 1.19 1.35 5.42 0.20 1.34 1.34 0.39 4.76 3.67 0.57
USF2 Q15853-3 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.28 1.10 NaN NaN NaN NaN NaN
USP1 B2R636 0.40 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.07 0.59 NaN 0.28 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
USP3 Q9Y6I4 0.64 0.89 2.69 0.64 6.14 0.19 NaN NaN NaN NaN NaN NaN NaN 0.59 0.86 0.86 6.00 0.11 0.11 3.69 0.33 2.71 NaN NaN 1.21 0.54
USP7 Q93009 0.29 1.82 2.62 0.23 1.97 0.65 0.61 1.12 0.89 0.85 1.02 1.13 1.70 0.72 3.42 0.25 3.36 0.20 30.30 0.01 2.30 0.45 20.45 0.06 0.33 1.88
VRK3 Q8IV63 NaN 0.22 NaN 1.47 NaN NaN 1.08 0.64 0.46 1.33 NaN 1.09 NaN NaN 0.49 NaN 0.63 1.07 0.52 1.08 0.95 0.70 0.59 0.97 0.49 NaN
VWA9 B4DJL6 0.91 0.48 0.66 0.86 0.74 0.77 0.61 NaN 0.73 0.64 0.90 0.79 1.03 1.47 0.49 0.64 0.57 0.88 4.74 0.24 0.89 0.54 1.06 0.89 NaN 0.35
WARS P23381 NaN 0.11 NaN NaN NaN NaN NaN NaN NaN NaN NaN 2.37 NaN NaN 0.38 NaN NaN NaN 0.35 NaN NaN NaN NaN NaN NaN NaN
WDR5 P61964 0.28 2.13 1.47 1.11 1.25 1.37 1.83 0.98 1.60 1.23 1.50 1.19 0.62 2.71 0.58 1.12 1.43 1.11 1.14 1.14 1.48 1.37 1.69 1.79 1.59 1.00
WDR5B Q86VZ2 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 2.06 0.45 NaN NaN NaN NaN NaN NaN NaN 0.32 1.65 NaN NaN NaN NaN NaN
WDR77 Q9BQA1 1.47 0.98 1.19 0.77 0.77 1.30 NaN 0.72 0.70 1.25 1.08 0.90 2.50 0.45 1.43 0.64 0.44 1.74 1.77 0.67 1.04 0.72 1.33 1.58 NaN NaN
WHSC1 O96028 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.49 NaN NaN NaN NaN NaN NaN NaN NaN 0.75 NaN NaN NaN NaN NaN
WHSC1 O96028-3 0.41 0.86 0.38 0.53 0.44 0.58 0.66 0.55 0.82 0.32 0.54 0.40 0.38 0.50 NaN NaN 0.48 0.48 3.80 0.23 0.54 0.40 3.54 0.36 0.43 0.35
WHSC1 O96028-5 NaN NaN NaN NaN 0.55 0.98 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.40 0.42 NaN NaN 0.47 0.37 NaN 0.53 NaN NaN
WHSC1 Q05CW4 NaN NaN NaN NaN NaN 0.96 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
WHSC1L1 Q9BZ95-4 0.62 0.68 0.71 1.05 1.02 1.10 0.89 1.23 1.17 1.04 1.09 0.89 NaN NaN NaN 0.18 2.09 0.33 17.75 0.19 2.46 0.32 3.75 0.70 1.64 0.68
WIZ B7ZM82 0.71 0.76 0.86 0.84 0.57 1.30 0.71 0.90 0.76 1.02 0.96 0.82 1.52 0.70 0.83 0.32 0.34 1.57 6.27 0.17 0.97 0.68 1.35 1.21 1.74 0.26
WIZ B9EGQ5 NaN NaN NaN NaN NaN 1.17 NaN NaN NaN NaN 1.16 0.82 NaN NaN NaN NaN NaN NaN NaN NaN 0.92 0.74 NaN NaN NaN NaN
WIZ O95785 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 1.30 NaN NaN NaN NaN
XPO1 O14980 1.14 1.38 0.77 1.03 1.33 0.63 1.49 0.47 0.69 0.90 0.55 0.78 1.27 0.68 0.92 0.12 1.74 0.88 1.22 0.42 0.62 1.50 NaN 1.09 2.17 0.58
XPO5 A8K5Y7 1.09 0.82 0.93 1.08 0.70 0.42 1.17 0.63 0.76 1.04 0.48 1.03 0.93 1.08 0.97 0.50 1.31 1.02 0.93 0.40 0.68 1.33 0.77 NaN 1.72 0.54
YKT6 Q9UES0 0.77 0.89 0.75 1.08 0.57 0.45 1.06 0.67 0.58 0.72 0.39 1.10 0.57 0.50 0.59 0.48 1.10 1.63 NaN NaN 0.35 1.08 NaN NaN 1.60 0.55
YOD1 Q5VVQ6-2 NaN NaN NaN NaN NaN NaN 0.11 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ZBED1 O96006 1.27 3.28 NaN NaN 0.43 0.43 NaN NaN NaN NaN 0.54 NaN NaN NaN 1.12 0.11 0.44 0.35 NaN NaN 0.25 NaN NaN NaN NaN NaN
ZBED6 P86452 NaN 0.26 0.40 NaN 0.66 1.07 0.46 NaN 0.82 0.56 0.88 0.58 0.46 NaN NaN NaN 0.31 1.08 NaN NaN 0.84 0.49 NaN NaN 1.27 0.38
ZBTB1 Q9Y2K1 0.44 1.23 0.68 0.53 0.41 1.29 0.44 NaN 0.40 0.81 0.69 0.81 0.35 1.92 0.33 1.85 0.29 1.02 1.90 0.31 0.76 0.52 0.17 4.31 2.38 0.29
ZBTB12 Q9Y330 0.31 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.44 0.19 NaN 0.24 11.40 0.07 NaN NaN 6.37 0.09 NaN NaN
ZBTB14 O43829 0.51 0.91 1.64 0.65 1.12 1.03 0.96 0.66 0.83 1.24 1.00 0.80 0.32 3.20 0.33 2.99 0.88 0.78 5.38 0.18 1.05 0.66 0.31 6.27 0.86 0.50
ZBTB33 Q86T24 0.79 0.78 NaN 1.01 NaN NaN NaN NaN NaN NaN 0.63 NaN 0.94 0.82 0.52 0.17 1.69 1.06 11.67 0.19 0.94 NaN 24.10 0.07 NaN NaN
ZBTB39 O15060 NaN NaN 1.47 1.00 0.74 2.78 1.15 1.01 1.15 1.87 1.07 1.41 NaN NaN NaN NaN 0.70 3.91 NaN NaN 1.29 1.36 NaN NaN 1.53 0.89
ZBTB4 Q9P1Z0 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 3.19 0.20 NaN NaN 3.21 0.25 NaN NaN
ZBTB43 O43298 NaN 1.50 1.34 0.62 2.07 1.33 NaN NaN NaN NaN 2.29 0.90 NaN NaN 0.09 5.84 0.95 1.63 11.00 0.16 2.30 1.00 1.07 1.06 NaN NaN
ZBTB44 H7BY22 NaN NaN NaN NaN 0.68 1.68 NaN NaN NaN NaN 0.65 0.63 NaN NaN NaN NaN 0.47 2.05 2.55 0.51 1.15 0.66 1.46 0.71 NaN NaN
ZC2HC1A Q96GY0 0.50 0.49 0.24 1.71 0.49 0.90 NaN NaN 1.23 0.33 0.91 0.48 0.25 0.87 0.38 NaN 0.48 0.71 2.82 NaN 0.74 0.53 NaN NaN 0.89 0.37
ZC3H11A B4DLG2 4.78 0.76 0.43 NaN 1.25 0.54 0.64 NaN 1.99 0.35 1.32 0.98 1.34 0.80 0.51 0.23 1.27 0.50 NaN NaN 0.62 1.07 NaN NaN 0.55 0.51
ZC3H14 B4DXU8 11.51 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ZC3H14 G3V4R5 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN
ZC3H14 Q6PJT7-5 6.20 1.01 0.29 1.35 0.74 0.49 NaN NaN 1.55 0.29 0.62 0.74 NaN 0.98 1.61 0.65 0.94 0.42 0.76 NaN 0.51 0.97 NaN NaN 0.43 0.44
ZC3HAV1 A8K9U6 1.23 1.45 0.96 NaN 0.78 0.61 NaN NaN NaN 0.50 0.82 0.96 NaN NaN 1.16 1.09 1.59 0.28 NaN NaN 1.03 0.49 NaN NaN NaN NaN
ZCCHC10 B3KVL5 NaN NaN NaN NaN NaN NaN NaN NaN 2.96 NaN NaN NaN NaN NaN 1.37 NaN NaN NaN 0.42 1.42 NaN NaN 0.75 0.78 NaN 2.93
































































ZHX1 Q9UKY1 0.35 0.71 0.74 0.48 2.25 0.23 NaN NaN 0.46 0.62 0.49 0.52 NaN NaN 0.29 NaN 1.85 0.18 41.17 0.11 0.47 0.64 24.81 0.12 NaN NaN
ZHX2 Q9Y6X8 0.42 0.57 NaN NaN NaN NaN NaN NaN NaN NaN 0.48 NaN NaN NaN 0.25 0.56 0.42 0.71 33.67 0.12 0.96 0.34 26.09 0.09 NaN NaN
ZHX3 A8K8Q0 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 19.41 0.14 NaN 0.39 17.43 0.15 NaN NaN
ZKSCAN3 Q9BRR0 0.52 0.46 0.53 0.92 0.62 0.85 0.67 NaN 0.60 0.69 0.68 0.53 0.53 0.88 0.53 NaN 0.55 0.73 4.22 0.50 0.59 0.59 0.84 0.83 NaN 0.50
ZMYM1 Q5SVZ6 0.88 1.22 1.07 NaN 0.62 2.22 1.05 1.55 0.57 2.61 1.30 1.96 NaN 1.79 0.50 0.31 0.30 3.05 6.90 3.06 2.12 0.88 1.18 8.86 NaN NaN
ZMYM2 Q9UBW7 0.76 0.63 NaN NaN 0.99 NaN NaN NaN 0.63 0.69 0.70 0.57 NaN NaN 0.53 0.19 1.64 0.30 26.45 0.16 2.82 0.24 0.90 NaN NaN NaN
ZMYND8 Q9ULU4-11 NaN 0.88 0.33 0.51 0.74 0.58 NaN NaN 0.61 0.43 0.72 0.58 0.47 2.29 0.46 NaN 0.49 0.90 15.95 0.26 1.15 0.38 10.81 0.90 NaN NaN
ZMYND8 Q9ULU4-9 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 7.83 NaN NaN NaN
ZNF131 P52739 0.44 1.21 1.17 0.70 1.12 1.07 0.96 0.92 0.84 1.02 0.97 1.02 0.58 1.36 0.48 3.26 1.03 0.81 1.63 0.85 0.92 0.85 0.59 2.17 0.91 0.74
ZNF148 Q9UQR1 1.40 0.65 1.36 0.81 0.57 2.07 0.98 1.11 1.04 1.41 1.17 1.17 0.32 4.18 0.25 3.30 0.42 2.43 20.20 0.18 1.77 0.73 1.68 0.81 2.40 0.35
ZNF280D A8K124 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.72 2.82 0.45 8.04 0.19 2.19 0.15 NaN NaN NaN NaN
ZNF282 Q86YG2 NaN NaN 1.77 0.77 NaN NaN NaN NaN 0.69 2.37 1.12 1.14 NaN NaN NaN NaN 0.44 3.37 NaN NaN 2.22 0.66 NaN NaN NaN NaN
ZNF354A Q86Y64 NaN NaN 0.43 NaN 0.54 0.92 NaN NaN NaN NaN 0.71 0.62 0.41 0.88 NaN NaN 0.48 0.64 NaN NaN 0.74 0.56 NaN NaN NaN NaN
ZNF444 Q53F81 1.06 0.29 0.81 1.16 0.60 2.13 1.09 0.95 0.82 0.92 0.98 0.83 0.59 1.41 0.41 0.69 0.38 1.79 2.50 0.39 1.10 0.67 1.24 0.93 NaN NaN
ZNF451 Q4KMR5 1.51 0.13 NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN NaN 0.45 NaN NaN NaN 0.29 0.41 NaN NaN NaN NaN
ZNF580 Q9UK33 NaN NaN 2.87 0.63 1.17 1.34 1.37 NaN 0.96 1.29 1.18 1.13 NaN NaN NaN 0.18 2.17 0.68 5.07 0.15 3.22 0.55 1.86 2.04 NaN 0.52
ZNF598 Q86UK7-2 1.10 1.44 NaN NaN 3.62 NaN NaN NaN NaN NaN NaN NaN NaN 1.24 0.55 0.12 NaN 1.19 1.03 0.65 NaN NaN 1.00 NaN NaN NaN
ZNF629 Q9UEG4 0.50 0.46 NaN NaN NaN NaN 0.37 NaN 0.44 NaN 0.88 0.41 NaN 0.99 0.31 NaN 1.16 0.33 2.98 0.17 4.22 0.24 NaN NaN NaN NaN
ZNF644 Q9H582 0.41 0.47 1.92 1.27 1.12 2.01 1.28 1.38 1.35 1.86 1.68 1.43 2.46 1.46 0.55 0.20 0.65 2.98 13.72 0.16 1.65 1.29 2.56 1.72 1.87 0.58
ZNF687 Q8N1G0 NaN NaN 0.51 0.48 0.59 0.68 NaN NaN 0.43 0.64 0.66 0.49 0.60 NaN 0.55 0.72 0.39 0.75 46.11 0.23 0.86 0.36 11.67 0.86 NaN NaN
ZNF770 A8K5X3 NaN NaN NaN NaN NaN NaN NaN NaN 0.42 NaN 0.40 0.43 NaN NaN NaN NaN NaN NaN 0.51 0.57 NaN NaN NaN NaN NaN NaN
ZRANB2 O95218-2 1.16 1.14 4.46 0.13 NaN NaN 0.71 0.69 0.64 0.51 NaN NaN NaN NaN 1.12 2.62 1.18 0.64 0.69 1.20 0.50 0.71 NaN 0.88 0.47 0.65
ZSCAN20 P17040-3 NaN 1.13 1.05 0.71 0.80 1.08 NaN NaN NaN 1.26 1.06 1.06 NaN NaN 0.29 NaN 1.00 1.08 6.98 0.17 1.26 0.84 0.44 2.04 15.72 NaN
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